+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 58975

Chapter 58975 contains a list of PDF Full Texts available from EurekaMag.





Novellasdemunt, L.; Antas, P.; Li, V.S.W., 2016:
Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms

Vilchez, V.; Turcios, L.; Marti, F.; Gedaly, R., 2017:
Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment

Madan, B.; Virshup, D.M., 2016:
Targeting Wnts at the source--new mechanisms, new biomarkers, new drugs

Chen, W.; Zhou, J.; Wu, K.; Huang, J.; Ding, Y.; Yun, E-Jin.; Wang, B.; Ding, C.; Hernandez, E.; Santoyo, J.; Chen, H.; Lin, H.; Sagalowsky, A.; He, D.; Zhou, J.; Hsieh, J-Tsong., 2016:
Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analogues

Wang, G.; Lu, X.; Dey, P.; Deng, P.; Wu, C.Chin.; Jiang, S.; Fang, Z.; Zhao, K.; Konaparthi, R.; Hua, S.; Zhang, J.; Li-Ning-Tapia, E.M.; Kapoor, A.; Wu, C-Jiun.; Patel, N.Bhaskar.; Guo, Z.; Ramamoorthy, V.; Tieu, T.N.; Heffernan, T.; Zhao, D.; Shang, X.; Khadka, S.; Hou, P.; Hu, B.; Jin, E-Jung.; Yao, W.; Pan, X.; Ding, Z.; Shi, Y.; Li, L.; Chang, Q.; Troncoso, P.; Logothetis, C.J.; McArthur, M.J.; Chin, L.; Wang, Y.Alan.; DePinho, R.A., 2016:
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression

Ji, W-Ping.; Dong, Y., 2016:
Targeting Yes-associated Protein with Evolved Peptide Aptamers to Disrupt TGF-β Signaling Pathway: Therapeutic Implication for Bone Tumor

Buell, J.M., 2016:
Targeting Zero Harm. Sharing Best Practices and Engaging the Care Team

Nilton, A.; Sayin, V.I.; Zou, Z.V.; Sayin, S.I.; Bondjers, C.; Gul, N.; Agren, P.; Fogelstrand, P.; Nilsson, O.; Bergo, M.O.; Lindahl, P., 2016:
Targeting Zfp148 activates p53 and reduces tumor initiation in the gut

Simon, N.; Antignani, A.; Sarnovsky, R.; Hewitt, S.M.; FitzGerald, D., 2017:
Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer

Mendell, J.T., 2016:
Targeting a Long Noncoding RNA in Breast Cancer

McLawhorn, A.S.; Sculco, P.K.; Weeks, K.Durham.; Nam, D.; Mayman, D.J., 2016:
Targeting a New Safe Zone: A Step in the Development of Patient-Specific Component Positioning for Total Hip Arthroplasty

Heideman, M.R.; Frei, A.; Hynes, N.E., 2016:
Targeting a Novel ER/HOXB7 Signaling Loop in Tamoxifen-Resistant Breast Cancer

Salim, N.N.; Ganaie, S.S.; Roy, A.; Jeeva, S.; Mir, M.A., 2016:
Targeting a Novel RNA-Protein Interaction for Therapeutic Intervention of Hantavirus Disease

Lerner, R.G.; Grossauer, S.; Kadkhodaei, B.; Meyers, I.; Sidorov, M.; Koeck, K.; Hashizume, R.; Ozawa, T.; Phillips, J.J.; Berger, M.S.; Nicolaides, T.; James, C.David.; Petritsch, C.K., 2016:
Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells

Dzierlenga, M.W.; Schwartz, S.D., 2018:
Targeting a Rate-Promoting Vibration with an Allosteric Mediator in Lactate Dehydrogenase

Karnthaler-Benbakka, C.; Groza, D.; Koblmüller, B.; Terenzi, A.; Holste, K.; Haider, M.; Baier, D.; Berger, W.; Heffeter, P.; Kowol, C.R.; Keppler, B.K., 2016:
Targeting a Targeted Drug: An Approach Toward Hypoxia-Activatable Tyrosine Kinase Inhibitor Prodrugs

Muellner, M.K.; Mair, B.; Ibrahim, Y.; Kerzendorfer, C.; Lechtermann, H.; Trefzer, C.; Klepsch, F.; Müller, Aé.C.; Leitner, E.; Macho-Maschler, S.; Superti-Furga, G.; Bennett, K.L.; Baselga, Jé.; Rix, U.; Kubicek, S.; Colinge, J.; Serra, V.; Nijman, S.M.B., 2016:
Targeting a cell state common to triple-negative breast cancers

Gema, L.Ramírez-Salinas.; Tolentino-Lopez, L.E.; Martínez-Ramos, F.; Padilla-Martínez, I.; García-Machorro, J.; Correa-Basurto, J., 2015:
Targeting a cluster of arginine residues of neuraminidase to avoid oseltamivir resistance in influenza A (H1N1): a theoretical study

Chio, C.M.; Lim, C.S.; Bishop, A.C., 2015:
Targeting a cryptic allosteric site for selective inhibition of the oncogenic protein tyrosine phosphatase Shp2

Jennings, L.A.; Reuben, D.B.; Kim, S-Bou.; Keeler, E.; Roth, C.P.; Zingmond, D.S.; Wenger, N.S.; Ganz, D.A., 2017:
Targeting a high-risk group for fall prevention: strategies for health plans

Vercauteren, K.; Brown, R.J.P.; Mesalam, A.Atef.; Doerrbecker, J.; Bhuju, S.; Geffers, R.; Van Den Eede, N.; McClure, C.Patrick.; Troise, F.; Verhoye, L.; Baumert, T.; Farhoudi, A.; Cortese, R.; Ball, J.K.; Leroux-Roels, G.; Pietschmann, T.; Nicosia, A.; Meuleman, P., 2015:
Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice

Aoyama, Y.; Murata, H.; Aihara, M., 2015:
Targeting a low-teen intraocular pressure by trabeculectomy with a fornix-based conjunctival flap: continuous Japanese case series by a single surgeon

Leanza, L.; Venturini, E.; Kadow, S.; Carpinteiro, A.; Gulbins, E.; Becker, K.Anne., 2016:
Targeting a mitochondrial potassium channel to fight cancer

Engelholm, L.H.; Melander, M.C.; Hald, A.; Persson, M.; Madsen, D.H.; Jürgensen, H.J.; Johansson, K.; Nielsen, C.; Nørregaard, K.S.; Ingvarsen, S.Z.; Kjaer, A.; Trovik, C.S.; Laerum, O.D.; Bugge, T.H.; Eide, J.; Behrendt, N., 2016:
Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180

Li, M.; Zhou, R.; Shan, Y.; Li, L.; Wang, L.; Liu, G., 2016:
Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis

Sekiguchi, T.; Takemoto, A.; Takagi, S.; Takatori, K.; Sato, S.; Takami, M.; Fujita, N., 2016:
Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis

Qiu, Y-Qi.; Yang, C-Wei.; Lee, Y-Zhi.; Yang, R-Bing.; Lee, C-Hao.; Hsu, H-Yu.; Chang, C-Chung.; Lee, S-Ju., 2015:
Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget

Benchikh ElFegoun, M.C.; Kohil, K.; L'Ollivier, C.; Lleu, M.; Babelhadj, B.; Piarroux, M.; Gharbi, M.; Piarroux, R., 2017:
Targeting abattoirs to control cystic echinococcosis in Algeria

Kleszcz, R.; Paluszczak, Jław.; Baer-Dubowska, W., 2016:
Targeting aberrant cancer metabolism - The role of sirtuins

Pal, D.; Kolluru, V.; Chandrasekaran, B.; Baby, B.V.; Aman, M.; Suman, S.; Sirimulla, S.; Sanders, M.Ann.; Alatassi, H.; Ankem, M.K.; Damodaran, C., 2016:
Targeting aberrant expression of Notch-1 in ALDH + cancer stem cells in breast cancer

Cubillos-Ruiz, J.R.; Glimcher, L.H., 2016:
Targeting abnormal ER stress responses in tumors: A new approach to cancer immunotherapy

Pang, J.; Wang, J.; Zhang, Y.; Xu, F.; Chen, Y., 2016:
Targeting acetaldehyde dehydrogenase 2 (ALDH2) in heart failure-Recent insights and perspectives

Roh, J-Lyel.; Park, J.Young.; Kim, E.Hye.; Jang, H.Jin., 2016 :
Targeting acid ceramidase sensitises head and neck cancer to cisplatin

Klevstig, M.; Ståhlman, M.; Lundqvist, A.; Scharin Täng, M.; Fogelstrand, P.; Adiels, M.; Andersson, L.; Kolesnick, R.; Jeppsson, A.; Borén, J.; Levin, M.C., 2017:
Targeting acid sphingomyelinase reduces cardiac ceramide accumulation in the post-ischemic heart

Jacobi, J.; García-Barros, Mónica.; Rao, S.; Rotolo, J.A.; Thompson, C.; Mizrachi, A.; Feldman, R.; Manova, K.; Bielawska, A.; Bielawska, J.; Fuks, Z.; Kolesnick, R.; Haimovitz-Friedman, A., 2016:
Targeting acid sphingomyelinase with anti-angiogenic chemotherapy

Deacon, J.C.; Engelman, D.M.; Barrera, F.N., 2015:
Targeting acidity in diseased tissues: mechanism and applications of the membrane-inserting peptide, pHLIP

Li, D.; He, L.; Guo, H.; Chen, H.; Shan, H., 2015:
Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging

Johnson, L.L., 2016:
Targeting activated macrophages to identify the vulnerable atherosclerotic plaque

Tiffen, J.C.; Gunatilake, D.; Gallagher, S.J.; Gowrishankar, K.; Heinemann, A.; Cullinane, C.; Dutton-Regester, K.; Pupo, G.M.; Strbenac, D.; Yang, J.Y.; Madore, J.; Mann, G.J.; Hayward, N.K.; McArthur, G.A.; Filipp, F.V.; Hersey, P., 2016:
Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes

Brennan, F.H.; Ruitenberg, M.J., 2015:
Targeting acute inflammation to complement spinal cord repair

Benton, C.B.; Ravandi, F., 2016:
Targeting acute myeloid leukemia with TP53-independent vosaroxin

Uttarkar, S.; Dassé, E.; Coulibaly, A.; Steinmann, S.; Jakobs, A.; Schomburg, C.; Trentmann, A.; Jose, J.; Schlenke, P.; Berdel, W.E.; Schmidt, T.J.; Müller-Tidow, C.; Frampton, J.; Klempnauer, K-Heinz., 2016:
Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction

Wang, Y-Gang.; Huang, P-Pan.; Zhang, R.; Ma, B-Yun.; Zhou, X-Mei.; Sun, Y-Fang., 2017:
Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma

Jones-Webb, R.; Toomey, T.L.; Lenk, K.M.; Nelson, T.F.; Erickson, D.J., 2016:
Targeting adults who provide alcohol to underage youth: results from a national survey of local law enforcement agencies

Borg, D.J.; Forbes, J.M., 2017:
Targeting advanced glycation with pharmaceutical agents: where are we now?

Mahon, B.P.; Okoh, C.O.; McKenna, R., 2016:
Targeting aggressive cancers with an artificial sweetener: could saccharin be a lead compound in anticancer therapy?

Tamaoki, J., 2016:
Targeting airway mucus hypersecretion in chronic obstructive pulmonary disease

Van Vleet, T.M.; DeGutis, J.M.; Merzenich, M.M.; Simpson, G.V.; Zomet, A.; Dabit, S., 2016:
Targeting alertness to improve cognition in older adults: A preliminary report of benefits in executive function and skill acquisition

Weikl, F.; Radl, V.; Munch, J.C.; Pritsch, K., 2015:
Targeting allergenic fungi in agricultural environments aids the identification of major sources and potential risks for human health

Ananieva, E., 2015:
Targeting amino acid metabolism in cancer growth and anti-tumor immune response

Sooriyaarachchi, S.; Chofor, Ré.; Risseeuw, M.D.P.; Bergfors, T.; Pouyez, J.; Dowd, C.S.; Maes, L.; Wouters, J.; Jones, T.Alwyn.; Van Calenbergh, S.; Mowbray, S.L., 2017:
Targeting an Aromatic Hotspot in Plasmodium falciparum 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase with β-Arylpropyl Analogues of Fosmidomycin

Bonventre, J.A.; Zielke, R.A.; Korotkov, K.V.; Sikora, A.E., 2016:
Targeting an Essential GTPase Obg for the Development of Broad-Spectrum Antibiotics

Fung, E.N.; Zambito, F.; Haulenbeek, J.; Piccoli, S.P.; Zhang, Y.; DeSilva, B.; Arnold, M.; Kozhich, A., 2015:
Targeting an acid labile aspartyl-prolyl amide bond as a viable alternative to trypsin digestion to generate a surrogate peptide for LC-MS/MS analysis

Kessler, J.; Ruggles, K.; Patel, A.; Nucifora, K.; Li, L.; Roberts, M.S.; Bryant, K.; Braithwaite, R.Scott., 2016:
Targeting an alcohol intervention cost-effectively to persons living with HIV/AIDS in East Africa

Shirazi, M.; Engelman, K.K.; Mbah, O.; Shirazi, A.; Robbins, I.; Bowie, J.; Popal, R.; Wahwasuck, A.; Whalen-White, D.; Greiner, A.; Dobs, A.; Bloom, J., 2015:
Targeting and Tailoring Health Communications in Breast Screening Interventions

Ikeda, Y.; Hisano, H.; Nishikawa, Y.; Nagasaki, Y., 2017:
Targeting and Treatment of Tumor Hypoxia by Newly Designed Prodrug Possessing High Permeability in Solid Tumors

Eichner, M.; Protze, J.; Piontek, A.; Krause, G.; Piontek, Jörg., 2016:
Targeting and alteration of tight junctions by bacteria and their virulence factors such as Clostridium perfringens enterotoxin

Oh, Y.Jun.; Hwang, I., 2016:
Targeting and biogenesis of transporters and channels in chloroplast envelope membranes: Unsolved questions

Haider, A.; Allen, S.M.; Jackson, K.E.; Ralph, S.A.; Habib, S., 2016:
Targeting and function of proteins mediating translation initiation in organelles of Plasmodium falciparum

Mayerhofer, P.U., 2016:
Targeting and insertion of peroxisomal membrane proteins: ER trafficking versus direct delivery to peroxisomes

Fleurence, J.; Cochonneau, D.; Fougeray, S.; Oliver, L.; Geraldo, F.; Terme, Mël.; Dorvillius, Mène.; Loussouarn, D.; Vallette, Fçois.; Paris, Fçois.; Birklé, Séphane., 2016:
Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside

Caudle, A.S.; Kuerer, H.M., 2016:
Targeting and limiting surgery for patients with node-positive breast cancer

Ding, Q.; Si, X.; Liu, D.; Peng, J.; Tang, H.; Sun, W.; Rui, M.; Chen, Q.; Wu, L.; Xu, Y., 2016:
Targeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseases

Gao, W.; Meng, T.; Shi, N.; Zhuang, H.; Yang, Z.; Qi, X., 2016:
Targeting and microenvironment-responsive lipid nanocarrier for the enhancement of tumor cell recognition and therapeutic efficiency

Girard, A.; Rochereau, N.; Roblin, X.; Genin, C.; Paul, Séphane., 2016:
Targeting and role of α4β7 integrin in the pathophysiology of IBD and HIV infection

Chung, E.Ji., 2017:
Targeting and therapeutic peptides in nanomedicine for atherosclerosis

Clavreul, A.; Montagu, Aélique.; Lainé, A-Laure.; Tétaud, Cément.; Lautram, N.; Franconi, F.; Passirani, C.; Vessières, A.; Montero-Menei, C.N.; Menei, P., 2016:
Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules

Wu, X-xun.; Zhang, C-zhen.; Wang, X.; Diao, Y., 2015:
Targeting angiogenesis and vascular remodeling as a novel therapeutic approach to liver fibrosis

Papa, A.; Zaccarelli, E.; Caruso, D.; Vici, P.; Benedetti Panici, P.; Tomao, F., 2016:
Targeting angiogenesis in endometrial cancer - new agents for tailored treatments

Vassilakopoulou, M.; Psyrri, A.; Argiris, A., 2015:
Targeting angiogenesis in head and neck cancer

Hilbe, W.; Manegold, C.; Pircher, A., 2012:
Targeting angiogenesis in lung cancer - Pitfalls in drug development

Stratigos, M.; Matikas, A.; Voutsina, A.; Mavroudis, D.; Georgoulias, V., 2016:
Targeting angiogenesis in small cell lung cancer

Wong, C.Hang.; Wong, C.S.C.; Chan, S.L., 2015:
Targeting angiogenic genes as a therapeutic approach for hepatocellular carcinoma

Chen, C-Yu.; Lin, Y-Song.; Chen, C-Long.; Chao, P-Zhir.; Chiou, J-Fong.; Kuo, C-Chun.; Lee, F-Peng.; Lin, Y-Feng.; Sung, Y-Hsuan.; Lin, Y-Tien.; Li, C-Fan.; Chen, Y-Ju.; Chen, C-Ho., 2016:
Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma

Zerp, S.F.; Stoter, T.Rianne.; Hoebers, F.J.P.; van den Brekel, M.W.M.; Dubbelman, R.; Kuipers, G.K.; Lafleur, M.Vincent.M.; Slotman, B.J.; Verheij, M., 2016:
Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer

Harris, M.Margaret.; Coon, Z.; Alqaeisoom, N.; Swords, B.; Holub, J.M., 2016:
Targeting anti-apoptotic Bcl2 proteins with scyllatoxin-based BH3 domain mimetics

Lee, B.; Boucher, H.W., 2015:
Targeting antimicrobial-resistant bacterial respiratory tract pathogens: it is time to 'get smart'

Lobos-González, L.; Silva, Vónica.; Araya, M.; Restovic, F.; Echenique, J.; Oliveira-Cruz, L.; Fitzpatrick, C.; Briones, M.; Villegas, J.; Villota, C.; Vidaurre, S.; Borgna, V.; Socias, M.; Valenzuela, Sán.; Lopez, C.; Socias, T.; Varas, M.; Díaz, J.; Burzio, L.O.; Burzio, Vónica.A., 2016:
Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factors

Bolger, G.; Roy, S.; Zapol'skii, V.A.; Kaufmann, D.E.; Schnürch, M.; Mihovilovic, M.D.; Nandy, R.K.; Tegge, W., 2017:
Targeting aphA : a new high-throughput screening assay identifies compounds that reduce prime virulence factors of Vibrio cholerae

Safe, S., 2015:
Targeting apoptosis pathways in cancer--letter

Haidarali, S.; Patil, C.R.; Ojha, S.; Mohanraj, R.; Arya, D.S.; Goyal, S.N., 2015:
Targeting apoptotic pathways in myocardial infarction: attenuated by phytochemicals

Roberts, A.W., 2016:
Targeting apoptotic pathways to treat lymphoid malignancies

Yarla, N.Sastry.; Bishayee, A.; Sethi, G.; Reddanna, P.; Kalle, A.M.; Dhananjaya, B.Lakkappa.; Dowluru, K.S.V.G.K.; Chintala, R.; Duddukuri, G.Rao., 2016:
Targeting arachidonic acid pathway by natural products for cancer prevention and therapy

Tain, Y-Lin.; Lee, W-Chia.; Wu, K.L.H.; Leu, S.; Chan, J.Y.H., 2016:
Targeting arachidonic acid pathway to prevent programmed hypertension in maternal fructose-fed male adult rat offspring

Qiu, F.; Huang, J.; Sui, M., 2015:
Targeting arginine metabolism pathway to treat arginine-dependent cancers

Savaraj, N.; Wu, C.; Li, Y-Ying.; Wangpaichitr, M.; You, M.; Bomalaski, J.; He, W.; Kuo, M.Tien.; Feun, L.G., 2016:
Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin

Soto, Y.; Mesa, N.; Alfonso, Y.; Pérez, A.; Batlle, F.; Griñán, T.; Pino, A.; Viera, J.; Frómeta, M.; Brito, V.; Olivera, A.; Zayas, F.; Vázquez, A.M., 2015:
Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody

Zhang, B.; Fan, J.; Zhang, X.; Shen, W.; Cao, Z.; Yang, P.; Xu, Z.; Ju, D., 2016:
Targeting asparagine and autophagy for pulmonary adenocarcinoma therapy

Thompson, D.D.; Murray, G.D.; Candelise, L.; Chen, Z.; Sandercock, P.A.G.; Whiteley, W.N., 2016:
Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta-analysis of three large randomized trials

Peng, L.; Li, B.; Verkhratsky, A., 2017:
Targeting astrocytes in bipolar disorder

Barreto, G.E., 2017:
Targeting astrocytes in brain injuries: A translational research approach

Peng, L.; Verkhratsky, A.; Gu, L.; Li, B., 2018:
Targeting astrocytes in major depression

Phillips, E.; Lang, V.; Bohlen, J.; Bethke, F.; Puccio, L.; Tichy, D.; Herold-Mende, C.; Hielscher, T.; Lichter, P.; Goidts, V., 2017:
Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism

Villanueva Paz, M.; Cotán, D.; Garrido-Maraver, J.; Cordero, M.D.; Oropesa-Ávila, M.; de La Mata, M.; Delgado Pavón, A.; de Lavera, I.; Alcocer-Gómez, E.; Sánchez-Alcázar, Jé.A., 2016:
Targeting autophagy and mitophagy for mitochondrial diseases treatment

Shan, N-Ning.; Dong, L-Li.; Zhang, X-Mei.; Liu, X.; Li, Y., 2016 :
Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy

Xi, G.; Wang, M.; Sun, B.; Shaikh, A.Sami.; Liu, Y.; Wang, W.; Lou, H.; Yuan, H., 2016:
Targeting autophagy augments the activity of DHA-E3 to overcome p-gp mediated multi-drug resistance

Mitou, Géraldine.; Frentzel, J.; Desquesnes, A.; Le Gonidec, S.; AlSaati, T.; Beau, I.; Lamant, L.; Meggetto, F.; Espinos, E.; Codogno, P.; Brousset, P.; Giuriato, S., 2016:
Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma

Sahni, S.; Kovacevic, Z.; Kalinowski, D.S.; Huang, M.; Menezes, S.; Krishan, S.; Lane, D.Jr.; Jansson, P.J.; Richardson, D.R., 2017:
Targeting autophagy in antitumor agent design: furthering the 'lysosomal love' strategy

Ozpolat, B.; Benbrook, D.M., 2015:
Targeting autophagy in cancer management - strategies and developments

Wang, W.; Kang, H.; Zhao, Y.; Min, I.; Wyrwas, B.; Moore, M.; Teng, L.; Zarnegar, R.; Jiang, X.; Fahey, T.J., 2016:
Targeting Autophagy Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib

Piya, S.; Andreeff, M.; Borthakur, G., 2016:
Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia

Kumar, A.; Singh, U.Kumar.; Chaudhary, A., 2016:
Targeting autophagy to overcome drug resistance in cancer therapy

Yan, Y.; Xu, Z.; Dai, S.; Qian, L.; Sun, L.; Gong, Z., 2016:
Targeting autophagy to sensitive glioma to temozolomide treatment

Anonymous, 2016:
Targeting backup DNA repair in cancer

Giri, K.; Yepes, L.Rivas.; Duncan, B.; Parameswaran, P.Kolumam.; Yan, B.; Jiang, Y.; Bilska, M.; Moyano, D.F.; Thompson, M.; Rotello, V.M.; Prakash, Y.S., 2016:
Targeting bacterial biofilms via surface engineering of gold nanoparticles

Murima, P.; McKinney, J.D.; Pethe, K., 2015:
Targeting bacterial central metabolism for drug development

Tse-Dinh, Y-Ching., 2016:
Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics

Tse-Dinh, Y-Ching., 2017:
Targeting bacterial topoisomerases: how to counter mechanisms of resistance

Ulm, H.; Schneider, T., 2017:
Targeting bactoprenol-coupled cell envelope precursors

Sahai, V.; Redig, A.J.; Collier, K.A.; Eckerdt, F.D.; Munshi, H.G., 2016:
Targeting BET bromodomain proteins in solid tumors

Richter, L.; Wang, Y.; Hyde, R.Katherine., 2016:
Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia

Bandyopadhyay, A.; Gao, J., 2016:
Targeting biomolecules with reversible covalent chemistry

Kwon, T.; Lee, B.; Yoo, E.; Chung, S.; Park, Y.; Kim, B., 2016:
Targeting bladder tumor cells in vivo and in the urine by a peptide identified using phage display

Hampshire, L.Aldridge.; Kline, R., 1998:
Targeting blindfolded staff

Yang, Y.; Zheng, B.; Han, Q.; Zhang, C.; Tian, Z.; Zhang, J., 2017:
Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinoma

Brimble, K.Scott., 2017:
Targeting blood pressure in people with diabetes mellitus

Figueiredo, S.; Tantot, A.; Duranteau, J., 2016:
Targeting blood products transfusion in trauma: what is the role of thromboelastography?

Mäger, I.; Meyer, A.H.; Li, J.; Lenter, M.; Hildebrandt, T.; Leparc, G.; Wood, M.J.A., 2016:
Targeting blood-brain-barrier transcytosis - perspectives for drug delivery

Uy, G.L.; Hsu, Y-Michael.S.; Schmidt, A.P.; Stock, W.; Fletcher, T.R.; Trinkaus, K.M.; Westervelt, P.; DiPersio, J.F.; Link, D.C., 2016:
Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia

Todenhöfer, T.; Stenzl, A.; Hofbauer, L.C.; Rachner, T.D., 2015:
Targeting bone metabolism in patients with advanced prostate cancer: current options and controversies

Gnant, M., 2016:
Targeting bone microenvironment: Clinical implications

Miyahara, K.; Kazama, H.; Kokuba, H.; Komatsu, S.; Hirota, A.; Takemura, J.; Hirasawa, K.; Moriya, S.; Abe, A.; Hiramoto, M.; Ishikawa, T.; Miyazawa, K., 2016:
Targeting bortezomib-induced aggresome formation using vinorelbine enhances the cytotoxic effect along with ER stress loading in breast cancer cell lines

Lerner, R.; Post, J.; Loch, S.; Lutz, B.; Bindila, L., 2016:
Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry

Salem, H.F.; Ahmed, S.M.; Hassaballah, A.E.; Omar, M.M., 2016:
Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study

Xu, P.; Cao, X.; Xu, Y., 2016:
Targeting brain estrogen receptor for binge eating

Zhang, I.; Zaorsky, N.G.; Palmer, J.D.; Mehra, R.; Lu, B., 2016:
Targeting brain metastases in ALK-rearranged non-small-cell lung cancer

Yu, Q-Jin.; Tao, H.; Wang, X.; Li, M-Chang., 2016:
Targeting brain microvascular endothelial cells: a therapeutic approach to neuroprotection against stroke

Rahman, S., 2016:
Targeting brain nicotinic acetylcholine receptors to treat major depression and co-morbid alcohol or nicotine addiction

Warrington, N.M.; Sun, T.; Rubin, J.B., 2015:
Targeting brain tumor cAMP: the case for sex-specific therapeutics

Broer, T.; Pickersgill, M., 2016:
Targeting brains, producing responsibilities: the use of neuroscience within British social policy

Pham, P.Van.; Le, H.Thi.; Vu, B.Thanh.; Pham, V.Quoc.; Le, P.Minh.; Phan, N.Lu-Chinh.; Trinh, N.Van.; Nguyen, H.Thi-Lam.; Nguyen, S.Truong.; Nguyen, T.Linh.; Phan, N.Kim., 2016:
Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results

Kai, M.; Kanaya, N.; Wu, S.V.; Mendez, C.; Nguyen, D.; Luu, T.; Chen, S., 2016:
Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin

Nienhuis, H.H.; Gaykema, S.B.M.; Timmer-Bosscha, H.; Jalving, M.; Brouwers, A.H.; Lub-de Hooge, M.N.; van der Vegt, B.; Overmoyer, B.; de Vries, E.G.E.; Schröder, C.P., 2015:
Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets

Mayer, E.L., 2015:
Targeting breast cancer with CDK inhibitors

Fahrenholtz, C.D.; Hadimani, M.; King, S.Bruce.; Torti, S.V.; Singh, R., 2016:
Targeting breast cancer with sugar-coated carbon nanotubes

Slany, A.; Bileck, A.; Muqaku, B.; Gerner, C., 2016:
Targeting breast cancer-associated fibroblasts to improve anti-cancer therapy

Bagci-Onder, T.; Du, W.; Figueiredo, J-Luiz.; Martinez-Quintanilla, J.; Shah, K., 2015:
Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells

Zhang, Q-gang.; Qian, J.; Zhu, Y-chang., 2016:
Targeting bromodomain-containing protein 4 (BRD4) benefits rheumatoid arthritis

Park, S.; Choi, J.; Biering, S.B.; Dominici, E.; Williams, L.E.; Hwang, S., 2018:
Targeting by AutophaGy proteins (TAG): Targeting of IFNG-inducible GTPases to membranes by the LC3 conjugation system of autophagy

Barat, S.; Bozko, P.; Chen, X.; Scholta, T.; Hanert, F.; Götze, J.; Malek, N.P.; Wilkens, L.; Plentz, R.R., 2016:
Targeting c-MET by LY2801653 for treatment of cholangiocarcinoma

Reyes-González, J.M.; Armaiz-Peña, G.N.; Mangala, L.S.; Valiyeva, F.; Ivan, C.; Pradeep, S.; Echevarría-Vargas, I.M.; Rivera-Reyes, A.; Sood, A.K.; Vivas-Mejía, P.E., 2016:
Targeting c-MYC in Platinum-Resistant Ovarian Cancer

Karagonlar, Z.F.; Korhan, P.; Atabey, Nşe., 2016:
Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma

Dai, X.Y.; Huang, X.R.; Zhou, L.; Zhang, L.; Fu, P.; Manthey, C.; Nikolic-Paterson, D.J.; Lan, H.Y., 2017:
Targeting c-fms kinase attenuates chronic aristolochic acid nephropathy in mice

Choudhary, S.; Pardo, A.; Rosinke, R.; Batra, J.K.; Barth, S.; Verma, R.S., 2016:
Targeting c-kit receptor in neuroblastomas and colorectal cancers using stem cell factor (SCF)-based recombinant bacterial toxins

Yang, H.; Yang, L., 2017:
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy

Brandes, F.; Schmidt, K.; Wagner, C.; Redekopf, J.; Schlitt, H.Jürgen.; Geissler, E.Kenneth.; Lang, S.Arke., 2016:
Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model

Lui, G.Y.L.; Kovacevic, Z.; Richardson, V.; Merlot, A.M.; Kalinowski, D.S.; Richardson, D.R., 2016:
Targeting cancer by binding iron: Dissecting cellular signaling pathways

Muscaritoli, M., 2018:
Targeting cancer cachexia: we're on the way

Cohen, R.; Neuzillet, C.; Tijeras-Raballand, Aï.; Faivre, S.; de Gramont, A.; Raymond, E., 2016:
Targeting cancer cell metabolism in pancreatic adenocarcinoma

Zhu, J.; Zheng, Y.; Zhang, H.; Sun, H., 2016:
Targeting cancer cell metabolism: The combination of metformin and 2-Deoxyglucose regulates apoptosis in ovarian cancer cells via p38 MAPK/JNK signaling pathway

Linton, S.S.; Sherwood, S.G.; Drews, K.C.; Kester, M., 2016:
Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine

Esner, M.; Graifer, D.; Lleonart, M.E.; Lyakhovich, A., 2016:
Targeting cancer cells through antibiotics-induced mitochondrial dysfunction requires autophagy inhibition

Okur, A.Ceren.; Erkoc, P.; Kizilel, S., 2017:
Targeting cancer cells via tumor-homing peptide CREKA functional PEG nanoparticles

Wiemann, J.; Heller, L.; Csuk, Ré., 2016:
Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates

Borzęcka, W.; Trindade, T.; Torres, Tás.; Tomé, Jão., 2016:
Targeting Cancer Cells with Photoactive Silica Nanoparticles

Shinjo, K.; Kondo, Y., 2016:
Targeting cancer epigenetics: Linking basic biology to clinical medicine

Chang, C-Wen.; Chen, Y-Syuan.; Chen, C-Chih.; Chan, I-On.; Chen, C-Chu.; Sheu, S-Je.; Lin, T-Wei.; Chou, S-Huey.; Liu, C-Ji.; Lee, T-Chang.; Lo, J-Fan., 2016:
Targeting cancer initiating cells by promoting cell differentiation and restoring chemosensitivity via dual inactivation of STAT3 and src activity using an active component of antrodia cinnamomea mycelia

McCracken, A.N.; Edinger, A.L., 2015:
Targeting cancer metabolism at the plasma membrane by limiting amino acid access through SLC6A14

Kim, S.M.; Roy, S.G.; Chen, B.; Nguyen, T.M.; McMonigle, R.J.; McCracken, A.N.; Zhang, Y.; Kofuji, S.; Hou, J.; Selwan, E.; Finicle, B.T.; Nguyen, T.T.; Ravi, A.; Ramirez, M.U.; Wiher, T.; Guenther, G.G.; Kono, M.; Sasaki, A.T.; Weisman, L.S.; Potma, E.O.; Tromberg, B.J.; Edwards, R.A.; Hanessian, S.; Edinger, A.L., 2016:
Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways

Ranji, P.; Salmani Kesejini, T.; Saeedikhoo, S.; Alizadeh, A.Mohammad., 2016:
Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance

Dandawate, P.R.; Subramaniam, D.; Jensen, R.A.; Anant, S., 2016:
Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy

Zhou, G.; Wilson, G.; George, J.; Qiao, L., 2015:
Targeting cancer stem cells as a therapeutic approach in liver cancer

Hong, I-Sun.; Jang, G-Beom.; Lee, H-Yong.; Nam, J-Seok., 2016:
Targeting cancer stem cells by using the nanoparticles

Wu, C-Hao.; Hong, B-Han.; Ho, C-Tang.; Yen, G-Chin., 2015:
Targeting cancer stem cells in breast cancer: potential anticancer properties of 6-shogaol and pterostilbene

So, J.Young.; Suh, N., 2015:
Targeting cancer stem cells in solid tumors by vitamin D

Lang, J.; Lan, X.; Liu, Y.; Jin, X.; Wu, T.; Sun, X.; Wen, Q.; An, R., 2016:
Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts

Tong, Y.; Qian, W., 2014:
Targeting cancer stem cells with oncolytic virus

Zhang, Z.; Liu, L.; Gomez-Casal, R.; Wang, X.; Hayashi, R.; Appella, E.; Kopelovich, L.; DeLeo, A.B., 2016:
Targeting cancer stem cells with p53 modulators

Kahlert, U.D.; Mooney, S.M.; Natsumeda, M.; Steiger, H-J.; Maciaczyk, J., 2016:
Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways

Khan, S.; Karmokar, A.; Howells, L.; Thomas, A.L.; Bayliss, R.; Gescher, A.; Brown, K., 2017:
Targeting cancer stem-like cells using dietary-derived agents - Where are we now?

Suri, A.; Jagadish, N.; Saini, S.; Gupta, N., 2015:
Targeting cancer testis antigens for biomarkers and immunotherapy in colorectal cancer: Current status and challenges

Brown, J.A.L.; Bourke, E.; Eriksson, L.A.; Kerin, M.J., 2017:
Targeting cancer using KAT inhibitors to mimic lethal knockouts

Cadete, A.; Alonso, Mía.José., 2017:
Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives

Gross, S.; Rahal, R.; Stransky, N.; Lengauer, C.; Hoeflich, K.P., 2015:
Targeting cancer with kinase inhibitors

Zhang, C.; Liu, Y., 2016:
Targeting cancer with sesterterpenoids: the new potential antitumor drugs

Blankenstein, T.; Leisegang, M.; Uckert, W.; Schreiber, H., 2016:
Targeting cancer-specific mutations by T cell receptor gene therapy

Krishnadas, D.K.; Bai, F.; Lucas, K.G., 2016:
Targeting cancer-testis antigens in recurrent pediatric brain tumors

Feng, R.; Tong, Q.; Xie, Z.; Cheng, H.; Wang, L.; Lentzsch, S.; Roodman, G.David.; Xie, X-Qun., 2016 :
Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption

Mallat, A.; Lotersztajn, S., 2018:
Targeting cannabinoid receptors in hepatocellular carcinoma?

Mahon, B.P.; Pinard, M.A.; McKenna, R., 2015:
Targeting carbonic anhydrase IX activity and expression

Faes, S.; Planche, A.; Uldry, E.; Santoro, T.; Pythoud, C.; Stehle, J-Christophe.; Horlbeck, J.; Letovanec, I.; Riggi, N.; Datta, D.; Demartines, N.; Dormond, O., 2016:
Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors

Wichert, M.; Krall, N., 2016:
Targeting carbonic anhydrase IX with small organic ligands

Moore-Morris, T.; Pucéat, M.; Evans, S.M., 2016:
Targeting cardiac fibroblasts: the pressure is on

Moro, C., 2016:
Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity

Roe, A.T.; Frisk, M.; Louch, W.E., 2015:
Targeting cardiomyocyte Ca2+ homeostasis in heart failure

Zeki, S.; Fitzgerald, R.C., 2016:
Targeting care in Barrett's oesophagus

Song, C.; Gowda, C.; Pan, X.; Ding, Y.; Tong, Y.; Tan, B-Hua.; Wang, H.; Muthusami, S.; Ge, Z.; Sachdev, M.; Amin, S.G.; Desai, D.; Gowda, K.; Gowda, R.; Robertson, G.P.; Schjerven, H.; Muschen, M.; Payne, K.J.; Dovat, S., 2016:
Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia

Murfitt, L.; Whiteley, G.; Iqbal, M.M.; Kitmitto, A., 2015:
Targeting caveolin-3 for the treatment of diabetic cardiomyopathy

Aalbers, M.; ter Horst, P.G.J.; Hospes, W.; Hijmering, M.L.; Spanjersberg, A.J., 2016:
Targeting cefuroxime plasma concentrations during coronary artery bypass graft surgery with cardiopulmonary bypass

Pals, S.T.; Kersten, M.José.; Spaargaren, M., 2017:
Targeting cell adhesion and homing as strategy to cure Waldenström's macroglobulinemia

Aleem, E.; Arceci, R.J., 2015:
Targeting cell cycle regulators in hematologic malignancies

Lessene, G., 2016:
Targeting cell death pathways with small molecules: playing with life and death at the cellular level to treat diseases

Tran, T.T.; Miller, W.R.; Shamoo, Y.; Arias, C.A., 2016:
Targeting cell membrane adaptation as a novel antimicrobial strategy

Asquith, D.L.; Bryce, S.A.; Nibbs, R.J.B., 2015:
Targeting cell migration in rheumatoid arthritis

Keirsse, J.; Laoui, D.; Van Overmeire, E.; Van Ginderachter, J.A., 2015:
Targeting cell-intrinsic and cell-extrinsic mechanisms of intravasation in invasive breast cancer

Mohr, N.; Kappel, C.; Kramer, S.; Bros, M.; Grabbe, S.; Zentel, R., 2016:
Targeting cells of the immune system: mannosylated HPMA-LMA block-copolymer micelles for targeting of dendritic cells

Thompson, M.L.; Jimenez-Andrade, J.M.; Chartier, S.; Tsai, J.; Burton, E.A.; Habets, G.; Lin, P.S.; West, B.L.; Mantyh, P.W., 2016:
Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancer

Tezcan, O.; Ojha, T.; Storm, G.; Kiessling, F.; Lammers, T., 2016:
Targeting cellular and microenvironmental multidrug resistance

Ausoni, S.; Boscolo-Rizzo, P.; Singh, B.; Da Mosto, M.Cristina.; Spinato, G.; Tirelli, G.; Spinato, R.; Azzarello, G., 2017:
Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives

Saito, K.; Shirasago, Y.; Suzuki, T.; Aizaki, H.; Hanada, K.; Wakita, T.; Nishijima, M.; Fukasawa, M., 2015:
Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus

Vethakanraj, H.Shiphrah.; Babu, T.Ahmed.; Sudarsanan, G.Babu.; Duraisamy, P.Kumar.; Ashok Kumar, S., 2015:
Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines

Aburasayn, H.; Al Batran, R.; Ussher, J.R., 2017:
Targeting ceramide metabolism in obesity

Suzuki, M.; Cao, K.; Kato, S.; Komizu, Y.; Mizutani, N.; Tanaka, K.; Arima, C.; Tai, M.Chee.; Yanagisawa, K.; Togawa, N.; Shiraishi, T.; Usami, N.; Taniguchi, T.; Fukui, T.; Yokoi, K.; Wakahara, K.; Hasegawa, Y.; Mizutani, Y.; Igarashi, Y.; Inokuchi, J-ichi.; Iwaki, S.; Fujii, S.; Satou, A.; Matsumoto, Y.; Ueoka, R.; Tamiya-Koizumi, K.; Murate, T.; Nakamura, M.; Kyogashima, M.; Takahashi, T., 2016:
Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells

St-Amour, I.; Aubé, B.; Rieux, M.; Cicchetti, F., 2016:
Targeting cerebrovascular impairments in Huntington's disease: a novel treatment perspective

Parker, L.Carleton.; Gleichsner, A.M.; Adedokun, O.A.; Forney, J., 2016:
Targeting change: Assessing a faculty learning community focused on increasing statistics content in life science curricula

Bose, S.; Cho, J., 2016:
Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders

Wong, Y.How.; Kadir, H.A.; Tayyab, S., 2015:
Targeting chemical and thermal stability of ovalbumin by simulated honey sugar cocktail

Shrivastava, M.S.; Hussain, Z.; Giricz, O.; Shenoy, N.; Polineni, R.; Maitra, A.; Verma, A., 2015:
Targeting chemokine pathways in esophageal adenocarcinoma

Liu, Y.; Carson-Walter, E.; Walter, K.A., 2015:
Targeting chemokine receptor CXCR7 inhibits glioma cell proliferation and mobility

Fricker, S.P., 2016:
Targeting chemokine receptors for HIV: past, present and future

Solari, R.; Pease, J.E., 2016:
Targeting chemokine receptors in disease--a case study of CCR4

Proudfoot, A.E.I.; Bonvin, P.; Power, C.A., 2016:
Targeting chemokines: Pathogens can, why can't we?

Chi, J-Ying.; Hsiao, Y-Wei.; Li, C-Feng.; Lo, Y-Chih.; Lin, Z-Yau.; Hong, J-Yi.; Liu, Y-Ming.; Han, X.; Wang, S-Ming.; Chen, B-Kuen.; Tsai, K.K.; Wang, J-Ming., 2016:
Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers

Galardy, P.J.; Bedekovics, T.; Hermiston, M.L., 2017:
Targeting childhood, adolescent and young adult non-Hodgkin lymphoma: therapeutic horizons

Mamta; Reddy, K.R.K.; Rajam, M.V., 2016:
Targeting chitinase gene of Helicoverpa armigera by host-induced RNA interference confers insect resistance in tobacco and tomato

Malgrange, B.; Varela-Nieto, I.; de Medina, P.; Paillasse, M.R., 2015:
Targeting cholesterol homeostasis to fight hearing loss: a new perspective

Arita, Y.; Nishimura, S.; Ishitsuka, R.; Kishimoto, T.; Ikenouchi, J.; Ishii, K.; Umeda, M.; Matsunaga, S.; Kobayashi, T.; Yoshida, M., 2016:
Targeting cholesterol in a liquid-disordered environment by theonellamides modulates cell membrane order and cell shape

Yamaguchi, R.; Perkins, G.; Hirota, K., 2016:
Targeting cholesterol with β-cyclodextrin sensitizes cancer cells for apoptosis

Cao, M.Dung.; Cheng, M.; Rizwan, A.; Jiang, L.; Krishnamachary, B.; Bhujwalla, Z.M.; Bathen, T.F.; Glunde, K., 2018:
Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion

Chan, S.Chiu.; Selth, L.A.; Li, Y.; Nyquist, M.D.; Miao, L.; Bradner, J.E.; Raj, G.V.; Tilley, W.D.; Dehm, S.M., 2015:
Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies

Costantino, S.; Paneni, F.; Cosentino, F., 2015:
Targeting chromatin remodeling to prevent cardiovascular disease in diabetes

Olcina, M.M.; O'Dell, S.; Hammond, E.M., 2015:
Targeting chromatin to improve radiation response

Crassini, K.; Mulligan, S.P.; Best, O.Giles., 2015:
Targeting chronic lymphocytic leukemia cells in the tumor microenviroment: A review of the in vitro and clinical trials to date

Ecker, J.; Oehme, I.; Mazitschek, R.; Korshunov, A.; Kool, M.; Hielscher, T.; Kiss, J.; Selt, F.; Konrad, C.; Lodrini, M.; Deubzer, H.E.; von Deimling, A.; Kulozik, A.E.; Pfister, S.M.; Witt, O.; Milde, T., 2016:
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma

Schimmel, D.R.; Sweis, R.; Cohen, E.R.; Davidson, C.; Wayne, D.B., 2016:
Targeting clinical outcomes: Endovascular simulation improves diagnostic coronary angiography skills

Brindisi, M.; Brogi, S.; Giovani, S.; Gemma, S.; Lamponi, S.; De Luca, F.; Novellino, E.; Campiani, G.; Docquier, J-Denis.; Butini, S., 2016:
Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors

Farrell, N.R.; Kemp, J.J.; Blakey, S.M.; Meyer, J.M.; Deacon, B.J., 2017:
Targeting clinician concerns about exposure therapy: A pilot study comparing standard vs. enhanced training

Ruf, W.; Rothmeier, A.S.; Graf, C., 2017:
Targeting clotting proteins in cancer therapy - progress and challenges

Hopp, S.; Albert-Weissenberger, C.; Mencl, S.; Bieber, M.; Schuhmann, M.K.; Stetter, C.; Nieswandt, B.; Schmidt, P.M.; Monoranu, C-Maria.; Alafuzoff, I.; Marklund, N.; Nolte, M.W.; Sirén, A-Leena.; Kleinschnitz, C., 2017:
Targeting coagulation factor XII as a novel therapeutic option in brain trauma

Wahyudi, H.; Reynolds, A.A.; Li, Y.; Owen, S.C.; Yu, S.Michael., 2016:
Targeting collagen for diagnostic imaging and therapeutic delivery

Ju, T.; Gao, D.; Fang, Z-Yu., 2016:
Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543

Ramasamy, T.Selvee.; Ayob, A.Zubaidah.; Myint, H.Hsu.Lynn.; Thiagarajah, S.; Amini, F., 2015:
Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy

Faïs, T.; Delmas, J.; Cougnoux, A.; Dalmasso, G.; Bonnet, R., 2016:
Targeting colorectal cancer-associated bacteria: A new area of research for personalized treatments

Buchanan, E., 2016:
Targeting composite treatment of type 2 diabetes in middle-income countries

Wing, J.; Jivan, D., 2016:
Targeting composite treatment of type 2 diabetes in middle-income countries--walking a tightrope between hyperglycaemia and the dangers of hypoglycaemia

Tong, M.; Seeliger, M.A., 2015:
Targeting conformational plasticity of protein kinases

Grek, C.L.; Rhett, J.Matthew.; Bruce, J.S.; Abt, M.A.; Ghatnekar, G.S.; Yeh, E.S., 2016:
Targeting connexin 43 with α-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1

Schweizer, M.T.; Plymate, S.R., 2018:
Targeting constitutively active androgen receptor splice variants in castration resistant prostate cancer

McCann, G.A.; Naidu, S.; Rath, K.S.; Bid, H.K.; Tierney, B.J.; Suarez, A.; Varadharaj, S.; Zhang, J.; Hideg, Kálmán.; Houghton, P.; Kuppusamy, P.; Cohn, D.E.; Selvendiran, K., 2015:
Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor

Denoyer, D.; Masaldan, S.; La Fontaine, S.; Cater, M.A., 2016:
Targeting copper in cancer therapy: 'Copper That Cancer'

Hamulakova, S.; Poprac, P.; Jomova, K.; Brezova, V.; Lauro, P.; Drostinova, L.; Jun, D.; Sepsova, V.; Hrabinova, M.; Soukup, O.; Kristian, P.; Gazova, Z.; Bednarikova, Z.; Kuca, K.; Valko, M., 2017:
Targeting copper(II)-induced oxidative stress and the acetylcholinesterase system in Alzheimer's disease using multifunctional tacrine-coumarin hybrid molecules

Giguère, K.; Alary, M., 2015:
Targeting core groups for gonorrhoea control: feasibility and impact

Dabrowska, J.; Martinon, D.; Moaddab, M.; Rainnie, D.G., 2016:
Targeting Corticotropin-Releasing Factor Projections from the Oval Nucleus of the Bed Nucleus of the Stria Terminalis Using Cell-Type Specific Neuronal Tracing Studies in Mouse and Rat Brain

Horiuchi, Y.; Takagi, A.; Uchida, T.; Akatsuka, T., 2016:
Targeting cryptic epitope with modified antigen coupled to the surface of liposomes induces strong antitumor CD8 T-cell immune responses in vivo

Wu, S.; Yu, L., 2015:
Targeting cullin-RING ligases for cancer treatment: rationales, advances and therapeutic implications

Alquézar, C.; Barrio, Eíbaliz.; Esteras, Ní.; de la Encarnación, A.; Bartolomé, F.; Molina, Jé.A.; Martín-Requero, Ángeles., 2015:
Targeting cyclin D3/CDK6 activity for treatment of Parkinson's disease

Ehrlich, S.M.; Liebl, J.; Ardelt, M.A.; Lehr, T.; De Toni, E.N.; Mayr, D.; Brandl, L.; Kirchner, T.; Zahler, S.; Gerbes, A.L.; Vollmar, A.M., 2016:
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma--A novel therapeutic approach

Peyressatre, M.; Prével, C.; Pellerano, M.; Morris, M.C., 2015:
Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors

Abjani, F.; Khan, N.Ahmed.; Yousuf, F.Abubakar.; Siddiqui, R., 2017:
Targeting cyst wall is an effective strategy in improving the efficacy of marketed contact lens disinfecting solutions against Acanthamoeba castellanii cysts

Poirier, D.; Roy, J.; Cortés-Benítez, F.; Dutour, Rël., 2016:
Targeting cytochrome P450 (CYP) 1B1 with steroid derivatives

Hirahara, K.; Schwartz, D.; Gadina, M.; Kanno, Y.; O'Shea, J.J., 2016:
Targeting cytokine signaling in autoimmunity: back to the future and beyond

Crowley, S.D.; Jeffs, A.D., 2016:
Targeting cytokine signaling in salt-sensitive hypertension

Brown, K.Alun.; Brown, G.A.; Lewis, S.M.; Beale, R.; Treacher, D.F., 2017:
Targeting cytokines as a treatment for patients with sepsis: A lost cause or a strategy still worthy of pursuit?

Nakase, H.; Onodera, K., 2016:
Targeting cytomegalovirus during ulcerative colitis flare-ups

van Hout, G.P.J.; Arslan, F.; Pasterkamp, G.; Hoefer, I.E., 2016:
Targeting danger-associated molecular patterns after myocardial infarction

O'Dwyer, D.N.; Armstrong, M.E.; Kooblall, M.; Donnelly, S.C., 2015:
Targeting defective Toll-like receptor-3 function and idiopathic pulmonary fibrosis

Young, K.; Starling, N.; Cunningham, D., 2017:
Targeting deficient DNA damage repair in gastric cancer

Newland, B.; Dunnett, S.B.; Dowd, Eís., 2018:
Targeting delivery in Parkinson's disease

Wang, L.; Yao, C.; Wu, F.; Lin, X.; Shen, L.; Feng, Y., 2016:
Targeting delivery of Radix Ophiopogonis polysaccharide to ischemic/reperfused rat myocardium by long-circulating macromolecular and liposomal carriers

Kuo, Y-Chih.; Chen, Y-Chun., 2015:
Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles

Harati, M.Dehghan.; Amiri, F.; Jaleh, F.; Mehdipour, A.; Harati, M.Dehghan.; Molaee, S.; Bahadori, M.; Shokrgozar, M.Ali.; Jalili, M.Ali.; Roudkenar, M.Habibi., 2015:
Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon cancer in order to inhibit liver metastasis in nude mice

Nam, J-Pyo.; Lee, K-Jae.; Choi, J-Woo.; Yun, C-Ok.; Nah, J-Woon., 2016:
Targeting delivery of tocopherol and doxorubicin grafted-chitosan polymeric micelles for cancer therapy: In vitro and in vivo evaluation

Sedel, Fédéric.; Bernard, D.; Mock, D.M.; Tourbah, A., 2015:
Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis

Graham, J.P.; Authie, P.; Yu, C.I.; Zurawski, S.M.; Li, X-Hua.; Marches, F.; Flamar, A-Laure.; Acharya, A.; Banchereau, J.; Palucka, A.Karolina., 2017:
Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes

Qian, Y.; Jin, H.; Qiao, S.; Dai, Y.; Huang, C.; Lu, L.; Luo, Q.; Zhang, Z., 2017:
Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy

Xie, X.; Zou, J.; Wang, Q-Yin.; Shi, P-Yong., 2016:
Targeting dengue virus NS4B protein for drug discovery

Cáceres, C.Joaquín.; Angulo, J.; Contreras, N.; Pino, K.; Vera-Otarola, J.; López-Lastra, M., 2016:
Targeting deoxyhypusine hydroxylase activity impairs cap-independent translation initiation driven by the 5'untranslated region of the HIV-1, HTLV-1, and MMTV mRNAs

Peterson, L.F.; Sun, H.; Liu, Y.; Potu, H.; Kandarpa, M.; Ermann, M.; Courtney, S.M.; Young, M.; Showalter, H.D.; Sun, D.; Jakubowiak, A.; Malek, S.N.; Talpaz, M.; Donato, N.J., 2015:
Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies

Petersen, N.; Reimann, F.; van Es, J.H.; van den Berg, B.M.; Kroone, C.; Pais, R.; Jansen, E.; Clevers, H.; Gribble, F.M.; de Koning, E.J.P., 2015:
Targeting development of incretin-producing cells increases insulin secretion

Bhattacharjee, P.; Sarkar, S.; Pandya, P.; Bhadra, K., 2015:
Targeting different RNA motifs by beta carboline alkaloid, harmalol: a comparative photophysical, calorimetric, and molecular docking approach

Kelestemur, T.; Yulug, B.; Caglayan, A.Burak.; Beker, M.Caglar.; Kilic, U.; Caglayan, B.; Yalcin, E.; Gundogdu, R.Zeynep.; Kilic, E., 2016:
Targeting different pathophysiological events after traumatic brain injury in mice: Role of melatonin and memantine

Ambrosy, A.P.; Gheorghiade, M., 2018:
Targeting digoxin dosing to serum concentration: is the bullseye too small?

Heller, G.T.; Sormanni, P.; Vendruscolo, M., 2016:
Targeting disordered proteins with small molecules using entropy

Ergen, C.; Heymann, F.; Al Rawashdeh, W'el.; Gremse, F.; Bartneck, M.; Panzer, U.; Pola, R.; Pechar, M.; Storm, G.; Mohr, N.; Barz, M.; Zentel, R.; Kiessling, F.; Trautwein, C.; Lammers, T.; Tacke, F., 2016:
Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles

Fiorini, V.; Ranieri, A.Maria.; Muzzioli, S.; Magee, K.D.M.; Zacchini, S.; Akabar, N.; Stefan, A.; Ogden, M.I.; Massi, M.; Stagni, S., 2015:
Targeting divalent metal cations with Re(I) tetrazolato complexes

Checco, J.W.; Kreitler, D.F.; Thomas, N.C.; Belair, D.G.; Rettko, N.J.; Murphy, W.L.; Forest, K.T.; Gellman, S.H., 2015:
Targeting diverse protein-protein interaction interfaces with α/β-peptides derived from the Z-domain scaffold

van Oorschot, B.; Granata, G.; Di Franco, S.; Ten Cate, R.; Rodermond, H.M.; Todaro, M.; Medema, J.Paul.; Franken, N.A.P., 2016:
Targeting DNA double strand break repair with hyperthermia and DNA-PKcs inhibition to enhance the effect of radiation treatment

Liang, Z.; Yang, N.; Jiang, Y.; Hou, C.; Zheng, J.; Shi, J.; Zhang, R.; Li, D.; Liu, Y.; Zuo, P., 2016:
Targeting docetaxel-PLA nanoparticles simultaneously inhibit tumor growth and liver metastases of small cell lung cancer

Hurst, R.E.; Bastian, A.; Bailey-Downs, L.; Ihnat, M.A., 2016:
Targeting dormant micrometastases: rationale, evidence to date and clinical implications

Clancy, R.M.; Markham, A.J.; Reed, J.H.; Blumenberg, M.; Halushka, M.K.; Buyon, J.P., 2016:
Targeting downstream transcription factors and epigenetic modifications following Toll-like receptor 7/8 ligation to forestall tissue injury in anti-Ro60 associated heart block

Ghannam, M.M.; El Gebaly, R.; Fadel, M., 2016:
Targeting doxorubicin encapsulated in stealth liposomes to solid tumors by non thermal diode laser

Strickland, L.Ray.; Pal, H.Chandra.; Elmets, C.A.; Afaq, F., 2015:
Targeting drivers of melanoma with synthetic small molecules and phytochemicals

Kalueff, A.V.; Stewart, A.Michael.; Nguyen, M.; Song, C.; Gottesman, I.I., 2016:
Targeting drug sensitivity predictors: New potential strategies to improve pharmacotherapy of human brain disorders

Chen, H.H.W.; Chen, W-Chung.; Liang, Z-Dong.; Tsai, W-Bin.; Long, Y.; Aiba, I.; Fu, S.; Broaddus, R.; Liu, J.; Feun, L.G.; Savaraj, N.; Kuo, M.Tien., 2016:
Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy

Zang, P.; Gong, A.; Zhang, P.; Yu, J., 2016:
Targeting druggable enzymome by exploiting natural medicines: An in silico-in vitro integrated approach to combating multidrug resistance in bacterial infection

Cao, J.; Li, H.; Chen, L., 2015:
Targeting drugs to APJ receptor: the prospect of treatment of hypertension and other cardiovascular diseases

Kalueff, A.V.; Stewart, A.Michael.; Song, C.; Gottesman, I.I., 2016:
Targeting dynamic interplay among disordered domains or endophenotypes to understand complex neuropsychiatric disorders: Translational lessons from preclinical models

Ziogas, D.E.; Glantzounis, G.; Liakakos, T.; Roukos, D.H., 2017:
Targeting dynamics of subclones of GI, liver and pancreatic cancers

Melis, N.; Rubera, I.; Cougnon, M.; Giraud, Sébastien.; Mograbi, B.; Belaid, A.; Pisani, D.F.; Huber, S.M.; Lacas-Gervais, S.; Fragaki, K.; Blondeau, N.; Vigne, P.; Frelin, C.; Hauet, T.; Duranton, C.; Tauc, M., 2016:
Targeting eIF5A Hypusination Prevents Anoxic Cell Death through Mitochondrial Silencing and Improves Kidney Transplant Outcome

Brusich, M.; Grieco, J.; Penney, N.; Tisgratog, R.; Ritthison, W.; Chareonviriyaphap, T.; Achee, N., 2016:
Targeting educational campaigns for prevention of malaria and dengue fever: an assessment in Thailand

Ding, J.; Feng, M.; Wang, F.; Wang, H.; Guan, W., 2016:
Targeting effect of PEGylated liposomes modified with the Arg-Gly-Asp sequence on gastric cancer

Holmes, A.R.; Cardno, T.S.; Strouse, J.Jacob.; Ivnitski-Steele, I.; Keniya, M.V.; Lackovic, K.; Monk, B.C.; Sklar, L.A.; Cannon, R.D., 2017:
Targeting efflux pumps to overcome antifungal drug resistance

Flores-Canales, J.C.; Kurnikova, M., 2016 :
Targeting electrostatic interactions in accelerated molecular dynamics with application to protein partial unfolding

McCoy, S.I.; Fahey, C.; Buzdugan, R.; Mushavi, A.; Mahomva, A.; Padian, N.S.; Cowan, F.M., 2017:
Targeting elimination of mother-to-child HIV transmission efforts using geospatial analysis of mother-to-child HIV transmission in Zimbabwe

Cai, C-Miao.; Xiao, X.; Wu, B-Hao.; Wei, B-Feng.; Han, Z-Guang., 2016:
Targeting endogenous DLK1 exerts antitumor effect on hepatocellular carcinoma through initiating cell differentiation

Duran-Aniotz, C.; Cornejo, V.Hugo.; Hetz, C., 2016:
Targeting endoplasmic reticulum acetylation to restore proteostasis in Alzheimer's disease

Durante, W., 2018:
Targeting endoplasmic reticulum stress in hypoxia-induced cardiac injury

Salvadó, L.; Palomer, X.; Barroso, E.; Vázquez-Carrera, M., 2016:
Targeting endoplasmic reticulum stress in insulin resistance

Wu, F-Ling.; Liu, W-Yue.; Van Poucke, S.; Braddock, M.; Jin, W-Min.; Xiao, J.; Li, X-Kun.; Zheng, M-Hua., 2017:
Targeting endoplasmic reticulum stress in liver disease

Rybinski, K.; Imtiyaz, H.Z.; Mittica, B.; Drozdowski, B.; Fulmer, J.; Furuuchi, K.; Fernando, S.; Henry, M.; Chao, Q.; Kline, B.; Albone, E.; Wustner, J.; Lin, J.; Nicolaides, N.C.; Grasso, L.; Zhou, Y., 2016:
Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature

Craft, C.Mae., 2015:
Targeting endostatin to potentially prevent retinal neovascularization using a hypoxia-responsive Müller glia cell-specific gene therapy

Alonso, F.; Domingos-Pereira, S.; Le Gal, Lïc.; Derré, L.; Meda, P.; Jichlinski, P.; Nardelli-Haefliger, D.; Haefliger, J-Antoine., 2017:
Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion

Ammendola, M.; Leporini, C.; Luposella, M.; Sacco, R.; Sammarco, G.; Russo, E.; Patruno, R.; De Sarro, G.; Ranieri, G., 2015:
Targeting endothelial progenitor cells in cancer as a novel biomarker and anti-angiogenic therapy

Rao, E.; Singh, P.; Li, Y.; Zhang, Y.; Chi, Y-In.; Suttles, J.; Li, B., 2016:
Targeting epidermal fatty acid binding protein for treatment of experimental autoimmune encephalomyelitis

Chapman, C.H.; Saba, N.F.; Yom, S.S., 2016:
Targeting epidermal growth factor receptor for head and neck squamous cell carcinoma: still lost in translation?

Yun, S.; Vincelette, N.D.; Abraham, I.; Robertson, K.D.; Fernandez-Zapico, M.E.; Patnaik, M.M., 2016:
Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials

Zhang, Z.; Hou, S.; Chen, H.; Ran, T.; Jiang, F.; Bian, Y.; Zhang, D.; Zhi, Y.; Wang, L.; Zhang, L.; Li, H.; Zhang, Y.; Tang, W.; Lu, T.; Chen, Y., 2017:
Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors

Ning, B.; Li, W.; Zhao, W.; Wang, R., 2017:
Targeting epigenetic regulations in cancer

Gelato, K.A.; Shaikhibrahim, Z.; Ocker, M.; Haendler, B., 2017:
Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs

Luft, F.C., 2016:
Targeting epithelial-mesenchymal transition

Deng, J.; Wang, L.; Chen, H.; Hao, J.; Ni, J.; Chang, L.; Duan, W.; Graham, P.; Li, Y., 2016:
Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer

Fan, H-Chuen.; Lin, S-Zong.; Harn, H-Jyh., 2016:
Targeting epithelial-mesenchymal transition phenotype for gastro-intestinal cancer

Wang, Z., 2015:
Targeting epithelial-to-mesenchymal transition for cancer therapy

Wei, X.; Liu, L.; Wang, G.; Li, W.; Xu, K.; Hu, X.; Qian, C.; Shao, J., 2016:
Targeting eradication of chronic myeloid leukemia using chimeric oncolytic adenovirus to drive IL-24 expression

Samuel, L.; Plebani, M., 2016:
Targeting errors in microbiology: the case of the Gram stain

Ruiz, A.; Pérez, D.; Muñoz, M.C.; Molina, J.M.; Taubert, A.; Jacobs-Lorena, M.; Vega-Rodríguez, J.; López, A.M.; Hermosilla, C., 2016:
Targeting essential Eimeria ninakohlyakimovae sporozoite ligands for caprine host endothelial cell invasion with a phage display peptide library

Pisano, A.; Preziuso, C.; Iommarini, L.; Perli, E.; Grazioli, P.; Campese, A.F.; Maresca, A.; Montopoli, M.; Masuelli, L.; Sadun, A.A.; d'Amati, G.; Carelli, V.; Ghelli, A.; Giordano, C., 2016:
Targeting estrogen receptor β as preventive therapeutic strategy for Leber's hereditary optic neuropathy

Shang, Z.; Li, Y.; Hsu, I.; Zhang, M.; Tian, J.; Wen, S.; Han, R.; Messing, E.M.; Chang, C.; Niu, Y.; Yeh, S., 2017:
Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer

Zaman, S.; Wang, R.; Gandhi, V., 2016:
Targeting executioner procaspase-3 with the procaspase-activating compound B-PAC-1 induces apoptosis in multiple myeloma cells

Zhang, X.M.; Luo, F.H.; Ding, H.M.; Li, B.; Zhang, J.J.; Wu, Y.J., 2018:
Targeting exogenous GDNF gene to the bovine somatic cell beta-casein locus for the production of transgenic bovine animals

Wu, N.; Zhang, X.; Li, J.; Gan, Y., 2016:
Targeting exosomal miRNA with pH-sensitive liposome coated chitosan-siRNA nanoparticles for inhibition of hepatocellular carcinoma metastasis

Gernapudi, R.; Yao, Y.; Zhang, Y.; Wolfson, B.; Roy, S.; Duru, N.; Eades, G.; Yang, P.; Zhou, Q., 2016:
Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer

Latorre-Rey, L.J.; Wintterle, S.; Dütting, S.; Kohlscheen, S.; Abel, T.; Schenk, F.; Wingert, S.; Rieger, M.A.; Nieswandt, B.; Heinz, N.; Modlich, U., 2016:
Targeting expression to megakaryocytes and platelets by lineage-specific lentiviral vectors

Siegel, E.L.; Orbai, A-Maria.; Ritchlin, C.T., 2015:
Targeting extra-articular manifestations in PsA: a closer look at enthesitis and dactylitis

Iordanskaia, T.; Malesevic, M.; Fischer, G.; Pushkarsky, T.; Bukrinsky, M.; Nadler, E.P., 2015:
Targeting Extracellular Cyclophilins Ameliorates Disease Progression in Experimental Biliary Atresia

Agarwal, R.; Agarwal, P., 2016:
Targeting extracellular matrix remodeling in disease: Could resveratrol be a potential candidate?

Fulda, S., 2015:
Targeting extrinsic apoptosis in cancer: Challenges and opportunities

Baumgartner, C.K.; Mattson, J.G.; Weiler, H.; Shi, Q.; Montgomery, R.R., 2016:
Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice

Bitzer, J.; Abalos, V.; Apter, D.; Martin, R.; Black, A., 2016:
Targeting factors for change: contraceptive counselling and care of female adolescents

Harjes, U.; Kalucka, J.; Carmeliet, P., 2016:
Targeting fatty acid metabolism in cancer and endothelial cells

Arumugam, S.; Sreedhar, R.; Thandavarayan, R.A.; Karuppagounder, V.; Watanabe, K., 2018:
Targeting fatty acid metabolism in heart failure: is it a suitable therapeutic approach?

Stinkens, R.; Goossens, G.H.; Jocken, J.W.E.; Blaak, E.E., 2016:
Targeting fatty acid metabolism to improve glucose metabolism

Wen, S.; Niu, Y.; Lee, S.Ok.; Yeh, S.; Shang, Z.; Gao, H.; Li, Y.; Chou, F.; Chang, C., 2016:
Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells

Chung, S-Hyuk., 2016:
Targeting female hormone receptors as cervical cancer therapy

Geninatti Crich, S.; Cadenazzi, M.; Lanzardo, S.; Conti, L.; Ruiu, R.; Alberti, D.; Cavallo, F.; Cutrin, J.C.; Aime, S., 2016:
Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells

Liu, W-Yue.; Xie, D-Mei.; Zhu, G-Qi.; Huang, G-Qian.; Lin, Y-Qian.; Wang, L-Ren.; Shi, K-Qing.; Hu, B.; Braddock, M.; Chen, Y-Ping.; Zheng, M-Hua., 2015:
Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target

Massari, F.; Ciccarese, C.; Santoni, M.; Lopez-Beltran, A.; Scarpelli, M.; Montironi, R.; Cheng, L., 2016:
Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma

Chudasama, P.; Renner, M.; Straub, M.; Mughal, S.S.; Hutter, B.; Kosaloglu, Z.; Schweßinger, R.; Scheffler, M.; Alldinger, I.; Schimmack, S.; Persigehl, T.; Kobe, C.; Jäger, D.; von Kalle, C.; Schirmacher, P.; Beckhaus, M-Kristin.; Wolf, S.; Heining, C.; Gröschel, S.; Wolf, Jürgen.; Brors, B.; Weichert, W.; Glimm, H.; Scholl, C.; Mechtersheimer, G.; Specht, K.; Fröhling, S., 2016:
Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma

Criscitiello, C.; Esposito, A.; De Placido, S.; Curigliano, G., 2016:
Targeting fibroblast growth factor receptor pathway in breast cancer

Morales-Barrera, R.; Suárez, C.; de Castro, A.Martínez.; Racca, F.; Valverde, C.; Maldonado, X.; Bastaros, J.Maria.; Morote, J.; Carles, J., 2016:
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope

Tarantino, D.; Cannalire, R.; Mastrangelo, E.; Croci, R.; Querat, G.; Barreca, M.Letizia.; Bolognesi, M.; Manfroni, G.; Cecchetti, V.; Milani, M., 2016:
Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor

Hande, S.; Goswami, K.; Sharma, R.; Bhoj, P.; Jena, L.; Reddy, M.Venkata.Rami., 2016:
Targeting folate metabolism for therapeutic option: A bioinformatics approach

Cheung, A.; Bax, H.J.; Josephs, D.H.; Ilieva, K.M.; Pellizzari, G.; Opzoomer, J.; Bloomfield, J.; Fittall, M.; Grigoriadis, A.; Figini, M.; Canevari, S.; Spicer, J.F.; Tutt, A.N.; Karagiannis, S.N., 2016:
Targeting folate receptor alpha for cancer treatment

Yang, X.; Chordia, M.D.; Du, X.; Graves, J.L.; Zhang, Y.; Park, Y-Sang.; Guo, Y.; Pan, D.; Cui, Q., 2017:
Targeting formyl peptide receptor 1 of activated macrophages to monitor inflammation of experimental osteoarthritis in rat

Smith, H.K.; Gil, C.Damas.; Oliani, S.M.; Gavins, F.N.E., 2015:
Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke

Anonymous, 2005:
Targeting four key areas of illness and death in the UK

Leporatti, L.; Ameri, M.; Trinchero, C.; Orcamo, P.; Montefiori, M., 2017:
Targeting frequent users of emergency departments: Prominent risk factors and policy implications

Bhadola, P.; Deo, N., 2018:
Targeting functional motifs of a protein family

Ma, M.; Weng, M.; Zhang, M.; Qin, Y.; Gong, W.; Quan, Z., 2016:
Targeting gallbladder cancer: hyaluronan sensitizes cancer cells to chemo-therapeutics

Schroeder, B.; Li, Z.; Cranmer, L.D.; Jones, R.L.; Pollack, S.M., 2016:
Targeting gastrointestinal stromal tumors: the role of regorafenib

Jung, A-Reum.; Hovland, R., 2017:
Targeting gender: A content analysis of alcohol advertising in magazines

Beck-Broichsitter, B.E.; Werk, A.N.; Smeets, R.; Gröbe, A.; Heiland, M.; Cascorbi, I.; Wiltfang, Jörg.; Häsler, R.; Becker, S.T., 2017:
Targeting gene expression during the early bone healing period in the mandible: A base for bone tissue engineering

Reilly, J.E.; Neighbors, J.D.; Tong, H.; Henry, M.D.; Hohl, R.J., 2015:
Targeting geranylgeranylation reduces adrenal gland tumor burden in a murine model of prostate cancer metastasis

Zhou, Y-Qun.; Liu, Z.; Liu, H-Quan.; Liu, D-Qiang.; Chen, S-Ping.; Ye, D-Wei.; Tian, Y-Ke., 2016:
Targeting glia for bone cancer pain

Khan, I.Saeed.; Ehtesham, M., 2015 :
Targeting glioblastoma cancer stem cells: the next great hope?

Im, C-Nim., 2016:
Targeting glioblastoma stem cells (GSCs) with peroxisome proliferator-activated receptor gamma (PPARγ) ligands

Dor-On, E.; Solomon, B., 2015:
Targeting glioblastoma via intranasal administration of Ff bacteriophages

Sun, T.; Li, Y.; Huang, Y.; Zhang, Z.; Yang, W.; Du, Z.; Zhou, Y., 2016:
Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy

Raj Kumar, K., 2016:
Targeting glucocerebrosidase: Reduced enzymatic activity and Parkinson's disease

Savic, L.Jeanette.; Chapiro, J.; Duwe, G.; Geschwind, J-François., 2016:
Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?

Xu, C-Fei.; Liu, Y.; Shen, S.; Zhu, Y-Hua.; Wang, J., 2016:
Targeting glucose uptake of glioma cells by siRNA delivery with polymer nanoparticle

Xu, C-Fei.; Liu, Y.; Shen, S.; Zhu, Y-Hua.; Wang, J., 2015:
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy

Tyler, A.; Johansson, A.; Karlsson, T.; Gudey, S.Kumar.; Brännström, T.; Grankvist, K.; Behnam-Motlagh, P., 2015:
Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells

Stefanovic, M.; Tutusaus, A.; Martinez-Nieto, G.A.; Bárcena, C.; de Gregorio, E.; Moutinho, C.; Barbero-Camps, E.; Villanueva, A.; Colell, A.; Marí, M.; García-Ruiz, C.; Fernandez-Checa, J.C.; Morales, A., 2016 :
Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma

Alasmari, F.; Al-Rejaie, S.S.; AlSharari, S.D.; Sari, Y., 2016:
Targeting glutamate homeostasis for potential treatment of nicotine dependence

Beck, K.; Javitt, D.C.; Howes, O.D., 2018:
Targeting glutamate to treat schizophrenia: lessons from recent clinical studies

Rao, P.S.S.; Bell, R.L.; Engleman, E.A.; Sari, Y., 2015:
Targeting glutamate uptake to treat alcohol use disorders

Gardoni, F.; Di Luca, M., 2015:
Targeting glutamatergic synapses in Parkinson's disease

Tanaka, K.; Sasayama, T.; Kohmura, E., 2016:
Targeting glutaminase and mTOR

Zhan, H.; Ciano, K.; Dong, K.; Zucker, S., 2016:
Targeting glutamine metabolism in myeloproliferative neoplasms

Gordon, E.B.; Hart, G.T.; Tran, T.M.; Waisberg, M.; Akkaya, M.; Kim, A.S.; Hamilton, S.E.; Pena, M.; Yazew, T.; Qi, C-Feng.; Lee, C-Fang.; Lo, Y-Chun.; Miller, L.H.; Powell, J.D.; Pierce, S.K., 2016:
Targeting glutamine metabolism rescues mice from late-stage cerebral malaria

Chakrabarti, G.; Moore, Z.R.; Luo, X.; Ilcheva, M.; Ali, A.; Padanad, M.; Zhou, Y.; Xie, Y.; Burma, S.; Scaglioni, P.P.; Cantley, L.C.; DeBerardinis, R.J.; Kimmelman, A.C.; Lyssiotis, C.A.; Boothman, D.A., 2015:
Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone

Jacque, N.; Bouscary, D., 2015:
Targeting glutamine uptake in AML

Jacque, N.; Ronchetti, A.Marie.; Larrue, Cément.; Meunier, G.; Birsen, R.; Willems, L.; Saland, E.; Decroocq, J.; Maciel, T.Trovati.; Lambert, M.; Poulain, L.; Hospital, M.Anne.; Sujobert, P.; Joseph, L.; Chapuis, N.; Lacombe, C.; Moura, I.Cruz.; Demo, S.; Sarry, J.Emmanuel.; Recher, C.; Mayeux, P.; Tamburini, Jérôme.; Bouscary, D., 2015:
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition

Attia, Y.M.; El-Abhar, H.S.; Al Marzabani, M.M.; Shouman, S.A., 2016:
Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines

van Niekerk, D.D.; Penkler, G.P.; du Toit, F.; Snoep, J.L., 2016:
Targeting glycolysis in the malaria parasite Plasmodium falciparum

Adage, T.; Konya, V.; Weber, C.; Strutzmann, E.; Fuchs, T.; Zankl, C.; Gerlza, T.; Jeremic, D.; Heinemann, A.; Kungl, A.J., 2015:
Targeting glycosaminoglycans in the lung by an engineered CXCL8 as a novel therapeutic approach to lung inflammation

Versura, P.; Buzzi, M.; Giannaccare, G.; Terzi, A.; Fresina, M.; Velati, C.; Campos, E.C., 2016:
Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops

Schneiderhan, J.; Master-Hunter, T.; Locke, A., 2016:
Targeting gut flora to treat and prevent disease

He, C.; Shan, Y.; Song, W., 2016:
Targeting gut microbiota as a possible therapy for diabetes

Chen, Z.; Zhu, S.; Xu, G., 2016:
Targeting gut microbiota: a potential promising therapy for diabetic kidney disease

Federico, A.; Dallio, M.; Godos, J.; Loguercio, C.; Salomone, F., 2016:
Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence

Méry, Bîte.; Guy, J-Baptiste.; Espenel, S.; Wozny, A-Sophie.; Simonet, Séphanie.; Vallard, A.; Alphonse, G.; Ardail, D.; Rodriguez-Lafrasse, C.; Magné, N., 2016:
Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectives

Jaff, D.; Singh, K.; Margolis, L., 2017:
Targeting health care in armed conflicts and emergencies: is it underestimated?

Dupas, P.; Hoffmann, V.; Kremer, M.; Zwane, A.Peterson., 2017:
Targeting health subsidies through a nonprice mechanism: A randomized controlled trial in Kenya

Dolansky, M.A.; Capone, L.; Leister, E.; Boxer, R.S., 2017:
Targeting heart failure rehospitalizations in a skilled nursing facility: A case report

Kanwar, M.; Walter, C.; Clarke, M.; Patarroyo-Aponte, M., 2016:
Targeting heart failure with preserved ejection fraction: current status and future prospects

Ali, M.R.K.; Ali, H.R.; Rankin, C.R.; El-Sayed, M.A., 2017:
Targeting heat shock protein 70 using gold nanorods enhances cancer cell apoptosis in low dose plasmonic photothermal therapy

Izraeli, S., 2018:
Targeting hedgehog in T-ALL

Arnhold, V.; Boos, J.; Lanvers-Kaminsky, C., 2016:
Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors

Boehme, K.A.; Zaborski, J.J.; Riester, R.; Schweiss, S.K.; Hopp, U.; Traub, F.; Kluba, T.; Handgretinger, R.; Schleicher, S.B., 2016:
Targeting hedgehog signalling by arsenic trioxide reduces cell growth and induces apoptosis in rhabdomyosarcoma

Moura-Melo, S.; Miranda-Castro, R.; de-Los-Santos-Álvarez, Ní.; Miranda-Ordieres, A.J.; Dos Santos Junior, J.Ribeiro.; da Silva Fonseca, R.A.; Lobo-Castañón, M.Jesús., 2016:
Targeting helicase-dependent amplification products with an electrochemical genosensor for reliable and sensitive screening of genetically modified organisms

Chen-Roetling, J.; Lu, X.; Regan, R.F., 2015:
Targeting heme oxygenase after intracerebral hemorrhage

Ryter, S.W.; Choi, A.M.K., 2016:
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation

Ramani, V.C.; Zhan, F.; He, J.; Barbieri, P.; Noseda, A.; Tricot, G.; Sanderson, R.D., 2016:
Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma

Xiang, M.; Wang, P-Xiao.; Wang, A-Bing.; Zhang, X-Jing.; Zhang, Y.; Zhang, P.; Mei, F-Hua.; Chen, M-Hua.; Li, H., 2018:
Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis

Dong, C.; Qu, L.; Wang, H.; Wei, L.; Dong, Y.; Xiong, S., 2016:
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication

Kennedy, E.M.; Kornepati, A.V.R.; Cullen, B.R., 2016:
Targeting hepatitis B virus cccDNA using CRISPR/Cas9

Hantel, C.; Shapiro, I.; Poli, G.; Chiapponi, C.; Bidlingmaier, M.; Reincke, M.; Luconi, M.; Jung, S.; Beuschlein, F., 2016:
Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation

Vartanian, A.; Agnihotri, S.; Wilson, M.R.; Burrell, K.E.; Tonge, P.D.; Alamsahebpour, A.; Jalali, S.; Taccone, M.S.; Mansouri, S.; Golbourn, B.; Aldape, K.D.; Zadeh, G., 2016 :
Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma

Deng, Y.; Lu, J., 2016:
Targeting hexokinase 2 in castration-resistant prostate cancer

Aslani, F.; Schuppe, H-Christian.; Guazzone, V.A.; Bhushan, S.; Wahle, E.; Lochnit, Günter.; Lustig, L.; Meinhardt, A.; Fijak, M., 2015:
Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis

Wang, X.; Gaustad, G.; Babbitt, C.W., 2016:
Targeting high value metals in lithium-ion battery recycling via shredding and size-based separation

Mooradian, A.D.; Haas, M.J., 2016:
Targeting high-density lipoproteins: increasing de novo production versus decreasing clearance

Mouterde, A-Laure.; Bourdelin, M.; Maison, Oélie.; Coursier, S.; Bontemps, Hé., 2016:
Targeting high-risk drugs to optimize clinical pharmacists' intervention

Stivarou, T.; Stellas, D.; Vartzi, G.; Thomaidou, D.; Patsavoudi, E., 2017:
Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo

Potnuri, A.Godwin.; Allakonda, L.; Appavoo, A.; Saheera, S.; Nair, R.R., 2016:
Targeting histamine-2 receptor for prevention of cardiac remodelling in chronic pressure overload

Woan, K.V.; Lienlaf, M.; Perez-Villaroel, P.; Lee, C.; Cheng, F.; Knox, T.; Woods, D.M.; Barrios, K.; Powers, J.; Sahakian, E.; Wang, H.W.; Canales, J.; Marante, D.; Smalley, K.S.M.; Bergman, J.; Seto, E.; Kozikowski, A.; Pinilla-Ibarz, J.; Sarnaik, A.; Celis, E.; Weber, J.; Sotomayor, E.M.; Villagra, A., 2016:
Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation

Chakrabarti, A.; Melesina, J.; Kolbinger, F.R.; Oehme, I.; Senger, J.; Witt, O.; Sippl, W.; Jung, M., 2017:
Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases

Moskowitz, A.J.; Horwitz, S.M., 2016:
Targeting histone deacetylases in T-cell lymphoma

Lkhagva, B.; Kao, Y-Hsun.; Chen, Y-Chang.; Chao, T-Fan.; Chen, S-Ann.; Chen, Y-Jen., 2017:
Targeting histone deacetylases: A novel therapeutic strategy for atrial fibrillation

Sharma, S.; Taliyan, R., 2015:
Targeting histone deacetylases: a novel approach in Parkinson's disease

Wang, Z-Ying.; Qin, W.; Yi, F., 2015:
Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease

McGrath, J.; Trojer, P., 2016:
Targeting histone lysine methylation in cancer

Song, Y.; Wu, F.; Wu, J., 2017:
Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives

Morera, L.; Lübbert, M.; Jung, M., 2016:
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy

Ward, A.; Khanna, K.Kum.; Wiegmans, A.P., 2015:
Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51

Blanc, F.; Furio, L.; Moisy, Dée.; Yen, H-Ling.; Chignard, M.; Letavernier, E.; Naffakh, N.; Mok, C.Ka.Pun.; Si-Tahar, M., 2017 :
Targeting host calpain proteases decreases influenza A virus infection

Villareal, V.A.; Rodgers, M.A.; Costello, D.A.; Yang, P.L., 2016:
Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses

Crispin, M.; Doores, K.J., 2016:
Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design

Erben, U.; Pawlowski, N.N.; Doerfel, K.; Loddenkemper, C.; Hoffmann, Jörg.C.; Siegmund, B.; Kühl, A.A., 2015:
Targeting human CD2 by the monoclonal antibody CB.219 reduces intestinal inflammation in a humanized transfer colitis model

Roy, S.M.; Grum-Tokars, V.L.; Schavocky, J.P.; Saeed, F.; Staniszewski, A.; Teich, A.F.; Arancio, O.; Bachstetter, A.D.; Webster, S.J.; Van Eldik, L.J.; Minasov, G.; Anderson, W.F.; Pelletier, J.C.; Watterson, D.Martin., 2016:
Targeting human central nervous system protein kinases: An isoform selective p38αMAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse models

Leisegang, M.; Kammertoens, T.; Uckert, W.; Blankenstein, T., 2016:
Targeting human melanoma neoantigens by T cell receptor gene therapy

Dietz, K.C.; Polanco, J.J.; Pol, S.U.; Sim, F.J., 2017:
Targeting human oligodendrocyte progenitors for myelin repair

Ferreira, D.; Seca, A.M.L.; C G A, D.; Silva, A.M.S., 2017:
Targeting human pathogenic bacteria by siderophores: A proteomics review

Ou, Z.; Wang, Y.; Gao, Y.; Wang, X.; Qian, Y.; Li, Y.; Wang, X., 2016:
Targeting human telomeric and c-myc G-quadruplexes with alkynylplatinum(II) terpyridine complexes under molecular crowding conditions

Anonymous, 2015 :
Targeting hunger to help promote population health

Sato, N.; Cheng, X-Bo.; Kohi, S.; Koga, A.; Hirata, K., 2016:
Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma

Lan, T.; Zhao, Z.; Qu, Y.; Zhang, M.; Wang, H.; Zhang, Z.; Zhou, W.; Fan, X.; Yu, C.; Zhan, Q.; Song, Y., 2016:
Targeting hyperactivated DNA-PKcs by KU0060648 inhibits glioma progression and enhances temozolomide therapy via suppression of AKT signaling

Noman, M.Zaeem.; Chouaib, S., 2015:
Targeting hypoxia at the forefront of anticancer immune responses

Colgan, S.P., 2017:
Targeting hypoxia in inflammatory bowel disease

Baumann, Ré.; Depping, R.; Delaperriere, M.; Dunst, J., 2017:
Targeting hypoxia to overcome radiation resistance in head & neck cancers: real challenge or clinical fairytale?

Semenza, G.L., 2017:
Targeting hypoxia-inducible factor 1 to stimulate tissue vascularization

Liu, F.; Dong, X.; Lv, H.; Xiu, P.; Li, T.; Wang, F.; Xu, Z.; Li, J., 2015:
Targeting hypoxia-inducible factor-2α enhances sorafenib antitumor activity via β-catenin/C-Myc-dependent pathways in hepatocellular carcinoma

Dilly, A.K.; Lee, Y.J.; Zeh, H.J.; Guo, Z.Sheng.; Bartlett, D.L.; Choudry, H.A., 2016:
Targeting hypoxia-mediated mucin 2 production as a therapeutic strategy for mucinous tumors

Lohse, I.; Rasowski, J.; Cao, P.; Pintilie, M.; Do, T.; Tsao, M-Sound.; Hill, R.P.; Hedley, D.W., 2018:
Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302

Nesbitt, H.; Byrne, N.M.; Williams, S.Nicole.; Ming, L.; Worthington, J.; Errington, R.J.; Patterson, L.H.; Smith, P.J.; McKeown, S.R.; McKenna, D.J., 2016:
Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression

Paolicchi, E.; Gemignani, F.; Krstic-Demonacos, M.; Dedhar, S.; Mutti, L.; Landi, S., 2017:
Targeting hypoxic response for cancer therapy

Ansell, S.M., 2016:
Targeting immune checkpoints in lymphoma

Zhang, X.; Zhu, S.; Li, T.; Liu, Y-Jun.; Chen, W.; Chen, J., 2016:
Targeting immune checkpoints in malignant glioma

Yun, S.; Vincelette, N.D.; Green, M.R.; Wahner Hendrickson, A.E.; Abraham, I., 2017:
Targeting immune checkpoints in unresectable metastatic cutaneous melanoma: a systematic review and meta-analysis of anti-CTLA-4 and anti-PD-1 agents trials

Marcq, E.; Pauwels, P.; van Meerbeeck, J.P.; Smits, E.L.J., 2016:
Targeting immune checkpoints: New opportunity for mesothelioma treatment?

Brusselle, G.; Bracke, K., 2015:
Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary disease

Vici, P.; Pizzuti, L.; Mariani, L.; Zampa, G.; Santini, D.; Di Lauro, L.; Gamucci, T.; Natoli, C.; Marchetti, P.; Barba, M.; Maugeri-Saccà, M.; Sergi, D.; Tomao, F.; Vizza, E.; Di Filippo, S.; Paolini, F.; Curzio, G.; Corrado, G.; Michelotti, A.; Sanguineti, G.; Giordano, A.; De Maria, R.; Venuti, A., 2017:
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies

Gaga, M.; Zervas, E.; Humbert, M., 2018:
Targeting immunoglobulin E in non-atopic asthma: crossing the red line?

Ghouzali, I.; Lemaitre, C.; Bahlouli, W.; Azhar, Sïda.; Bôle-Feysot, C.; Meleine, M.; Ducrotté, P.; Déchelotte, P.; Coëffier, Mïse., 2016:
Targeting immunoproteasome and glutamine supplementation prevent intestinal hyperpermeability

Skornitzke, S.; Fritz, F.; Mayer, P.; Koell, M.; Hansen, J.; Pahn, G.; Hackert, T.; Kauczor, H-Ulrich.; Stiller, W., 2018:
Dual-energy CT iodine maps as an alternative quantitative imaging biomarker to abdominal CT perfusion: determination of appropriate trigger delays for acquisition using bolus tracking

Liénart, Séphanie.; Stockis, J.; Dedobbeleer, O.; Lucas, S., 2016:
Targeting immunosuppression by Tregs with monoclonal antibodies against GARP

Folkvord, F.; Veling, H.; Hoeken, H., 2017:
Targeting implicit approach reactions to snack food in children: Effects on intake

Thompson, M.; Henshall, C.; Garrison, L.P.; Griffin, A.D.; Coyle, D.; Long, S.; Khayat, Z.A.; Anger, D.L.; Yu, R., 2016:
Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders

Farhan, M.; Rizvi, A.; Naseem, I.; Hadi, S.M.; Ahmad, A., 2016:
Targeting increased copper levels in diethylnitrosamine induced hepatocellular carcinoma cells in rats by epigallocatechin-3-gallate

Ali, J.; Bolton, E.; Saeb-Parsy, K.; Bradley, J.Andrew.; Pettigrew, G., 2015:
Targeting indirect pathway CD4 T-cell alloresponses in the prevention of chronic transplant rejection

Pinchoff, J.; Larsen, D.A.; Renn, S.; Pollard, D.; Fornadel, C.; Maire, M.; Sikaala, C.; Sinyangwe, C.; Winters, B.; Bridges, D.J.; Winters, A.M., 2016:
Targeting indoor residual spraying for malaria using epidemiological data: a case study of the Zambia experience

Fath, R., 2016:
Targeting inflammation

Allison, D.J.; Thomas, A.; Beaudry, K.; Ditor, D.S., 2017:
Targeting inflammation as a treatment modality for neuropathic pain in spinal cord injury: a randomized clinical trial

Perez-Gomez, M.Vanessa.; Sanchez-Niño, M.Dolores.; Sanz, A.Belen.; Zheng, B.; Martín-Cleary, C.; Ruiz-Ortega, M.; Ortiz, A.; Fernandez-Fernandez, B., 2017:
Targeting inflammation in diabetic kidney disease: early clinical trials

Welty, F.K.; Alfaddagh, A.; Elajami, T.K., 2016:
Targeting inflammation in metabolic syndrome

Steele, C.William.; Kaur Gill, N.Angharad.; Jamieson, N.Balfour.; Carter, C.Ross., 2016:
Targeting inflammation in pancreatic cancer: Clinical translation

Carbone, F.; Liberale, L.; Bonaventura, A.; Cea, M.; Montecucco, F., 2016:
Targeting Inflammation in Primary Cardiovascular Prevention

Shen, J.; Shang, Q.; Tam, L-Shan., 2016:
Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis

Lee, C-Hsing.; Changchien, C-Ying.; Hung, Y-Jen., 2015:
Targeting inflammation in type 2 diabetes by antibody-mediated Tyro-3, Axl, Mer receptor activation

Allison, D.J.; Ditor, D.S., 2016:
Targeting inflammation to influence mood following spinal cord injury: a randomized clinical trial

Beloqui, A.; Coco, Régis.; Préat, Véronique., 2016:
Targeting Inflammatory Bowel Diseases by Nanocarriers Loaded with Small and Biopharmaceutical Anti-Inflammatory Drugs

Doss, H.Madhuri.; Dey, C.; Sudandiradoss, C.; Rasool, M.Khan., 2016:
Targeting inflammatory mediators with ferulic acid, a dietary polyphenol, for the suppression of monosodium urate crystal-induced inflammation in rats

Lozano, T.; Soldevilla, M.Martínez.; Casares, N.; Villanueva, H.; Bendandi, M.; Lasarte, J.Jose.; Pastor, F., 2016:
Targeting inhibition of Foxp3 by a CD28 2'-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy

Opel, D.; Schnaiter, A.; Dodier, D.; Jovanovic, M.; Gerhardinger, A.; Idler, I.; Mertens, D.; Bullinger, L.; Stilgenbauer, S.; Fulda, S., 2016:
Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemia

Andreasson, K.I.; Bachstetter, A.D.; Colonna, M.; Ginhoux, F.; Holmes, C.; Lamb, B.; Landreth, G.; Lee, D.C.; Low, D.; Lynch, M.A.; Monsonego, A.; O'Banion, M.Kerry.; Pekny, M.; Puschmann, T.; Russek-Blum, N.; Sandusky, L.A.; Selenica, M-Linda.B.; Takata, K.; Teeling, J.; Town, T.; Van Eldik, L.J., 2017:
Targeting innate immunity for neurodegenerative disorders of the central nervous system

Bednar, K.J.; Ridgway, W.M., 2015:
Targeting innate immunity for treatment of type 1 diabetes

Wu, X-Ming.; Yang, C-Qing.; Mao, Y-Bo.; Wang, L-Jian.; Shangguan, X-Xia.; Chen, X-Ya., 2017:
Targeting insect mitochondrial complex I for plant protection

Migliorini, A.; Roscioni, S.S.; Lickert, H., 2017:
Targeting insulin-producing beta cells for regenerative therapy

Sundaram, A.; Chen, C.; Khalifeh-Soltani, A.; Atakilit, A.; Ren, X.; Qiu, W.; Jo, H.; DeGrado, W.; Huang, X.; Sheppard, D., 2016:
Targeting integrin α5β1 ameliorates severe airway hyperresponsiveness in experimental asthma

Chu, P-Chen.; Kulp, S.K.; Bekaii-Saab, T.; Chen, C-Shih., 2016:
Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer

Zhang, Y.; Zhang, X-Jing.; Li, H., 2015:
Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges

Choi, H.Joung.; Lui, A.; Ogony, J.; Jan, R.; Sims, P.J.; Lewis-Wambi, J., 2015:
Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death

Mathian, A.; Hie, M.; Cohen-Aubart, F.; Amoura, Z., 2016:
Targeting interferons in systemic lupus erythematosus: current and future prospects

Li, N.; Jiang, J.; Fu, J.; Yu, T.; Wang, B.; Qin, W.; Xu, A.; Wu, M.; Chen, Y.; Wang, H., 2017:
Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma

Lee, W-Hwa.; Wu, H-Hsiung.; Huang, C-Kai., 2016:
Targeting interleukin-17 receptors

Schliemann, C.; Gutbrodt, K.L.; Kerkhoff, A.; Pohlen, M.; Wiebe, S.; Silling, G.; Angenendt, L.; Kessler, T.; Mesters, R.M.; Giovannoni, L.; Schäfers, M.; Altvater, B.; Rossig, C.; Grünewald, I.; Wardelmann, E.; Köhler, G.; Neri, D.; Stelljes, M.; Berdel, W.E., 2016:
Targeting interleukin-2 to the bone marrow stroma for therapy of acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation

Zhong, Y.; Dong, S.; Strattan, E.; Ren, L.; Butchar, J.P.; Thornton, K.; Mishra, A.; Porcu, P.; Bradshaw, J.Michael.; Bisconte, A.; Owens, T.D.; Verner, E.; Brameld, K.A.; Funk, J.Oliver.; Hill, R.J.; Johnson, A.J.; Dubovsky, J.A., 2015:
Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694

Lin, P., 2015 :
Targeting interleukin-6 for noninfectious uveitis

Nepal, M.; Thangamani, S.; Seleem, M.N.; Chmielewski, J., 2016:
Targeting intracellular bacteria with an extended cationic amphiphilic polyproline helix

Nair, S.G.; Sharma, A.; Amin, S.; Roberston, G., 2016:
Targeting intracellular signaling pathways in soft tissue sarcoma (STS)

Schweizer, M.T.; Yu, E.Y., 2016:
Targeting intratumoral androgens: statins and beyond

Ambadipudi, S.; Zweckstetter, M., 2016:
Targeting intrinsically disordered proteins in rational drug discovery

Yang, F.; Ma, H.; Belcher, J.; Butler, M.R.; Redmond, T.Michael.; Boye, S.L.; Hauswirth, W.W.; Ding, X-Qin., 2016:
Targeting iodothyronine deiodinases locally in the retina is a therapeutic strategy for retinal degeneration

Kale, V.Pralhad.; Amin, S.G.; Pandey, M.K., 2015:
Targeting ion channels for cancer therapy by repurposing the approved drugs

Mall, M.A.; Galietta, L.J.V., 2016:
Targeting ion channels in cystic fibrosis

Cecconi, F.; Jäättelä, M., 2015:
Targeting ions-induced autophagy in cancer

Picard, E.; Le Rouzic, Q.; Oudar, A.; Berdugo, M.; El Sanharawi, M.; Andrieu-Soler, C.; Naud, M-Christine.; Jonet, L.; Latour, Cé.; Klein, C.; Galiacy, Séphane.; Malecaze, Fçois.; Coppin, Hélène.; Roth, M-Paule.; Jeanny, J-Claude.; Courtois, Y.; Behar-Cohen, F., 2016:
Targeting iron-mediated retinal degeneration by local delivery of transferrin

Affolter, A.; Muller, M-France.; Sommer, K.; Stenzinger, A.; Zaoui, K.; Lorenz, K.; Wolf, T.; Sharma, S.; Wolf, J.; Perner, S.; Weber, K-Josef.; Freier, K.; Plinkert, P.K.; Hess, J.; Weichert, W., 2018:
Targeting irradiation-induced mitogen-activated protein kinase activation in vitro and in an ex vivo model for human head and neck cancer

Fujii, T.; Khawaja, M.Rizwan.; DiNardo, C.D.; Atkins, J.T.; Janku, F., 2017:
Targeting isocitrate dehydrogenase (IDH) in cancer

Regula, Jörg.T.; Lundh von Leithner, P.; Foxton, R.; Barathi, V.A.; Cheung, C.Ming.Gemmy.; Bo Tun, S.Bo.; Wey, Y.Sia.; Iwata, D.; Dostalek, M.; Moelleken, Jörg.; Stubenrauch, K.G.; Nogoceke, E.; Widmer, G.; Strassburger, P.; Koss, M.J.; Klein, C.; Shima, D.T.; Hartmann, G., 2016:
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases

Austin, C.J.D.; Rendina, L.M., 2016:
Targeting key dioxygenases in tryptophan-kynurenine metabolism for immunomodulation and cancer chemotherapy

Guerram, M.; Hamdi, A.Mejda.; Zhang, L-Yong.; Jiang, Z., 2016:
Targeting Key Metabolic Enzymes Involved in Lipid and Protein Biosyntheses for Breast Anticancer Therapies

Teixeira, J.; Ferraz, P.; Gouveia, C.; Azevedo, F.; Neves, São.; Fidalgo, F.; Silva, Aán.M.T., 2016:
Targeting key metabolic points for an enhanced phytoremediation of wastewaters pre-treated by the photo-Fenton process using Solanum nigrum L

Doerig, C.; Grevelding, C.G., 2015:
Targeting kinases in Plasmodium and Schistosoma: Same goals, different challenges

Morais-Santos, F.; Granja, S.; Miranda-Gonçalves, V.; Moreira, Aónio.H.J.; Queirós, S.; Vilaça, Jão.L.; Schmitt, F.C.; Longatto-Filho, A.; Paredes, J.; Baltazar, Fátima.; Pinheiro, Céline., 2016:
Targeting lactate transport suppresses in vivo breast tumour growth

Friedman, N.; Shushan, A.; Rojansky, N.; Shveiky, D.; Levitzki, R.; Chaouat, M.; Ben-Bassat, H., 2016:
Targeting leiomyomas with all-trans-retinoic acid at phosphoinositide 3-kinase pathway suppression: Effective roles of β-catenin and of signaling interactions

Lepore, M.; de Lalla, C.; Mori, L.; Dellabona, P.; De Libero, G.; Casorati, G., 2015:
Targeting leukemia by CD1c-restricted T cells specific for a novel lipid antigen

Belmonte, M.; Hoofd, C.; Weng, A.P.; Giambra, V., 2016:
Targeting leukemia stem cells: which pathways drive self-renewal activity in T-cell acute lymphoblastic leukemia?

Samudio, I.; Konopleva, M., 2016:
Targeting leukemia's "fatty tooth"

Naglah, A.M.; Shinwari, Z.; Bhat, M.A.; Al-Tahhan, M.; Al-Omar, M.A.; Al-Dhfyan, A., 2016:
Targeting leukemic side population cells by isatin derivatives of nicotinic acid amide

Uckun, F.M.; Qazi, S.; Cheng, J., 2016:
Targeting leukemic stem cells with multifunctional bioactive polypeptide nanoparticles

Arseneau, K.O.; Cominelli, F., 2015:
Targeting leukocyte trafficking for the treatment of inflammatory bowel disease

von Roemeling, C.A.; Copland, J.A., 2016:
Targeting lipid metabolism for the treatment of anaplastic thyroid carcinoma

Abeti, R.; Uzun, E.; Renganathan, I.; Honda, T.; Pook, M.A.; Giunti, P., 2016:
Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia

Man, L.C.; Kelly, E.; Duffy, D., 2015:
Targeting lipoprotein (a): an evolving therapeutic landscape

Hénaut, L.; Sanchez-Nino, M.Dolores.; Aldamiz-Echevarría Castillo, G.; Sanz, A.B.; Ortiz, A., 2016:
Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcification

Anonymous, 2015:
Targeting low literacy patients pays off for health system

Yang, Y.; Xu, H.; Huang, W.; Ding, M.; Xiao, J.; Yang, D.; Li, H.; Liu, X-Yuan.; Chu, L., 2016:
Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus

Syljuåsen, R.G.; Hasvold, G.; Hauge, S.; Helland, Åslaug., 2015:
Targeting lung cancer through inhibition of checkpoint kinases

Ghanghoria, R.; Kesharwani, P.; Tekade, R.K.; Jain, N.K., 2016:
Targeting luteinizing hormone-releasing hormone: A potential therapeutics to treat gynecological and other cancers

D'Alessio, S.; Tacconi, C.; Danese, S., 2016:
Targeting lymphatics in inflammatory bowel disease

Torchia, J.; Weiskopf, K.; Levy, R., 2016:
Targeting lymphoma with precision using semisynthetic anti-idiotype peptibodies

Tsukamoto, O.; Asanuma, H.; Kitakaze, M., 2016:
Targeting lysosomal Ca2+ to reduce reperfusion injury

Wuest, M.; Kuchar, M.; Sharma, S.Kiran.; Richter, S.; Hamann, I.; Wang, M.; Vos, L.; Mackey, J.R.; Wuest, F.; Löser, R., 2016:
Targeting lysyl oxidase for molecular imaging in breast cancer

Bao, B.; Maruyama, R.; Yokota, T., 2016:
Targeting mRNA for the treatment of facioscapulohumeral muscular dystrophy

Aderhold, C.; Faber, A.; Umbreit, C.; Birk, R.; Weiss, C.; Sommer, Jörg.Ulrich.; Hörmann, K.; Schultz, J.David., 2015:
Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive and -negative SCC

Madka, V.; Mohammed, A.; Li, Q.; Zhang, Y.; Biddick, L.; Patlolla, J.M.R.; Lightfoot, S.; Towner, R.A.; Wu, X-Ru.; Steele, V.E.; Kopelovich, L.; Rao, C.V., 2016:
Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo

Lee, J-Hoon.Scott.; Vo, T-Trang.; Fruman, D.A., 2016:
Targeting mTOR for the treatment of B cell malignancies

Iriana, S.; Ahmed, S.; Gong, J.; Annamalai, A.Anand.; Tuli, R.; Hendifar, A.Eugene., 2016:
Targeting mTOR in Pancreatic Ductal Adenocarcinoma

Kassem, L.; Abdel-Rahman, O., 2017:
Targeting mTOR pathway in gynecological malignancies: Biological rationale and systematic review of published data

Hatem, R.; El Botty, R.; Chateau-Joubert, S.; Servely, J-Luc.; Labiod, D.; de Plater, L.; Assayag, F.; Coussy, F.; Callens, Céline.; Vacher, S.; Reyal, F.; Cosulich, S.; Diéras, Véronique.; Bièche, I.; Marangoni, E., 2016:
Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers

Pazoki-Toroudi, H.; Amani, H.; Ajami, M.; Nabavi, S.Fazel.; Braidy, N.; Kasi, P.Devi.; Nabavi, S.Mohammad., 2017:
Targeting mTOR signaling by polyphenols: A new therapeutic target for ageing

Carneiro, B.A.; Kaplan, J.B.; Altman, J.K.; Giles, F.J.; Platanias, L.C., 2016:
Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia

Tramutola, A.; Lanzillotta, C.; Di Domenico, F., 2016:
Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies

Gu, L.; Xie, L.; Zuo, C.; Ma, Z.; Zhang, Y.; Zhu, Y.; Gao, J., 2016:
Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt Lymphoma

Karunakaran, D.; Geoffrion, M.; Wei, L.; Gan, W.; Richards, L.; Shangari, P.; DeKemp, E.M.; Beanlands, R.A.; Perisic, L.; Maegdefessel, L.; Hedin, U.; Sad, S.; Guo, L.; Kolodgie, F.D.; Virmani, R.; Ruddy, T.; Rayner, K.J., 2017:
Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis

Philip, P.A., 2018:
Targeting macrophages to treat pancreatic cancer

Diabate, A.; Tripet, Fédéric., 2016:
Targeting male mosquito mating behaviour for malaria control

Oliveira, P.F.; Alves, M.G., 2015:
Targeting mammalian spermatogenesis: a matter of support

Leporini, C.; Ammendola, M.; Marech, I.; Sammarco, G.; Sacco, R.; Gadaleta, C.Damiano.; Oakley, C.; Russo, E.; De Sarro, G.; Ranieri, G., 2016:
Targeting mast cells in gastric cancer with special reference to bone metastases

Singh, J.; Shah, R.; Singh, D., 2016:
Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases

Binda, M.Mercedes.; Donnez, J.; Dolmans, M-Madeleine., 2016:
Targeting mast cells: a new way to treat endometriosis

Nukarinen, E.; Tervahartiala, T.; Valkonen, M.; Hynninen, M.; Kolho, E.; Pettilä, V.; Sorsa, T.; Backman, J.; Hästbacka, J., 2016:
Targeting matrix metalloproteinases with intravenous doxycycline in severe sepsis--A randomised placebo-controlled pilot trial

Wei, D.; Zhang, Q.; Schreiber, J.S.; Parsels, L.A.; Abulwerdi, F.A.; Kausar, T.; Lawrence, T.S.; Sun, Y.; Nikolovska-Coleska, Z.; Morgan, M.A., 2015:
Targeting mcl-1 for radiosensitization of pancreatic cancers

Holers, V.Michael., 2018:
Targeting mechanisms at sites of complement activation for imaging and therapy

Saeed, M.; van Brakel, M.; Zalba, S.; Schooten, E.; Rens, J.A.P.; Koning, G.A.; Debets, R.; Ten Hagen, T.L.M., 2016:
Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody

Vizoso, M.; Esteller, M., 2016:
Targeting melanoma: unusual epigenetics reveals the dynamic rewiring of metastatic cells

Ehlers, M.R.; Rigby, M.R., 2016:
Targeting memory T cells in type 1 diabetes

Sylvester, P.W., 2014:
Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer

Tabatabaei-Malazy, O.; Larijani, B.; Abdollahi, M., 2015:
Targeting metabolic disorders by natural products

Fuentes-Antrás, Jús.; Picatoste, Bén.; Ramírez, E.; Egido, Jús.; Tuñón, Jé.; Lorenzo, Óscar., 2016:
Targeting metabolic disturbance in the diabetic heart

Chaube, B.; Malvi, P.; Singh, S.Vikram.; Mohammad, N.; Meena, A.Singh.; Bhat, M.Kumar., 2016:
Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression

Abdel-Rahman, O., 2016:
Targeting metabolic peculiarities: a potentially novel therapeutic approach for KRAS-mutant lung cancer?

Xu, Q.; Biener-Ramanujan, E.; Yang, W.; Ramanujan, V.Krishnan., 2015:
Targeting metabolic plasticity in breast cancer cells via mitochondrial complex I modulation

Smith, L.K.; Rao, A.D.; McArthur, G.A., 2017:
Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma

Mehta, M.M.; Chandel, N.S., 2016:
Targeting metabolism for lupus therapy

Long, J-Pei.; Li, X-Na.; Zhang, F., 2016:
Targeting metabolism in breast cancer: How far we can go?

Nacarelli, T.; Sell, C., 2016:
Targeting metabolism in cellular senescence, a role for intervention

Amalric, M., 2015:
Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease

Ragsdale, S.W., 2016:
Targeting methanogenesis with a nitrooxypropanol bullet

Eissa, A.G.; Blaxland, J.A.; Williams, R.O.; Metwally, K.A.; El-Adl, S.M.; Lashine, E-Sayed.M.; Baillie, L.W.J.; Simons, C., 2017:
Targeting methionyl tRNA synthetase: design, synthesis and antibacterial activity against Clostridium difficile of novel 3-biaryl-N-benzylpropan-1-amine derivatives

Jin, Y.; Zhou, J.; Xu, F.; Jin, B.; Cui, L.; Wang, Y.; Du, X.; Li, J.; Li, P.; Ren, R.; Pan, J., 2016:
Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia

Winkler, M.A.; Dib, C.; Ljubimov, A.V.; Saghizadeh, M., 2016:
Targeting miR-146a to treat delayed wound healing in human diabetic organ-cultured corneas

Liang, H.; Dong, Z.; Liu, J-Feng.; Chuang, W.; Gao, L-Zhen.; Ren, Y-Guo., 2016:
Targeting miR-155 suppresses proliferation and induces apoptosis of HL-60 cells by targeting Slug/PUMA signal

Reddy, M.A.; Natarajan, R., 2018:
Targeting miR-200c to Ameliorate Diabetes-Induced Endothelial Dysfunction

Wang, W-Zhang.; Lin, X-Hua.; Pu, Q-Hong.; Liu, M-Yu.; Li, L.; Wu, L-Rong.; Wu, Q-Qing.; Mao, J-Wen.; Zhu, J-Yong.; Jin, X-Bao., 2014:
Targeting miR-21 sensitizes Ph+ ALL Sup-b15 cells to imatinib-induced apoptosis through upregulation of PTEN

Wang, Y.; Zhu, Y.; Lv, P.; Li, L., 2016:
Targeting miR-21 with AS-miR-21 suppresses aggressive growth of human tongue squamous cell carcinoma in vivo

Báez-Vega, P.M.; Echevarría Vargas, I.M.; Valiyeva, F.; Encarnación-Rosado, J.; Roman, A.; Flores, J.; Marcos-Martínez, Mía.J.; Vivas-Mejía, P.E., 2016:
Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells

Wang, C-Y.; Ren, J-B.; Liu, M.; Yu, L., 2017:
Targeting miR-29 induces apoptosis of osteosarcoma MG-63 cells via regulation of TGF-β1/PUMA signal

Wang, Z.; Yang, J.; Xu, G.; Wang, W.; Liu, C.; Yang, H.; Yu, Z.; Lei, Q.; Xiao, L.; Xiong, J.; Zeng, L.; Xiang, J.; Ma, J.; Li, G.; Wu, M., 2016:
Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors

Zhu, J.; Zhou, Q.; Tan, S., 2016:
Targeting miRNAs associated with surface expression of death receptors to modulate TRAIL resistance in breast cancer

Motavaf, M.; Safari, S.; Alavian, S.M., 2015:
Targeting microRNA-122: walking on cutting edge of hepatitis C virus infection therapy

Paladini, L.; Fabris, L.; Bottai, G.; Raschioni, C.; Calin, G.A.; Santarpia, L., 2016:
Targeting microRNAs as key modulators of tumor immune response

Jeker, L.T.; Marone, R., 2016:
Targeting microRNAs for immunomodulation

Lv, D.; Liu, J.; Zhao, C.; Sun, Q.; Zhou, Q.; Xu, J.; Xiao, J., 2015:
Targeting microRNAs in Pathological Hypertrophy and Cardiac Failure

Garg, M., 2015:
Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer

Duygu, B.; de Windt, L.J.; da Costa Martins, P.A., 2016:
Targeting microRNAs in heart failure

Lopaschuk, G.D.; Ussher, J.R., 2015:
Targeting microRNAs to limit myocardial lipid accumulation

Saint-Georges-Chaumet, Y.; Attaf, D.; Pelletier, E.; Edeas, M., 2016:
Targeting microbiota-mitochondria inter-talk: Microbiota control mitochondria metabolism

Chen, Y-Chu.; Chiang, C-Feng.; Wu, S-Kai.; Chen, L-Fang.; Hsieh, W-Yuan.; Lin, W-Li., 2016:
Targeting microbubbles-carrying TGFβ1 inhibitor combined with ultrasound sonication induce BBB/BTB disruption to enhance nanomedicine treatment for brain tumors

Martin, M.; Wei, H.; Lu, T., 2016:
Targeting microenvironment in cancer therapeutics

McGeer, P.L.; McGeer, E.G., 2015:
Targeting microglia for the treatment of Alzheimer's disease

Roseblade, A.; Luk, F.; Ung, A.; Bebawy, M., 2016:
Targeting microparticle biogenesis: a novel approach to the circumvention of cancer multidrug resistance

Walsh, M.T.; Hussain, M.Mahmood., 2016:
Targeting microsomal triglyceride transfer protein and lipoprotein assembly to treat homozygous familial hypercholesterolemia

Pokorný, Jří.; Pokorný, J.; Kobilková, J.; Jandová, A.; Vrba, J.; Vrba, J., 2015:
Targeting mitochondria for cancer treatment - two types of mitochondrial dysfunction

Kirkby, C.; Ghasroddashti, E., 2015:
Targeting mitochondria in cancer cells using gold nanoparticle-enhanced radiotherapy: a Monte Carlo study

Cairns, A.G.; McQuaker, S.J.; Murphy, M.P.; Hartley, R.C., 2015:
Targeting mitochondria with small molecules: the preparation of MitoB and MitoP as exomarkers of mitochondrial hydrogen peroxide

Fielden, L.F.; Kang, Y.; Newton, H.J.; Stojanovski, D., 2016:
Targeting mitochondria: how intravacuolar bacterial pathogens manipulate mitochondria

Bralha, F.N.; Liyanage, S.U.; Hurren, R.; Wang, X.; Son, M.Hi.; Fung, T.A.; Chingcuanco, F.B.; Tung, A.Y.W.; Andreazza, A.C.; Psarianos, P.; Schimmer, A.D.; Salmena, L.; Laposa, R.R., 2016 :
Targeting mitochondrial RNA polymerase in acute myeloid leukemia

Hey-Mogensen, M.; Clausen, T.R., 2016:
Targeting Mitochondrial Biogenesis and Mitochondrial Substrate Utilization to Treat Obesity and Insulin Resistance, Respectively - Two Data-Driven Hypotheses

Zhang, G.; Frederick, D.T.; Wu, L.; Wei, Z.; Krepler, C.; Srinivasan, S.; Chae, Y.Chan.; Xu, X.; Choi, H.; Dimwamwa, E.; Ope, O.; Shannan, B.; Basu, D.; Zhang, D.; Guha, M.; Xiao, M.; Randell, S.; Sproesser, K.; Xu, W.; Liu, J.; Karakousis, G.C.; Schuchter, L.M.; Gangadhar, T.C.; Amaravadi, R.K.; Gu, M.; Xu, C.; Ghosh, A.; Xu, W.; Tian, T.; Zhang, J.; Zha, S.; Liu, Q.; Brafford, P.; Weeraratna, A.; Davies, M.A.; Wargo, J.A.; Avadhani, N.G.; Lu, Y.; Mills, G.B.; Altieri, D.C.; Flaherty, K.T.; Her, 2017:
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors

Ozkaya, A.Burak.; Ak, H.; Atay, S.; Aydin, H.Hakan., 2015:
Targeting mitochondrial citrate transport in breast cancer cell lines

Schöckel, L.; Glasauer, A.; Basit, F.; Bitschar, K.; Truong, H.; Erdmann, G.; Algire, C.; Hägebarth, A.; Willems, P.Hgm.; Kopitz, C.; Koopman, W.Jh.; Héroult, Mélanie., 2015:
Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth

Sabbah, H.N., 2016:
Targeting mitochondrial dysfunction in the treatment of heart failure

Gut, P., 2016:
Targeting mitochondrial energy metabolism with TSPO ligands

Chhetri, J.; Gueven, N., 2017:
Targeting mitochondrial function to protect against vision loss

Gueven, N.; Nadikudi, M.; Daniel, A.; Chhetri, J., 2016:
Targeting mitochondrial function to treat optic neuropathy

Jannig, P.R.; Ruas, J.L., 2016:
Targeting mitochondrial mRNA translation to tackle obesity-induced insulin resistance: thumbs up for exercise

Liddell, J.R., 2016:
Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration

Adesina, S.E.; Kang, B-Yong.; Bijli, K.M.; Ma, J.; Cheng, J.; Murphy, T.C.; Michael Hart, C.; Sutliff, R.L., 2016:
Targeting mitochondrial reactive oxygen species to modulate hypoxia-induced pulmonary hypertension

Erfle, H.; Pashayeva, K.; Harder, N.; Zhang, L.; Rohr, K.; Schadendorf, D.; Ugurel, S.; Keese, M., 2016:
Targeting mitosis-regulating genes in cisplatin-sensitive and -resistant melanoma cells: A live-cell RNAi screen displays differential nucleus-derived phenotypes

Wang, A-Li.; Lowen, S.B.; Shi, Z.; Bissey, B.; Metzger, D.S.; Langleben, D.D., 2017:
Targeting modulates audiences' brain and behavioral responses to safe sex video ads

Singh, A.; Mallick, B.Nath., 2015:
Targeting modulation of noradrenalin release in the brain for amelioration of REMS loss-associated effects

Ostojic, S.M., 2015:
Targeting molecular hydrogen to mitochondria: barriers and gateways

Vega-Rodriguez, J.; Perez-Barreto, D.; Ruiz-Reyes, A.; Jacobs-Lorena, M., 2016:
Targeting molecular interactions essential for Plasmodium sexual reproduction

Chandrasekar, T.; Yang, J.C.; Gao, A.C.; Evans, C.P., 2016:
Targeting molecular resistance in castration-resistant prostate cancer

Maiese, K., 2015:
Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders

Zheng, X.; Andruska, N.; Lambrecht, M.J.; He, S.; Parissenti, A.; Hergenrother, P.J.; Nelson, E.R.; Shapiro, D.J., 2016:
Targeting multidrug-resistant ovarian cancer through estrogen receptor α dependent ATP depletion caused by hyperactivation of the unfolded protein response

Tzelepis, F.; Paul, C.L.; Wiggers, J.; Kypri, K.; Bonevski, B.; McElduff, P.; Hill, M.Ann.; Morgan, P.J.; Lynagh, M.; Collins, C.E.; Campbell, E.; Courtney, R.J.; Chapman, K.; Wolfenden, L.; Guillaumier, A.; Searles, A., 2015:
Targeting multiple health risk behaviours among vocational education students using electronic feedback and online and telephone support: protocol for a cluster randomised trial

Swamy, S.G.; Kameshwar, V.H.; Shubha, P.B.; Looi, C.Yeng.; Shanmugam, M.K.; Arfuso, F.; Dharmarajan, A.; Sethi, G.; Shivananju, N.Swamy.; Bishayee, A., 2016:
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma

Zang, C.; Eucker, J.; Habbel, P.; Neumann, C.; Schulz, C-Oliver.; Bangemann, N.; Kissner, L.; Riess, H.; Liu, H., 2016:
Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer

de Rooy, C.; Grossmann, M.; Zajac, J.D.; Cheung, A.S., 2016:
Targeting muscle signaling pathways to minimize adverse effects of androgen deprivation

Vu, H.Linh.; Aplin, A.E., 2017:
Targeting mutant NRAS signaling pathways in melanoma

Verissimo, C.S.; Overmeer, Ré.M.; Ponsioen, B.; Drost, J.; Mertens, S.; Verlaan-Klink, I.; Gerwen, B.van.; van der Ven, M.; Wetering, M.van.de.; Egan, D.A.; Bernards, Ré.; Clevers, H.; Bos, J.L.; Snippert, H.J., 2016:
Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening

Oren, M.; Tal, P.; Rotter, V., 2018:
Targeting mutant p53 for cancer therapy

Mantovani, F.; Walerych, D.; Sal, G.Del., 2016:
Targeting mutant p53 in cancer: a long road to precision therapy

Khan, A.Nazmul.H.; Kolomeyevskaya, N.; Singel, K.L.; Grimm, M.J.; Moysich, K.B.; Daudi, S.; Grzankowski, K.S.; Lele, S.; Ylagan, L.; Webster, G.A.; Abrams, S.I.; Odunsi, K.; Segal, B.H., 2016:
Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer

Zhang, Y.; Xu, T.; Wu, B.; Chen, H.; Pan, Z.; Huang, Y.; Mei, L.; Dai, Y.; Liu, X.; Shan, X.; Liang, G., 2016:
Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury

Trikha, P.; Plews, R.L.; Stiff, A.; Gautam, S.; Hsu, V.; Abood, D.; Wesolowski, R.; Landi, I.; Mo, X.; Phay, J.; Chen, C-Shih.; Byrd, J.; Caligiuri, M.; Tridandapani, S.; Carson, W., 2016:
Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator

Holmgaard, R.B.; Zamarin, D.; Lesokhin, A.; Merghoub, T.; Wolchok, J.D., 2017:
Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors

Monassier, L.; Ayme-Dietrich, E.; Aubertin-Kirch, Gëlle.; Pathak, A., 2016:
Targeting myocardial reperfusion injuries with cyclosporine in the CIRCUS Trial - pharmacological reasons for failure

Yossef, R.; Gur, C.; Shemesh, A.; Guttman, O.; Hadad, U.; Nedvetzki, S.; Miletić, A.; Nalbandyan, K.; Cerwenka, A.; Jonjic, S.; Mandelboim, O.; Porgador, A., 2016:
Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes

Zhang, H.; Zhang, J.; Chen, L.; Weng, Z.; Tian, Y.; Zhao, H.; Li, Y.; Chen, L.; Liang, Z.; Zheng, H.; Zhao, W.; Zhong, S.; Li, Y., 2016:
Targeting naturally occurring epitope variants of hepatitis C virus with high-affinity T-cell receptors

Chaluvally-Raghavan, P.; Mills, G.B., 2015:
Targeting ncRNAs in the 3q26.2 amplicon

Godbersen, J.Claire.; Paiva, C.; Danilova, O.V.; Berger, A.; Brown, J.R.; Danilov, A.V., 2016:
Targeting neddylation effectively antagonizes nuclear factor-κB in chronic lymphocytic leukemia B-cells

Kurimori, M.; Shiozawa, P.; Bikson, M.; Aboseria, M.; Cordeiro, Q., 2016:
Targeting negative symptoms in schizophrenia: results from a proof-of-concept trial assessing prefrontal anodic tDCS protocol

Lu, Y-Chen.; Robbins, P.F., 2018:
Targeting neoantigens for cancer immunotherapy

Maffei, R.; Fiorcari, S.; Martinelli, S.; Potenza, L.; Luppi, M.; Marasca, R., 2016:
Targeting neoplastic B cells and harnessing microenvironment: the "double face" of ibrutinib and idelalisib

Broutier, L.; Creveaux, M.; Vial, J.; Tortereau, A.; Delcros, J-Guy.; Chazot, G.; McCarron, M.J.; Léon, S.; Pangault, Céline.; Gadot, N.; Colombe, Aélie.; Boulland, M-Laure.; Blachier, J.; Marie, J.C.; Traverse-Glehen, A.; Donzé, O.; Chassagne-Clément, C.; Salles, G.; Tarte, K.; Mehlen, P.; Castets, M., 2016:
Targeting netrin-1/DCC interaction in diffuse large B-cell and mantle cell lymphomas

Vlachostergios, P.J.; Papandreou, C.N., 2015:
Targeting neuroendocrine prostate cancer: molecular and clinical perspectives

Bronzuoli, M.Rosanna.; Iacomino, A.; Steardo, L.; Scuderi, C., 2016:
Targeting neuroinflammation in Alzheimer's disease

Deardorff, W.James.; Grossberg, G.T., 2016:
Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics

Alam, J.; Scheper, W., 2016:
Targeting neuronal MAPK14/p38α activity to modulate autophagy in the Alzheimer disease brain

Onysko, M.; Legerski, P.; Potthoff, J.; Erlandson, M., 2016:
Targeting neuropathic pain: consider these alternatives

Frau, R.; Abbiati, F.; Bini, V.; Casti, A.; Caruso, D.; Devoto, P.; Bortolato, M., 2016:
Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress

Yuan, L.; Li, J.; Zha, J.; Wang, Z., 2016:
Targeting neurotrophic factors and their receptors, but not cholinesterase or neurotransmitter, in the neurotoxicity of TDCPP in Chinese rare minnow adults (Gobiocypris rarus)

Müller-Redetzky, H., 2015:
Targeting neutrophil extracellular traps in acute lung injury: a novel therapeutic approach in acute respiratory distress syndrome?

Bruijnzeel, P.L.B.; Uddin, M.; Koenderman, L., 2016:
Targeting neutrophilic inflammation in severe neutrophilic asthma: can we target the disease-relevant neutrophil phenotype?

Jamesdaniel, S.; Rathinam, R.; Neumann, W.L., 2016:
Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity

Hardy, K.M.; Strizzi, L.; Margaryan, N.V.; Gupta, K.; Murphy, G.F.; Scolyer, R.A.; Hendrix, M.J.C., 2016:
Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma

Huang, K.; Liu, D., 2017:
Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer

Maracle, C.X.; Kucharzewska, P.; Helder, B.; van der Horst, C.; Correa de Sampaio, P.; Noort, A-Ri.; van Zoest, K.; Griffioen, A.W.; Olsson, H.; Tas, S.W., 2016:
Targeting non-canonical nuclear factor-κB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis

Denby, L.; Baker, A.H., 2016:
Targeting non-coding RNA for the therapy of renal disease

Hojjat-Farsangi, M., 2016:
Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances

Luraguiz, N.S.; Yong, T.; Yin, H.; Sun, A., 2016:
Targeting notch signaling and estrogen receptor pathways in human breast cancer stem cells

Sakamoto, K.M.; Grant, S.; Saleiro, D.; Crispino, J.D.; Hijiya, N.; Giles, F.; Platanias, L.; Eklund, E.A., 2016:
Targeting novel signaling pathways for resistant acute myeloid leukemia

Chon, J.; Stover, P.J.; Field, M.S., 2016:
Targeting nuclear thymidylate biosynthesis

Stelma, T.; Chi, A.; van der Watt, P.J.; Verrico, A.; Lavia, P.; Leaner, V.D., 2016:
Targeting nuclear transporters in cancer: Diagnostic, prognostic and therapeutic potential

Chen, F.; Jiang, J.; Tian, D-Dan.; Wen, Q.; Li, Y-Hui.; Zhang, J-Qing.; Cheng, C.; Wang, T., 2016:
Targeting Obesity for the Prevention of Chronic Cardiovascular Disease Through Gut Microbiota-Herb Interactions: An Opportunity for Traditional Herbs

Osadnik, C.R.; Cavalheri, V., 2016:
Targeting obesity in COPD through allied health therapies

Gucalp, A.; Iyengar, N.M.; Hudis, C.A.; Dannenberg, A.J., 2016:
Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression

Ma, Q.; Jiao, Y.; Hao, Y.; Yan, S.; Lyu, N.; Gao, H.; Li, D.; Liu, Q.; Zheng, J.; Song, N., 2016:
Targeting of NHERF1 through RNA interference inhibits the proliferation and migration of metastatic prostate cancer cells

Vyas, A.; Jain, A.; Hurkat, P.; Jain, A.; Jain, S.K., 2016:
Targeting of AIDS related encephalopathy using phenylalanine anchored lipidic nanocarrier

Kim, J.; Yang, G.; Ha, J., 2016:
Targeting of AMP-activated protein kinase: prospects for computer-aided drug design

Verdier, P.; Morthorst, S.K.; Pedersen, L.B., 2018:
Targeting of ASH Domain-Containing Proteins to the Centrosome

Ebron, J.Sabith.; Weyman, C.M.; Shukla, G.C., 2013:
Targeting of Androgen Receptor Expression by Andro-miRs as Novel Adjunctive Therapeutics in Prostate Cancer

Klanova, M.; Andera, L.; Brazina, J.; Svadlenka, J.; Benesova, S.; Soukup, J.; Prukova, D.; Vejmelkova, D.; Jaksa, R.; Helman, K.; Vockova, P.; Lateckova, L.; Molinsky, J.; Maswabi, B.Calvin.Lenyeletse.; Alam, M.; Kodet, R.; Pytlik, R.; Trneny, M.; Klener, P., 2016:
Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma

Lin, X.; Qureshi, M.Z.; Attar, R.; Khalid, S.; Tahir, F.; Yaqub, A.; Aslam, A.; Yaylim, I.; De Carlos Back, L.K.; Farooqi, A.A.; Ismail, M., 2017:
Targeting of BCR-ABL: Lessons learned from BCR-ABL inhibition

Bolomsky, A.; Schlangen, K.; Schreiner, W.; Zojer, N.; Ludwig, H., 2016:
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment

Mansouri, N.; Movafagh, A.; Sayad, A.; Heidary Pour, A.; Taheri, M.; Soleimani, S.; Mirzaei, H.Reza.; Alizadeh Shargh, S.; Azargashb, E.; Bazmi, H.; Allah Moradi, H.; Zandnia, F.; Hashemi, M.; Massoudi, N.; Mortazavi-Tabatabaei, S.A., 2017:
Targeting of BUB1b Gene Expression in Sentinel Lymph Node Biopsies of Invasive Breast Cancer in Iranian Female Patients

Roblek, M.; Strutzmann, E.; Zankl, C.; Adage, T.; Heikenwalder, M.; Atlic, A.; Weis, R.; Kungl, A.; Borsig, L., 2016:
Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding

Atmaja, B.; Lui, B.H.; Hu, Y.; Beck, S.E.; Frank, C.W.; Cochran, J.R., 2010:
Targeting of Cancer Cells Using Quantum Dot-Polypeptide Hybrid Assemblies that Function as Molecular Imaging Agents and Carrier Systems

Ma, H.; Takahashi, A.; Sejimo, Y.; Adachi, A.; Kubo, N.; Isono, M.; Yoshida, Y.; Kanai, T.; Ohno, T.; Nakano, T., 2016:
Targeting of Carbon Ion-Induced G2 Checkpoint Activation in Lung Cancer Cells Using Wee-1 Inhibitor MK-1775

Gokare, P.; Navaraj, A.; Zhang, S.; Motoyama, N.; Sung, S-Shu.; Finnberg, N.K., 2017:
Targeting of Chk2 as a countermeasure to dose-limiting toxicity triggered by topoisomerase-II (TOP2) poisons

Mahendiran, D.; Kumar, R.Senthil.; Viswanathan, V.; Velmurugan, D.; Rahiman, A.Kalilur., 2018:
Targeting of DNA molecules, BSA/c-Met tyrosine kinase receptors and anti-proliferative activity of bis(terpyridine)copper(ii) complexes

Schiavinato, A.; Keene, D.R.; Wohl, A.P.; Corallo, D.; Colombatti, A.; Wagener, R.; Paulsson, M.; Bonaldo, P.; Sengle, G., 2017:
Targeting of EMILIN-1 and EMILIN-2 to Fibrillin Microfibrils Facilitates their Incorporation into the Extracellular Matrix

Skwarska, A.; Augustin, E.; Beffinger, Mł.; Wojtczyk, A.; Konicz, S.; Laskowska, K.; Polewska, J., 2015:
Targeting of FLT3-ITD kinase contributes to high selectivity of imidazoacridinone C-1311 against FLT3-activated leukemia cells

Johnston, A.J.; Murphy, K.T.; Jenkinson, L.; Laine, D.; Emmrich, K.; Faou, P.; Weston, R.; Jayatilleke, K.M.; Schloegel, J.; Talbo, G.; Casey, J.L.; Levina, V.; Wong, W.Wei-Lynn.; Dillon, H.; Sahay, T.; Hoogenraad, J.; Anderton, H.; Hall, C.; Schneider, P.; Tanzer, M.; Foley, M.; Scott, A.M.; Gregorevic, P.; Liu, S.Yingchun.; Burkly, L.C.; Lynch, G.S.; Silke, J.; Hoogenraad, N.J., 2015:
Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival

Draper, L.M.; Kwong, M.Li.M.; Gros, A.; Stevanović, S.; Tran, E.; Kerkar, S.; Raffeld, M.; Rosenberg, S.A.; Hinrichs, C.S., 2016:
Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6

Becirovic, L.; Brown, I.R., 2016:
Targeting of Heat Shock Protein HSPA6 (HSP70B') to the Periphery of Nuclear Speckles is Disrupted by a Transcription Inhibitor Following Thermal Stress in Human Neuronal Cells

Skouloubris, Séphane.; Djaout, K.; Lamarre, I.; Lambry, J-Christophe.; Anger, K.; Briffotaux, J.; Liebl, U.; de Reuse, H.; Myllykallio, H., 2016:
Targeting of Helicobacter pylori thymidylate synthase ThyX by non-mitotoxic hydroxy-naphthoquinones

Lin, X.; Zou, X.; Wang, Z.; Fang, Q.; Chen, S.; Huang, J.; Zhe, N.; Yu, M.; Zhang, Y.; Wang, J., 2016:
Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL

Suzuki, A.; Leland, P.; Joshi, B.H.; Puri, R.K., 2016:
Targeting of IL-4 and IL-13 receptors for cancer therapy

Cuenca, M.; Romero, X.; Sintes, J.; Terhorst, C.; Engel, P., 2016:
Targeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody Responses

Hu, K.Yao.; Wang, D.Gui.; Liu, P.Fei.; Cao, Y.Wei.; Wang, Y.Hua.; Yang, X.Cheng.; Hu, C.Xia.; Sun, L.Jiang.; Niu, H.Tao., 2017:
Targeting of MCT1 and PFKFB3 influences cell proliferation and apoptosis in bladder cancer by altering the tumor microenvironment

Heigener, D.F.; Gandara, D.R.; Reck, M., 2016:
Targeting of MEK in lung cancer therapeutics

Liu, Q.; Pan, D.; Cheng, C.; Zhang, A.; Ma, C.; Wang, L.; Zhang, D.; Liu, H.; Jiang, H.; Wang, T.; Xu, Y.; Yang, R.; Chen, F.; Yang, M.; Zuo, C., 2016:
Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide

Stermann, A.; Huebener, N.; Seidel, D.; Fest, S.; Eschenburg, G.; Stauder, M.; Schramm, A.; Eggert, A.; Lode, H.N., 2015:
Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice

Zhang, J.; Link, D.C., 2016:
Targeting of Mesenchymal Stromal Cells by Cre-Recombinase Transgenes Commonly Used to Target Osteoblast Lineage Cells

Pattni, B.S.; Nagelli, S.G.; Aryasomayajula, B.; Deshpande, P.P.; Kulkarni, A.; Hartner, W.C.; Thakur, G.; Degterev, A.; Torchilin, V.P., 2017:
Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model

Bykov, V.J.N.; Zhang, Q.; Zhang, M.; Ceder, S.; Abrahmsen, L.; Wiman, K.G., 2016:
Targeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer Therapy

Xie, L.; Jiang, F-Chao.; Zhang, L-Min.; He, W-Tao.; Liu, J-Hua.; Li, M-Qiang.; Zhang, X.; Xing, S.; Guo, H.; Zhou, P., 2016:
Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer

Dosoki, H.; Stegemann, A.; Taha, M.; Schnittler, H.; Luger, T.A.; Schröder, K.; Distler, Jörg.H.W.; Kerkhoff, C.; Böhm, M., 2016:
Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis

Brazil, J.C.; Sumagin, R.; Cummings, R.D.; Louis, N.A.; Parkos, C.A., 2016:
Targeting of Neutrophil Lewis X Blocks Transepithelial Migration and Increases Phagocytosis and Degranulation

Huisinga, K.L.; Riddle, N.C.; Leung, W.; Shimonovich, S.; McDaniel, S.; Figueroa-Clarevega, A.; Elgin, S.C.R., 2016:
Targeting of P-Element Reporters to Heterochromatic Domains by Transposable Element 1360 in Drosophila melanogaster

Herrero-Sánchez, Mª.Carmen.; Rodríguez-Serrano, Cón.; Almeida, J.; San Segundo, L.; Inogés, S.; Santos-Briz, Ángel.; García-Briñón, Jús.; Corchete, L.Antonio.; San Miguel, Jús.F.; Del Cañizo, C.; Blanco, Bén., 2016:
Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development

Verma, N.; Müller, A-Katharina.; Kothari, C.; Panayotopoulou, E.; Kedan, A.; Selitrennik, M.; Mills, G.B.; Nguyen, L.K.; Shin, S.; Karn, T.; Holtrich, U.; Lev, S., 2016:
Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis

Engel, J.B.; Tinneberg, H-Rudolf.; Rick, F.G.; Berkes, E.; Schally, A.V., 2016:
Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer

Shaukat, I.; Barré, L.; Venkatesan, N.; Li, D.; Jaquinet, J-Claude.; Fournel-Gigleux, S.; Ouzzine, M., 2016:
Targeting of Proteoglycan Synthesis Pathway: A New Strategy to Counteract Excessive Matrix Proteoglycan Deposition and Transforming Growth Factor-β1-Induced Fibrotic Phenotype in Lung Fibroblasts

Lopergolo, A.; Perrone, R.; Tortoreto, M.; Doria, F.; Beretta, G.L.; Zuco, V.; Freccero, M.; Borrello, M.Grazia.; Lanzi, C.; Richter, S.N.; Zaffaroni, N.; Folini, M., 2016:
Targeting of RET oncogene by naphthalene diimide-mediated gene promoter G-quadruplex stabilization exerts anti-tumor activity in oncogene-addicted human medullary thyroid cancer

Lee, S.Hee.; Jung, Y.Dong.; Choi, Y.Sun.; Lee, Y.Mie., 2016:
Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells

Mathew, G.; Hannan, A.; Hertzler-Schaefer, K.; Wang, F.; Feng, G-Sheng.; Zhong, J.; Zhao, J.J.; Downward, J.; Zhang, X., 2016:
Targeting of Ras-mediated FGF signaling suppresses Pten-deficient skin tumor

Owen, S.; Sanders, A.J.; Mason, M.D.; Jiang, W.G., 2016:
Targeting of Receptor Activator of Nuclear Kappa B (RANK) in PC-3 Cells Increases Cell Proliferation and Matrix Adhesion In Vitro

Taipaleenmäki, H.; Browne, G.; Akech, J.; Zustin, J.; van Wijnen, A.J.; Stein, J.L.; Hesse, E.; Stein, G.S.; Lian, J.B., 2016:
Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease

Zhang, W.; Liu, Y.; Li, Y.Feng.; Yue, Y.; Yang, X.; Peng, L., 2017:
Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells

Huang, H-Ling.; Chiang, C-Hsiang.; Hung, W-Chun.; Hou, M-Feng., 2015:
Targeting of TGF-β-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer

Lee, Y-Chieh.; Lee, C-Hong.; Tsai, H-Ping.; An, H-Wei.; Lee, C-Ming.; Wu, J-Chine.; Chen, C-Shu.; Huang, S-Hao.; Hwang, J.; Cheng, K-Ta.; Leiw, P-Ly.; Chen, C-Long.; Lin, C-Mao., 2016:
Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer

Maher, J.; Wilkie, S.; Davies, D.M.; Arif, S.; Picco, G.; Julien, S.; Foster, J.; Burchell, J.; Taylor-Papadimitriou, J., 2017:
Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells

Kang, W.; Tong, J.H.M.; Lung, R.W.M.; Dong, Y.; Zhao, J.; Liang, Q.; Zhang, L.; Pan, Y.; Yang, W.; Pang, J.C.S.; Cheng, A.S.L.; Yu, J.; To, K.Fai., 2016:
Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma

Babadjanova, Z.; Wiedinger, K.; Gosselin, E.J.; Bitsaktsis, C., 2016:
Targeting of a Fixed Bacterial Immunogen to Fc Receptors Reverses the Anti-Inflammatory Properties of the Gram-Negative Bacterium, Francisella tularensis, during the Early Stages of Infection

Lim, L.; Sayers, C.P.; Goodman, C.D.; McFadden, G.I., 2017:
Targeting of a Transporter to the Outer Apicoplast Membrane in the Human Malaria Parasite Plasmodium falciparum

Fernandes-Cerqueira, Cátia.; Ossipova, E.; Gunasekera, S.; Hansson, M.; Mathsson, L.; Catrina, A.I.; Sommarin, Y.; Klareskog, L.; Lundberg, K.; Rönnelid, J.; Göransson, U.; Jakobsson, P-Johan., 2016:
Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens

Valdebenito, Río.; Ruminot, Ián.; Garrido-Gerter, P.; Fernández-Moncada, I.; Forero-Quintero, L.; Alegría, K.; Becker, H.M.; Deitmer, J.W.; Barros, L.Felipe., 2015:
Targeting of astrocytic glucose metabolism by beta-hydroxybutyrate

Domanović, D.; Kitchen, A.; Politis, C.; Panagiotopoulos, T.; Bluemel, J.; Van Bortel, W.; Overbosch, D.; Lieshout-Krikke, R.; Fabra, C.; Facco, G.; Zeller, H., 2017:
Targeting of blood safety measures to affected areas with ongoing local transmission of malaria

Kuzawińska, O.; Lis, K.; Cessak, G.; Mirowska-Guzel, D.; Bałkowiec-Iskra, E., 2016:
Targeting of calcitonin gene-related peptide action as a new strategy for migraine treatment

Strønen, E.; Toebes, M.; Kelderman, S.; van Buuren, M.M.; Yang, W.; van Rooij, N.; Donia, M.; Böschen, M-Lu.; Lund-Johansen, F.; Olweus, J.; Schumacher, T.N., 2016:
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires

Momparler, R.L.; Côté, S., 2016:
Targeting of cancer stem cells by inhibitors of DNA and histone methylation

Li, M.; Li, M.; Yin, T.; Shi, H.; Wen, Y.; Zhang, B.; Chen, M.; Xu, G.; Ren, K.; Wei, Y., 2016:
Targeting of cancer‑associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment

Hauge, M.; Bruserud, Øystein.; Hatfield, K.Joanne., 2016:
Targeting of cell metabolism in human acute myeloid leukemia--more than targeting of isocitrate dehydrogenase mutations and PI3K/AKT/mTOR signaling?

Yao, M.; Xie, C.; Kiang, M-Yee.; Teng, Y.; Harman, D.; Tiffen, J.; Wang, Q.; Sved, P.; Bao, S.; Witting, P.; Holst, J.; Dong, Q., 2016:
Targeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells

Kochounian, H.; Zhang, Z.; Spee, C.; Hinton, D.R.; Fong, H.K.W., 2016:
Targeting of exon VI-skipping human RGR-opsin to the plasma membrane of pigment epithelium and co-localization with terminal complement complex C5b-9

Lynn, R.C.; Poussin, M.; Kalota, A.; Feng, Y.; Low, P.S.; Dimitrov, D.S.; Powell, D.J., 2015:
Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells

Munkarah, A.; Mert, I.; Chhina, J.; Hamid, S.; Poisson, L.; Hensley-Alford, S.; Giri, S.; Rattan, R., 2016:
Targeting of free fatty acid receptor 1 in EOC: A novel strategy to restrict the adipocyte-EOC dependence

Iqbal, A.; Eckerdt, F.; Bell, J.; Nakano, I.; Giles, F.J.; Cheng, S-Yuan.; Lulla, R.R.; Goldman, S.; Platanias, L.C., 2017:
Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibition

Fest, S.; Soldati, R.; Christiansen, N.M.; Zenclussen, M.L.; Kilz, J.; Berger, E.; Starke, S.; Lode, H.N.; Engel, C.; Zenclussen, A.C.; Christiansen, H., 2016:
Targeting of heme oxygenase-1 as a novel immune regulator of neuroblastoma

Hasan, M.Nabiul.; Queudeville, M.; Trentin, L.; Eckhoff, S.Mirjam.; Bronzini, I.; Palmi, C.; Barth, T.; Cazzaniga, G.; te Kronnie, G.; Debatin, K-Michael.; Meyer, Lüder.Hinrich., 2015:
Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model

Ma, Y-Feng.; Chen, C.; Li, D.; Liu, M.; Lv, Z-Wei.; Ji, Y.; Xu, J., 2016:
Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer

Testa, U.; Lo-Coco, F., 2015:
Targeting of leukemia-initiating cells in acute promyelocytic leukemia

Heredia, A.; Le, N.; Gartenhaus, R.B.; Sausville, E.; Medina-Moreno, S.; Zapata, J.C.; Davis, C.; Gallo, R.C.; Redfield, R.R., 2015:
Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice

Zhang, X.; Wang, X.; Xu, T.; Zhong, S.; Shen, Z., 2015:
Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma

Ernsting, M.J.; Hoang, B.; Lohse, I.; Undzys, E.; Cao, P.; Do, T.; Gill, B.; Pintilie, M.; Hedley, D.; Li, S-Dar., 2016:
Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle

Mohammadi-Yeganeh, S.; Mansouri, A.; Paryan, M., 2016:
Targeting of miR9/NOTCH1 interaction reduces metastatic behavior in triple-negative breast cancer

Wang, D.; Li, Z.; Zhang, Y.; Wang, G.; Wei, M.; Hu, Y.; Ma, S.; Jiang, Y.; Che, N.; Wang, X.; Yao, J.; Yin, J., 2017:
Targeting of microRNA-199a-5p protects against pilocarpine-induced status epilepticus and seizure damage via SIRT1-p53 cascade

Su, Y-Hao.; Tang, W-Chun.; Cheng, Y-Wen.; Sia, P.; Huang, C-Chen.; Lee, Y-Chao.; Jiang, H-Yi.; Wu, M-Heng.; Lai, I-Lu.; Lee, J-Wei.; Lee, K-Haur., 2015:
Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer

Pan, Y.; Meng, M.; Zheng, N.; Cao, Z.; Yang, P.; Xi, X.; Zhou, Q., 2016:
Targeting of multiple senescence-promoting genes and signaling pathways by triptonide induces complete senescence of acute myeloid leukemia cells

Zhang, X.; Cheng, L.; Minn, K.; Madan, R.; Godwin, A.K.; Shridhar, V.; Chien, J., 2015:
Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells

Bourseau-Guilmain, E.; Menard, J.A.; Belting, M., 2016:
Targeting of non-cycling cells of hypoxic tumors

Holst, P.J.; Jensen, B.A.H.; Ragonnaud, E.; Thomsen, A.R.; Christensen, J.P., 2015:
Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection

Igea, A.; Gupta, J.; Nebreda, A.R., 2016:
Targeting of non-oncogene addiction

Baranowska, M.; Hauge, A.G.; Hoornaert, Cé.; Bogen, B.; Grødeland, G., 2016:
Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza

McCranor, B.J.; Hofstetter, C.A.; Olert, M.A.; Moorad-Doctor, D.; Cerasoli, D.M.; Garcia, G.E., 2016:
Targeting of organophosphorus compound bioscavengers to the surface of red blood cells

Yu, L.; Yang, Q.; Xiang, J.; Sun, H.; Wang, L.; Li, Q.; Guan, A.; Tang, Y., 2015:
Targeting of parallel c-myc G-quadruplex by dimeric cyanine dye supramolecular assembly: dependence on the linker length

Patil, Y.; Amitay, Y.; Ohana, P.; Shmeeda, H.; Gabizon, A., 2016:
Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity

Macho, A.P.; Zipfel, C., 2015:
Targeting of plant pattern recognition receptor-triggered immunity by bacterial type-III secretion system effectors

Barro, F.; Iehisa, J.C.M.; Giménez, Mía.J.; García-Molina, Mía.D.; Ozuna, C.V.; Comino, I.; Sousa, C.; Gil-Humanes, J., 2016:
Targeting of prolamins by RNAi in bread wheat: effectiveness of seven silencing-fragment combinations for obtaining lines devoid of coeliac disease epitopes from highly immunogenic gliadins

Granato, M.; Santarelli, R.; Gonnella, R.; Farina, A.; Trivedi, P.; Faggioni, A.; Cirone, M., 2015:
Targeting of prosurvival pathways as therapeutic approaches against primary effusion lymphomas: past, present, and Future

Fung, E.K.; Cheal, S.M.; Fareedy, S.B.; Punzalan, B.; Beylergil, V.; Amir, J.; Chalasani, S.; Weber, W.A.; Spratt, D.E.; Veach, D.R.; Bander, N.H.; Larson, S.M.; Zanzonico, P.B.; Osborne, J.R., 2016:
Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling

Nihonmatsu, I.; Ohkawa, N.; Saitoh, Y.; Inokuchi, K., 2015:
Targeting of ribosomal protein S6 to dendritic spines by in vivo high frequency stimulation to induce long-term potentiation in the dentate gyrus

Badillo-Godinez, O.; Gutierrez-Xicotencatl, L.; Plett-Torres, T.; Pedroza-Saavedra, A.; Gonzalez-Jaimes, A.; Chihu-Amparan, L.; Maldonado-Gama, M.; Espino-Solis, G.; Bonifaz, L.C.; Esquivel-Guadarrama, F., 2016:
Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice

Kwon, T-Rin.; Choi, E.Ja.; Oh, C.Taek.; Bak, D-Ho.; Im, S-I.; Ko, E.Jung.; Hong, H.Ki.; Choi, Y.Shik.; Seok, J.; Choi, S.Young.; Ahn, G.Young.; Kim, B.Joon., 2016 :
Targeting of sebaceous glands to treat acne by micro-insulated needles with radio frequency in a rabbit ear model

Bidaux, G.; Borowiec, A-Sophie.; Dubois, C.; Delcourt, P.; Schulz, Céline.; Vanden Abeele, F.; Lepage, G.; Desruelles, E.; Bokhobza, A.; Dewailly, E.; Slomianny, C.; Roudbaraki, M.; Héliot, L.; Bonnal, J-Louis.; Mauroy, B.; Mariot, P.; Lemonnier, Lïc.; Prevarskaya, N., 2018:
Targeting of short TRPM8 isoforms induces 4TM-TRPM8-dependent apoptosis in prostate cancer cells

Dong, A.; Jiao, X.; Chen, D.; Hao, F.; Zhang, K., 2016:
Targeting of slug sensitizes anaplastic thyroid carcinoma SW1736 cells to doxorubicin via PUMA upregulation

Song, L.; Wang, W.; Liu, D.; Zhao, Y.; He, J.; Wang, X.; Dai, Z.; Zhang, H.; Li, X., 2016:
Targeting of sonic hedgehog-Gli signaling: A potential therapeutic target for patients with breast cancer

Principe, M.; Ceruti, P.; Shih, N-Yao.; Chattaragada, M.S.; Rolla, S.; Conti, L.; Bestagno, M.; Zentilin, L.; Yang, S-Hui.; Migliorini, P.; Cappello, P.; Burrone, O.; Novelli, F., 2016:
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells

Xiao, M.; Ai, H.; Li, T.; Rajoria, P.; Shahu, P.; Li, X., 2016:
Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function

Rossow, L.; Eke, I.; Dickreuter, E.; Cordes, N., 2016:
Targeting of the EGFR/β1 integrin connecting proteins PINCH1 and Nck2 radiosensitizes three-dimensional SCC cell cultures

Roh, J-Lyel.; Jang, H.; Kim, E.Hye.; Shin, D., 2016:
Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer

Khan, A.A.; Harrison, C.N.; McLornan, D.P., 2015:
Targeting of the Hedgehog pathway in myeloid malignancies: still a worthy chase?

Cao, J.; Heijkants, R.C.; Jochemsen, A.G.; Dogrusöz, M.; de Lange, M.J.; van der Velden, P.A.; van der Burg, S.H.; Jager, M.J.; Verdijk, R.M., 2016:
Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy

Giannuzzo, A.; Saccomano, M.; Napp, J.; Ellegaard, M.; Alves, F.; Novak, I., 2017:
Targeting of the P2X7 receptor in pancreatic cancer and stellate cells

Liška, Fšek.; Peterková, R.; Peterka, M.; Landa, Vír.; Zídek, Václav.; Mlejnek, P.; Šilhavý, J.; Šimáková, M.; Křen, Vír.; Starker, C.G.; Voytas, D.F.; Izsvák, Z.; Pravenec, M., 2017:
Targeting of the Plzf Gene in the Rat by Transcription Activator-Like Effector Nuclease Results in Caudal Regression Syndrome in Spontaneously Hypertensive Rats

Dagvadorj, N.; Deuretzbacher, A.; Weisenberger, D.; Baumeister, E.; Trebing, J.; Lang, I.; Köchel, C.; Kapp, M.; Kapp, K.; Beilhack, A.; Hünig, T.; Einsele, H.; Wajant, H.; Grigoleit, Götz.Ulrich., 2016:
Targeting of the WT1 91-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination

Balderman, S.R.; Li, A.J.; Hoffman, C.M.; Frisch, B.J.; Goodman, A.N.; LaMere, M.W.; Georger, M.A.; Evans, A.G.; Liesveld, J.L.; Becker, M.W.; Calvi, L.M., 2016:
Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome

Zhou, M.; Wang, T.; Lai, H.; Zhao, X.; Yu, Q.; Zhou, J.; Yang, Y., 2015:
Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance

Fontenot, K.R.; Ongarora, B.G.; LeBlanc, L.E.; Zhou, Z.; Jois, S.D.; Vicente, M.Graça.H., 2016:
Targeting of the epidermal growth factor receptor with mesoporphyrin IX-peptide conjugates

Pang, J.; Wu, Y.; Li, Z.; Hu, Z.; Wang, X.; Hu, X.; Wang, X.; Liu, X.; Zhou, M.; Liu, B.; Wang, Y.; Feng, M.; Liang, D., 2016:
Targeting of the human F8 at the multicopy rDNA locus in Hemophilia A patient-derived iPSCs using TALENickases

Helms, J.Bernd.; Kaloyanova, D.V.; Strating, J.R.P.; van Hellemond, J.J.; van der Schaar, H.M.; Tielens, A.G.M.; van Kuppeveld, F.J.M.; Brouwers, J.F., 2016:
Targeting of the hydrophobic metabolome by pathogens

Varga, N.; Csapó, E.; Majláth, Z.; Ilisz, I.; Krizbai, I.A.; Wilhelm, I.; Knapp, L.; Toldi, J.; Vécsei, L.; Dékány, I., 2016:
Targeting of the kynurenic acid across the blood-brain barrier by core-shell nanoparticles

Shen, Z-Hua.; Zeng, D-Feng.; Wang, X-Yan.; Ma, Y-Ying.; Zhang, X.; Kong, P-Yan., 2016:
Targeting of the leukemia microenvironment by c(RGDfV) overcomes the resistance to chemotherapy in acute myeloid leukemia in biomimetic polystyrene scaffolds

Hamel, W.; Köppen, J.A.; Alesch, Fçois.; Antonini, A.; Barcia, J.A.; Bergman, H.; Chabardes, S.; Contarino, M.Fiorella.; Cornu, P.; Demmel, W.; Deuschl, Günther.; Fasano, A.; Kühn, A.A.; Limousin, P.; McIntyre, C.C.; Mehdorn, H.Maximilian.; Pilleri, M.; Pollak, P.; Rodríguez-Oroz, M.C.; Rumià, J.; Samuel, M.; Timmermann, L.; Valldeoriola, F.; Vesper, J.; Visser-Vandewalle, V.; Volkmann, J.; Lozano, A.M., 2016:
Targeting of the Subthalamic Nucleus for Deep Brain Stimulation: A Survey Among Parkinson Disease Specialists

Bai, Y.; Li, L-Dong.; Li, J.; Lu, X., 2017:
Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer

Hasanpourghadi, M.; Karthikeyan, C.; Pandurangan, A.Kumar.; Looi, C.Yeng.; Trivedi, P.; Kobayashi, K.; Tanaka, K.; Wong, W.Fen.; Mustafa, M.Rais., 2016:
Targeting of tubulin polymerization and induction of mitotic blockage by Methyl 2-(5-fluoro-2-hydroxyphenyl)-1H-benzo[d]imidazole-5-carboxylate (MBIC) in human cervical cancer HeLa cell

Horwacik, I.; Rokita, H., 2015:
Targeting of tumor-associated gangliosides with antibodies affects signaling pathways and leads to cell death including apoptosis

Li, X.; Yao, W.; Yuan, Y.; Chen, P.; Li, B.; Li, J.; Chu, R.; Song, H.; Xie, D.; Jiang, X.; Wang, H., 2015:
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma

Gang, B.P.; Dilda, P.J.; Hogg, P.J.; Blackburn, A.C., 2015:
Targeting of two aspects of metabolism in breast cancer treatment

Crow, M.K.; Olferiev, M.; Kirou, K.A., 2015:
Targeting of type I interferon in systemic autoimmune diseases

Raslan, Z.; Magwenzi, S.; Aburima, A.; Taskén, K.; Naseem, K.M., 2016:
Targeting of type I protein kinase A to lipid rafts is required for platelet inhibition by the 3',5'-cyclic adenosine monophosphate-signaling pathway

Bala, G.; Blykers, A.; Xavier, C.; Descamps, B.; Broisat, A.; Ghezzi, C.; Fagret, D.; Van Camp, G.; Caveliers, V.; Vanhove, C.; Lahoutte, T.; Droogmans, S.; Cosyns, B.; Devoogdt, N.; Hernot, S., 2017:
Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques

Hashimoto, K., 2016:
Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker

Lin, T-chen.; Neuner, A.; Schiebel, E., 2016:
Targeting of γ-tubulin complexes to microtubule organizing centers: conservation and divergence

Egal, M.; de Geus, H.R.H.; van Bommel, J.; Groeneveld, A.B.Johan., 2018:
Targeting oliguria reversal in perioperative restrictive fluid management does not influence the occurrence of renal dysfunction: A systematic review and meta-analysis

Tain, Y-Lin.; Hsu, C-Ning., 2017:
Targeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of Hypertension

Carlino, M.S.; Long, G.V.; Kefford, R.F.; Rizos, H., 2016:
Targeting oncogenic BRAF and aberrant MAPK activation in the treatment of cutaneous melanoma

Wang, Z.Dong.; Wei, S.Quan.; Wang, Q.Yi., 2016:
Targeting oncogenic KRAS in non-small cell lung cancer cells by phenformin inhibits growth and angiogenesis

Cui, X-Bin.; Li, S.; Li, T-Ting.; Peng, H.; Jin, T-Ting.; Zhang, S-Mao.; Liu, C-Xia.; Yang, L.; Shen, Y-Yuan.; Li, S-Gang.; Li, N.; Li, Y.; Hu, J-Ming.; Jiang, J-Fang.; Suo, J.; Qi, Y.; Liang, W-Hua.; Wang, L-Hai.; Dang, H-Wei.; Li, L.; Cao, W-Wei.; Wei, Y.; Laibo-Yin; Wu, C-Yue.; Yuan, X-Lin.; Zhou, H.; Zheng, Y.; Chen, Y-Zhao.; Li, F., 2016:
Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma

Fields, A.P.; Ali, S.A.; Justilien, V.; Murray, N.R., 2016:
Targeting oncogenic protein kinase Cι for treatment of mutant KRAS LADC

Gambari, R.; Brognara, E.; Spandidos, D.A.; Fabbri, E., 2017:
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review)

Liu, X.Johné., 2016:
Targeting oocyte maturation to improve fertility in older women

Kolar, G.R.; Grote, S.M.; Yosten, G.L.C., 2016:
Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146

Lamour, V.; Henry, Aélie.; Kroonen, Jérôme.; Nokin, M-Julie.; von Marschall, Z.; Fisher, L.W.; Chau, T-Lan.; Chariot, A.; Sanson, M.; Delattre, J-Yves.; Turtoi, A.; Peulen, O.; Rogister, B.; Castronovo, V.; Bellahcène, A., 2016:
Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo

Mohamed, I.A.; Mraiche, F., 2015:
Targeting osteopontin, the silent partner of Na+/H+ exchanger isoform 1 in cardiac remodeling

Reed, D.E.; Shokat, K.M., 2015:
Targeting osteosarcoma

Guan, M.; Wang, J.; Yang, L.; Zhao, Z.; Lu, K.; Zhao, L.; Xiao, J.; Li, Z.; Shi, Z., 2014:
Targeting osteosarcoma vasculature with peptide obtained by phage display

Bernardo, I.; Bozinovski, S.; Vlahos, R., 2016:
Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities

Poulet, B.; Beier, F., 2016:
Targeting oxidative stress to reduce osteoarthritis

Harlev, A.; Gupta, S.; Agarwal, A., 2016:
Targeting oxidative stress to treat endometriosis

Reuschenbach, M., 2015:
Targeting p16(INK4a) by therapeutic vaccination : Concept and status of clinical investigations in HPV-associated head and neck cancers

Jagadeeshan, S.; Venkatraman, G.; Rayala, S.K., 2016:
Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer

Ogiwara, H.; Sasaki, M.; Mitachi, T.; Oike, T.; Higuchi, S.; Tominaga, Y.; Kohno, T., 2016:
Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression

Zou, X.; Blank, M., 2016:
Targeting p38 MAP kinase signaling in cancer through post-translational modifications

Schwaller, F.; Beggs, S.; Walker, S.M., 2015:
Targeting p38 Mitogen-activated Protein Kinase to Reduce the Impact of Neonatal Microglial Priming on Incision-induced Hyperalgesia in the Adult Rat

Lalaoui, N.; Hänggi, K.; Brumatti, G.; Chau, D.; Nguyen, N-Y.N.; Vasilikos, L.; Spilgies, L.M.; Heckmann, D.A.; Ma, C.; Ghisi, M.; Salmon, J.M.; Matthews, G.M.; de Valle, E.; Moujalled, D.M.; Menon, M.B.; Spall, S.Kaur.; Glaser, S.P.; Richmond, J.; Lock, R.B.; Condon, S.M.; Gugasyan, R.; Gaestel, M.; Guthridge, M.; Johnstone, R.W.; Munoz, L.; Wei, A.; Ekert, P.G.; Vaux, D.L.; Wong, W.Wei-Lynn.; Silke, J., 2016:
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics

Liu, J.; Chen, G.; Pelicano, H.; Liao, J.; Huang, J.; Feng, L.; Keating, M.J.; Huang, P., 2016:
Targeting p53-deficient chronic lymphocytic leukemia cells in vitro and in vivo by ROS-mediated mechanism

Vekaria, P.Harsukhbhai.; Home, T.; Weir, S.; Schoenen, F.J.; Rao, R., 2016:
Targeting p97 to Disrupt Protein Homeostasis in Cancer

Morris, L.Deidrè.; Louw, Q.Abegail.; Grimmer, K.Anne.; Meintjes, E., 2015:
Targeting pain catastrophization in patients with fibromyalgia using virtual reality exposure therapy: a proof-of-concept study

Antonini, A.; Tinazzi, M., 2016:
Targeting pain in Parkinson's disease

Minjie, S.; Defei, H.; Zhimin, H.; Weiding, W.; Yuhua, Z., 2016:
Targeting pancreatic cancer cells by a novel hydroxamate-based histone deacetylase (HDAC) inhibitor ST-3595

Haqq, J.; Howells, L.M.; Garcea, G.; Dennison, A.R., 2017:
Targeting pancreatic cancer using a combination of gemcitabine with the omega-3 polyunsaturated fatty acid emulsion, Lipidem™

Martin-Montalvo, A.; Lorenzo, P.I.; López-Noriega, L.; Gauthier, B.R., 2016:
Targeting pancreatic expressed PAX genes for the treatment of diabetes mellitus and pancreatic neuroendocrine tumors

Mohammed, A.; Janakiram, N.B.; Madka, V.; Brewer, M.; Ritchie, R.L.; Lightfoot, S.; Kumar, G.; Sadeghi, M.; Patlolla, J.Mohan.R.; Yamada, H.Y.; Cruz-Monserrate, Z.; May, R.; Houchen, C.W.; Steele, V.E.; Rao, C.V., 2016:
Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression

Atkinson, C.; Qiao, F.; Yang, X.; Zhu, P.; Reaves, N.; Kulik, L.; Goddard, M.; Holers, V.Michael.; Tomlinson, S., 2015:
Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury

Campbell, N.P.; Hensing, T.A.; Bhayani, M.K.; Shaikh, A.Y.; Brockstein, B.E., 2017:
Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck

Steele, M.K.; Remais, J.V.; Gambhir, M.; Glasser, J.W.; Handel, A.; Parashar, U.D.; Lopman, B.A., 2016:
Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination options

Beretta, G.L.; De Cesare, M.; Albano, L.; Magnifico, A.; Carenini, N.; Corna, E.; Perego, P.; Gatti, L., 2016:
Targeting peptidyl-prolyl isomerase pin1 to inhibit tumor cell aggressiveness

Oikonomou, E.; Tousoulis, D., 2017:
Targeting percutaneous cardiovascular interventions at all who will benefit the most: The reality of the Eastern European countries

Ambrosini, A.; D'Alessio, C.; Magis, D.; Schoenen, J., 2016:
Targeting pericranial nerve branches to treat migraine: Current approaches and perspectives

Wei, W.; Liu, C.; Qin, D.; Song, L.; Xia, L.; Lei, H.; Yu, Y.; Wang, W.; Pu, J.; Sun, H.; Wu, Y.; Xu, H.; Hao, S., 2016:
Targeting peroxiredoxin I potentiates 1,25-dihydroxyvitamin D3-induced cell differentiation in leukemia cells

Graham, L.; Schweizer, M.T., 2016 :
Targeting persistent androgen receptor signaling in castration-resistant prostate cancer

Doeser, A.; Dickhof, G.; Reitze, M.; Uebachs, M.; Schaub, C.; Pires, N.Miguel.; Bonifácio, M.João.; Soares-da-Silva, Pício.; Beck, H., 2015:
Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug

Doody, K.M.; Stanford, S.M.; Sacchetti, C.; Svensson, M.N.D.; Coles, C.H.; Mitakidis, N.; Kiosses, W.B.; Bartok, B.; Fos, C.; Cory, E.; Sah, R.L.; Liu-Bryan, R.; Boyle, D.L.; Arnett, H.A.; Mustelin, T.; Corr, M.; Esko, J.D.; Tremblay, M.L.; Firestein, G.S.; Aricescu, A.Radu.; Bottini, N., 2016:
Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy

Pandey, R.; Kapur, R., 2016:
Targeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloproliferative neoplasms

Zhang, H-Ting., 2015:
Targeting phosphodiesterases (PDEs) for treatment of CNS diseases

Kang, D.Woo.; Choi, C.Yeol.; Cho, Y-Hee.; Tian, H.; Di Paolo, G.; Choi, K-Yell.; Min, D.Sik., 2015:
Targeting phospholipase D1 attenuates intestinal tumorigenesis by controlling β-catenin signaling in cancer-initiating cells

Low, M.; Infantino, S.; Grigoriadis, G.; Tarlinton, D., 2016:
Targeting plasma cells: are we any closer to a panacea for diseases of antibody-secreting cells?

Vögtle, T.; Cherpokova, D.; Bender, M.; Nieswandt, B., 2016:
Targeting platelet receptors in thrombotic and thrombo-inflammatory disorders

Brandwein, J.M., 2015:
Targeting polo-like kinase 1 in acute myeloid leukemia

Berges, C.; Chatterjee, M.; Topp, M.S.; Einsele, H., 2017 :
Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells

Bussey, K.J.; Bapat, A.; Linnehan, C.; Wandoloski, M.; Dastrup, E.; Rogers, E.; Gonzales, P.; Demeure, M.J., 2016:
Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma

Edinger, N.; Lebendiker, M.; Klein, S.; Zigler, M.; Langut, Y.; Levitzki, A., 2017:
Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF

Gupta, E.Dogra.; Pachauri, M.; Ghosh, P.Chandra.; Rajam, M.Venkat., 2017:
Targeting polyamine biosynthetic pathway through RNAi causes the abrogation of MCF 7 breast cancer cell line

Murray-Stewart, T.R.; Woster, P.M.; Casero, R.A., 2017:
Targeting polyamine metabolism for cancer therapy and prevention

Ilari, A.; Fiorillo, A.; Baiocco, P.; Poser, E.; Angiulli, G.; Colotti, G., 2015:
Targeting polyamine metabolism for finding new drugs against leishmaniasis: a review

Wen, S.; Harvard, K.E.; Gueye, C.Smith.; Canavati, S.E.; Chancellor, A.; Ahmed, B-Nazir.; Leaburi, J.; Lek, D.; Namgay, R.; Surya, A.; Thakur, G.D.; Whittaker, M.Anne.; Gosling, R.D., 2017:
Targeting populations at higher risk for malaria: a survey of national malaria elimination programmes in the Asia Pacific

Gupta, G.; Jangir, S.; Sharma, V.L., 2015:
Targeting post-ejaculation sperm for value-added contraception

Hsu, Y-C.; Hsieh, Y-H.; Liao, C-C.; Chong, L-W.; Lee, C-Y.; Yu, Y-L.; Chou, R-H., 2016:
Targeting post-translational modifications of histones for cancer therapy

Herath, H.M.M.; Weerarathna, T.P.; Fonseka, C.L.; Vidanagamage, A.S., 2016 :
Targeting postprandial blood sugar over fasting blood sugar: A clinic based comparative study

Carnegie, N.B.; Goodreau, S.M.; Liu, A.; Vittinghoff, E.; Sanchez, J.; Lama, J.R.; Buchbinder, S., 2015:
Targeting pre-exposure prophylaxis among men who have sex with men in the United States and Peru: partnership types, contact rates, and sexual role

Mallarkey, G.; Mangoni, A.A., 2015:
Targeting precision medicine toxicity: recent developments

Hu, D., 2016:
Targeting primary and secondary prevention of stroke

Söderberg, K.Löfgren.; Guterstam, P.; Langel, U.; Gräslund, A., 2015:
Targeting prion propagation using peptide constructs with signal sequence motifs

Santos, T.G.; Lopes, M.H.; Martins, V.R., 2016:
Targeting prion protein interactions in cancer

Al-Hilal, T.A.; Chung, S.Woo.; Choi, J.Uk.; Alam, F.; Park, J.; Kim, S.Who.; Kim, S.Yoon.; Ahsan, F.; Kim, I-San.; Byun, Y., 2016:
Targeting prion-like protein doppel selectively suppresses tumor angiogenesis

Bozinovski, S.; Anthony, D.; Vlahos, R., 2014:
Targeting pro-resolution pathways to combat chronic inflammation in COPD

Wang, F.; Liu, Y.; Wang, L.; Yang, J.; Zhao, Y.; Wang, N.; Cao, Q.; Gong, P.; Wu, C., 2016:
Targeting procaspase-3 with WF-208, a novel PAC-1 derivative, causes selective cancer cell apoptosis

Kosmala, A.; Weng, A.Max.; Krauss, B.; Knop, S.; Bley, T.Alexander.; Petritsch, B., 2018:
Dual-energy CT of the bone marrow in multiple myeloma: diagnostic accuracy for quantitative differentiation of infiltration patterns

Pomares, H.; Palmeri, C.M.; Iglesias-Serret, D.; Moncunill-Massaguer, C.; Saura-Esteller, Jé.; Núñez-Vázquez, S.; Gamundi, E.; Arnan, M.; Preciado, S.; Albericio, F.; Lavilla, R.; Pons, G.; González-Barca, E.M.; Cosialls, A.M.; Gil, J., 2016:
Targeting prohibitins induces apoptosis in acute myeloid leukemia cells

Bassi, D.E.; Zhang, J.; Renner, C.; Klein-Szanto, A.J., 2016:
Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth

Sadeghi, R.Najjar.; Karami-Tehrani, F.; Salami, S., 2015:
Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes

Park, K., 2016:
Targeting prostate cancer cells en route to dissemination

Zhang, W.; Garg, S.; Eldi, P.; Zhou, F.Huan-Huan.; Johnson, I.R.D.; Brooks, D.A.; Lam, F.; Rychkov, G.; Hayball, J.; Albrecht, H., 2016:
Targeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptide

Jadhavar, P.S.; Ramachandran, S.A.; Riquelme, E.; Gupta, A.; Quinn, K.P.; Shivakumar, D.; Ray, S.; Zende, D.; Nayak, A.K.; Miglani, S.K.; Sathe, B.D.; Raja, M.; Farias, O.; Alfaro, I.; Belmar, Sán.; Guerrero, J.; Bernales, Sán.; Chakravarty, S.; Hung, D.T.; Lindquist, J.N.; Rai, R., 2016:
Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors

Santoni, M.; Scarpelli, M.; Mazzucchelli, R.; Lopez-Beltran, A.; Cheng, L.; Cascinu, S.; Montironi, R., 2015:
Targeting prostate-specific membrane antigen for personalized therapies in prostate cancer: morphologic and molecular backgrounds and future promises

Zhang, B.; Dong, S.; Zhu, R.; Hu, C.; Hou, J.; Li, Y.; Zhao, Q.; Shao, X.; Bu, Q.; Li, H.; Wu, Y.; Cen, X.; Zhao, Y., 2016:
Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3

Zhang, B.; Dong, S.; Li, Z.; Lu, L.; Zhang, S.; Chen, X.; Cen, X.; Wu, Y., 2016:
Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin

Campbell, A.E.; Bennett, D., 2017:
Targeting protein function: the expanding toolkit for conditional disruption

Reilly, J.E.; Neighbors, J.D.; Hohl, R.J., 2016:
Targeting protein geranylgeranylation slows tumor development in a murine model of prostate cancer metastasis

Ahmed, M.; Machado, P.M.; Miller, A.; Spicer, C.; Herbelin, L.; He, J.; Noel, J.; Wang, Y.; McVey, A.L.; Pasnoor, M.; Gallagher, P.; Statland, J.; Lu, C-Hua.; Kalmar, B.; Brady, S.; Sethi, H.; Samandouras, G.; Parton, M.; Holton, J.L.; Weston, A.; Collinson, L.; Taylor, J.Paul.; Schiavo, G.; Hanna, M.G.; Barohn, R.J.; Dimachkie, M.M.; Greensmith, L., 2016:
Targeting protein homeostasis in sporadic inclusion body myositis

Sapio, L.; Di Maiolo, F.; Illiano, M.; Esposito, A.; Chiosi, E.; Spina, A.; Naviglio, S., 2014:
Targeting protein kinase A in cancer therapy: an update

Rauert-Wunderlich, H.; Rudelius, M.; Ott, G.; Rosenwald, A., 2017:
Targeting protein kinase C in mantle cell lymphoma

Martin-Liberal, J.; Cameron, A.J.; Claus, J.; Judson, I.R.; Parker, P.J.; Linch, M., 2015:
Targeting protein kinase C in sarcoma

Storz, P., 2015:
Targeting protein kinase C subtypes in pancreatic cancer

Zhang, X.; Yang, X.; Yang, C.; Li, P.; Yuan, W.; Deng, X.; Cheng, Y.; Li, P.; Yang, H.; Tao, J.; Lu, Q., 2016:
Targeting protein kinase CK2 suppresses bladder cancer cell survival via the glucose metabolic pathway

Pravin, N.; Devaraji, V.; Raman, N., 2016:
Targeting protein kinase and DNA molecules by diimine-phthalate complexes in antiproliferative activity

Chen, H.; Shen, J.; Choy, E.; Hornicek, F.J.; Duan, Z., 2016:
Targeting protein kinases to reverse multidrug resistance in sarcoma

Wang, Y.; Luo, Z.; Pan, Y.; Wang, W.; Zhou, X.; Jeong, L.Shin.; Chu, Y.; Liu, J.; Jia, L., 2016:
Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells

Martineau, Y.; Müller, D.; Pyronnet, Séphane., 2015:
Targeting protein synthesis in cancer cells

Garg, A.; Wesolowski, D.; Alonso, D.; Deitsch, K.W.; Ben Mamoun, C.; Altman, S., 2015:
Targeting protein translation, RNA splicing, and degradation by morpholino-based conjugates in Plasmodium falciparum

Sammak, S.; Zinzalla, G., 2016:
Targeting protein-protein interactions (PPIs) of transcription factors: Challenges of intrinsically disordered proteins (IDPs) and regions (IDRs)

Fry, D.C., 2015:
Targeting protein-protein interactions for drug discovery

Calejo, A.I.; Taskén, K., 2015:
Targeting protein-protein interactions in complexes organized by A kinase anchoring proteins

Cierpicki, T.; Grembecka, J., 2015:
Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?

Nissen, K.B.; Haugaard-Kedström, L.M.; Wilbek, T.S.; Nielsen, L.S.; Åberg, E.; Kristensen, A.S.; Bach, A.; Jemth, P.; Strømgaard, K., 2016:
Targeting protein-protein interactions with trimeric ligands: high affinity inhibitors of the MAGUK protein family

Gao, M.; Cheng, K.; Yin, H., 2016:
Targeting protein-protein interfaces using macrocyclic peptides

Ludwików, A., 2015:
Targeting proteins for proteasomal degradation-a new function of Arabidopsis ABI1 protein phosphatase 2C

Meng, M-Bin.; Wang, H-Huan.; Guo, W-Hao.; Wu, Z-Qiang.; Zeng, X-Liang.; Zaorsky, N.G.; Shi, H-Shan.; Qian, D.; Niu, Z-Min.; Jiang, B.; Zhao, L-Jun.; Yuan, Z-Yong.; Wang, P., 2015:
Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo

Bucio-Cano, A.; Reyes-Arellano, A.; Correa-Basurto, Jé.; Bello, M.; Torres-Jaramillo, J.; Salgado-Zamora, Héctor.; Curiel-Quesada, E.; Peralta-Cruz, J.; Avila-Sorrosa, A., 2016:
Targeting quorum sensing by designing azoline derivatives to inhibit the N-hexanoyl homoserine lactone-receptor CviR: Synthesis as well as biological and theoretical evaluations

Zhang, Y.; Lai, J.; Du, Z.; Gao, J.; Yang, S.; Gorityala, S.; Xiong, X.; Deng, O.; Ma, Z.; Yan, C.; Susana, G.; Xu, Y.; Zhang, J., 2017:
Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress

Durand, N.; Storz, P., 2016:
Targeting reactive oxygen species in development and progression of pancreatic cancer

Checco, J.W.; Gellman, S.H., 2016:
Targeting recognition surfaces on natural proteins with peptidic foldamers

Tain, Y-Lin., 2016:
Targeting redox balance to deprogramme obesity: are we starting early enough?

Liu, C.; Workman, C.J.; Vignali, D.A.A., 2017:
Targeting regulatory T cells in tumors

Hayes, M.A.; Gallagher, M.W.; Gilbert, K.Stavitsky.; Creech, S.K.; DeCandia, C.J.; Beach, C.A.; Taft, C.T., 2015:
Targeting relational aggression in veterans: the Strength at Home Friends and Family intervention

Beyenbach, K.W.; Yu, Y.; Piermarini, P.M.; Denton, J., 2015:
Targeting renal epithelial channels for the control of insect vectors

Vallon, V.; Thomson, S.C., 2016:
Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition

Kishore, B.K.; Carlson, N.G.; Ecelbarger, C.M.; Kohan, D.E.; Müller, C.E.; Nelson, R.D.; Peti-Peterdi, J.; Zhang, Y., 2016:
Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus

Hausenloy, D.J.; Botker, H.Erik.; Engstrom, T.; Erlinge, D.; Heusch, G.; Ibanez, B.; Kloner, R.A.; Ovize, M.; Yellon, D.M.; Garcia-Dorado, D., 2016:
Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations

Lønborg, J.Thomsen., 2015:
Targeting reperfusion injury in the era of primary percutaneous coronary intervention: hope or hype?

Demicheva, E.; Cui, Y-Fang.; Bardwell, P.; Barghorn, S.; Kron, M.; Meyer, A.H.; Schmidt, M.; Gerlach, Börn.; Leddy, M.; Barlow, E.; O'Connor, E.; Choi, C-Ho.; Huang, L.; Veldman, G.M.; Rus, H.; Shabanzadeh, A.P.; Tassew, N.G.; Monnier, P.P.; Müller, T.; Calabresi, P.A.; Schoemaker, H.; Mueller, B.K., 2015:
Targeting repulsive guidance molecule A to promote regeneration and neuroprotection in multiple sclerosis

Vatrinet, R.; Iommarini, L.; Kurelac, I.; De Luise, M.; Gasparre, G.; Porcelli, A.Maria., 2016:
Targeting respiratory complex I to prevent the Warburg effect

Huang, O.; Wu, D.; Xie, F.; Lin, L.; Wang, X.; Jiang, M.; Li, Y.; Chen, W.; Shen, K.; Hu, X., 2016:
Targeting rho guanine nucleotide exchange factor ARHGEF5/TIM with auto-inhibitory peptides in human breast cancer

Shi, L.; Wang, L.; Hou, J.; Zhu, B.; Min, Z.; Zhang, M.; Song, D.; Cheng, Y.; Wang, X., 2016:
Targeting roles of inflammatory microenvironment in lung cancer and metastasis

Novak, A.; Nyflot, M.J.; Ermoian, R.P.; Jordan, L.E.; Sponseller, P.A.; Kane, G.M.; Ford, E.C.; Zeng, J., 2017:
Targeting safety improvements through identification of incident origination and detection in a near-miss incident learning system

Kremer, D.; Hartung, H-Peter.; Küry, P., 2016:
Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men

Xu, M.; Palmer, A.K.; Ding, H.; Weivoda, M.M.; Pirtskhalava, T.; White, T.A.; Sepe, A.; Johnson, K.O.; Stout, M.B.; Giorgadze, N.; Jensen, M.D.; LeBrasseur, N.K.; Tchkonia, T.; Kirkland, J.L., 2016:
Targeting senescent cells enhances adipogenesis and metabolic function in old age

Klein, C., 2018:
Targeting sequence domain: a captain at the helm precisely steering DNMT1 through maintenance methylation?

O'Neill, W.Charles., 2017:
Targeting serum calcium in chronic kidney disease and end-stage renal disease: is normal too high?

Berdel, H.O.; Yin, H.; Liu, J.Yao.; Grochowska, K.; Middleton, C.; Yanasak, N.; Abdelsayed, R.; Berdel, W.E.; Mozaffari, M.; Yu, J.C.; Baban, B., 2015:
Targeting serum glucocorticoid-regulated kinase-1 in squamous cell carcinoma of the head and neck: a novel modality of local control

Edelman, N.L.; de Visser, R.O.; Mercer, C.H.; McCabe, L.; Cassell, J.A., 2016:
Targeting sexual health services in primary care: A systematic review of the psychosocial correlates of adverse sexual health outcomes reported in probability surveys of women of reproductive age

Tangayi, S., 2017:
Targeting sickle cell disease

Wetzler, M.; Brady, M.T.; Donohue, K.A.; Lee, S-H.; Tighe, S.M.; Ford, L.A.; Wang, E.S.; Baer, M.R.; Baumann, H., 2016:
Targeting signal transducer and activator of transcription 3 protein with arsenic trioxide: A phase I clinical trial

Iqbal, W.; Alkarim, S.; AlHejin, A.; Mukhtar, H.; Saini, K.S., 2016:
Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis

Kaplowitz, N.; Win, S.; Than, T.Aung.; Liu, Z-Xu.; Dara, L., 2016:
Targeting signal transduction pathways which regulate necrosis in acetaminophen hepatotoxicity

Yang, X-Dong.; Sun, S-Cong., 2016:
Targeting signaling factors for degradation, an emerging mechanism for TRAF functions

Gupta, S.; Singh, S.Kumar.; Girotra, P., 2014:
Targeting silymarin for improved hepatoprotective activity through chitosan nanoparticles

Zhan, X-Yong.; Hu, C-Hui.; Zhu, Q-Yi., 2016:
Targeting single-nucleotide polymorphisms in the 16S rRNA gene to detect and differentiate Legionella pneumophila and non-Legionella pneumophila species

Suffredini, A.F., 2015:
Targeting sirtuin to modulate human inflammation

Gordon, J.W.; Dolinsky, V.W.; Mughal, W.; Gordon, G.R.J.; McGavock, J., 2015:
Targeting skeletal muscle mitochondria to prevent type 2 diabetes in youth

Shen, L., 2015:
Targeting smokers with empathy appeal antismoking public service announcements: a field experiment

Eack, S.M., 2016:
Targeting social and non-social cognition to improve cognitive remediation outcomes in schizophrenia

Cheng, Y.; Schorey, J.S., 2017:
Targeting soluble proteins to exosomes using a ubiquitin tag

Nikitenko, N.A.; Speiseder, T.; Groitl, P.; Spirin, P.V.; Prokofjeva, M.M.; Lebedev, T.D.; Rubtsov, P.M.; Lam, E.; Riecken, K.; Fehse, B.; Dobner, T.; Prassolov, V.S., 2016:
Targeting species D adenoviruses replication to counteract the epidemic keratoconjunctivitis

Frias-Lopez, J., 2015:
Targeting specific bacteria in the oral microbiome

Zhang, F.; Lin, Y-An.; Kannan, S.; Kannan, R.M., 2015:
Targeting specific cells in the brain with nanomedicines for CNS therapies

Terada, T.; Wilson, B.J.; Myette-Cόté, E.; Kuzik, N.; Bell, G.J.; McCargar, L.J.; Boulé, N.G., 2016:
Targeting specific interstitial glycemic parameters with high-intensity interval exercise and fasted-state exercise in type 2 diabetes

Bizama, C.; García, P.; Espinoza, J.A.; Weber, H.; Leal, P.; Nervi, B.; Roa, J.Carlos., 2015:
Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy

Nguyen, S.Truong.; Nguyen, H.Lam.; Pham, V.Quoc.; Nguyen, G.Thuy.; Tran, C.Do-Thanh.; Phan, N.Kim.; Pham, P.Van., 2015:
Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations

Bellini, L.; Campana, Mélanie.; Mahfouz, R.; Carlier, Aélie.; Véret, J.; Magnan, C.; Hajduch, E.; Le Stunff, Hé., 2017:
Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes

Powell, J.A.; Lewis, A.C.; Zhu, W.; Toubia, J.; Pitman, M.R.; Wallington-Beddoe, C.T.; Moretti, P.A.B.; Iarossi, D.; Samaraweera, S.E.; Cummings, N.; Ramshaw, H.S.; Thomas, D.; Wei, A.H.; Lopez, A.F.; D'Andrea, R.J.; Lewis, I.D.; Pitson, S.M., 2016:
Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia

Xun, C.; Chen, M-Bin.; Qi, L.; Tie-Ning, Z.; Peng, X.; Ning, L.; Zhi-Xiao, C.; Li-Wei, W., 2016:
Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo

Ebenezer, D.L.; Fu, P.; Natarajan, V., 2016:
Targeting sphingosine-1-phosphate signaling in lung diseases

Nahrendorf, M.; Dutta, P., 2016:
Targeting splenic hematopoietic stem cells in cardiovascular disease

Li, S.; Zou, D.; Li, C.; Meng, H.; Sui, W.; Feng, S.; Cheng, T.; Zhai, Q.; Qiu, L., 2016:
Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment

Vallard, A.; Espenel, S.; Guy, J-Baptiste.; Diao, P.; Xia, Y.; El Meddeb Hamrouni, A.; Ben Mrad, M.; Falk, A.Tuan.; Rodriguez-Lafrasse, C.; Rancoule, Cé.; Magné, N., 2016:
Targeting stem cells by radiation: From the biological angle to clinical aspects

Oh, S.Jin.; Noh, K.Hee.; Lee, Y-Ho.; Hong, S-Oh.; Song, K-Ho.; Lee, H-Jung.; Kim, S.; Kim, T.Min.; Jeon, J-Hong.; Seo, J.Hong.; Kim, D-Wan.; Kim, T.Woo., 2016:
Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells

Pomel, Sébastien.; Cojean, S.; Loiseau, P.M., 2016 :
Targeting sterol metabolism for the development of antileishmanials

Wang, G.; Wang, J.Jie.; Tang, H.Ming.; To, S.Shun.Tony., 2015:
Targeting strategies on miRNA-21 and PDCD4 for glioblastoma

Milisav, I.; Ribarič, S.; Šuput, Dšan., 2015:
Targeting stress responses for regenerative medicine

Mei, L.; Du, W.; Ma, W.Wee., 2016:
Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promises

Giannoni, E.; Taddei, M.Letizia.; Morandi, A.; Comito, G.; Calvani, M.; Bianchini, F.; Richichi, B.; Raugei, G.; Wong, N.; Tang, D.; Chiarugi, P., 2016:
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread

Roman-Blas, J.A.; Herrero-Beaumont, G., 2015:
Targeting subchondral bone in osteoporotic osteoarthritis

Levick, S.P.; Meléndez, G.C., 2016:
Targeting substance P and relaxin: A future combination therapy approach for heart failure?

Kruspig, Börn.; Valter, K.; Skender, B.; Zhivotovsky, B.; Gogvadze, V., 2017:
Targeting succinate:ubiquinone reductase potentiates the efficacy of anticancer therapy

Jiang, Y-Yi.; Lin, D-Chen.; Mayakonda, A.; Hazawa, M.; Ding, L-Wen.; Chien, W-Wen.; Xu, L.; Chen, Y.; Xiao, J-Fen.; Senapedis, W.; Baloglu, E.; Kanojia, D.; Shang, L.; Xu, X.; Yang, H.; Tyner, J.W.; Wang, M-Rong.; Koeffler, H.Phillip., 2016:
Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma

Liu, Q.; Du, X.; Hong, X.; Li, T.; Zheng, B.; He, L.; Wang, Y.; Otto, M.; Li, M., 2016:
Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection

Ferru-Clément, R.; Spanova, M.; Dhayal, S.; Morgan, N.G.; Hélye, R.; Becq, Fédéric.; Hirose, H.; Antonny, B.; Vamparys, L.; Fuchs, P.F.J.; Ferreira, T., 2017:
Targeting surface voids to counter membrane disorders in lipointoxication-related diseases

Kandalaft, H.; Hussack, G.; Aubry, A.; van Faassen, H.; Guan, Y.; Arbabi-Ghahroudi, M.; MacKenzie, R.; Logan, S.M.; Tanha, J., 2016:
Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease

Zhu, J.; Sun, C.; Wang, L.; Xu, M.; Zang, Y.; Zhou, Y.; Liu, X.; Tao, W.; Xue, B.; Shan, Y.; Yang, D., 2016:
Targeting survivin using a combination of miR‑494 and survivin shRNA has synergistic effects on the suppression of prostate cancer growth

Smith, A.M.; Little, E.B.; Zivanovic, A.; Hong, P.; Liu, A.K.S.; Burow, R.; Stinson, C.; Hallahan, A.R.; Moore, A.S., 2015:
Targeting survivin with YM155 (Sepantronium Bromide): a novel therapeutic strategy for paediatric acute myeloid leukaemia

Yenkejeh, R.A.; Sam, M.R.; Esmaeillou, M., 2016:
Targeting survivin with prodigiosin isolated from cell wall of Serratia marcescens induces apoptosis in hepatocellular carcinoma cells

Benad-Mehner, P.; Thiele, S.; Rachner, T.D.; Göbel, A.; Rauner, M.; Hofbauer, L.C., 2014:
Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin

Khanal, S.; Ferraris, E.Daniel.; Zahin, M.; Joh, J.; Ghim, S-je.; Jenson, A.Bennett., 2016:
Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development

Paul, J.M.; Toosi, B.; Vizeacoumar, F.S.; Bhanumathy, K.Kalyanasundaram.; Li, Y.; Gerger, C.; El Zawily, A.; Freywald, T.; Anderson, D.H.; Mousseau, D.; Kanthan, R.; Zhang, Z.; Vizeacoumar, F.J.; Freywald, A., 2016:
Targeting synthetic lethality between the SRC kinase and the EPHB6 receptor may benefit cancer treatment

Corsetti, M.; Akyuz, F.; Tack, J., 2016:
Targeting tachykinin receptors for the treatment of functional gastrointestinal disorders with a focus on irritable bowel syndrome

Henssen, A.G.; Odersky, A.; Szymansky, A.; Seiler, M.; Althoff, K.; Beckers, A.; Speleman, F.; Schäfers, S.; De Preter, K.; Astrahanseff, K.; Struck, J.; Schramm, A.; Eggert, A.; Bergmann, A.; Schulte, J.H., 2016:
Targeting tachykinin receptors in neuroblastoma

Rafii, M.S., 2016:
Targeting tau protein in Alzheimer's disease

Waghorn, P.A.; Jackson, M.R.; Gouverneur, V.; Vallis, K.A., 2016:
Targeting telomerase with radiolabeled inhibitors

Da Pozzo, E.; Giacomelli, C.; Barresi, E.; Costa, B.; Taliani, S.; Passetti, F.Da.Settimo.; Martini, C., 2016:
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection

Boland, K.; Flanagan, L.; McCawley, N.; Pabari, R.; Kay, E.W.; McNamara, D.A.; Murray, F.; Byrne, A.T.; Ramtoola, Z.; Concannon, Cín.G.; Prehn, J.H.M., 2017:
Targeting the 19S proteasomal subunit, Rpt4, for the treatment of colon cancer

Popovics, P.; Frigo, D.E.; Schally, A.V.; Rick, F.G., 2015:
Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer

Anderson, D.J.; Le Moigne, R.; Djakovic, S.; Kumar, B.; Rice, J.; Wong, S.; Wang, J.; Yao, B.; Valle, E.; Kiss von Soly, S.; Madriaga, A.; Soriano, F.; Menon, M-Kamala.; Wu, Z.Yong.; Kampmann, M.; Chen, Y.; Weissman, J.S.; Aftab, B.T.; Yakes, F.Michael.; Shawver, L.; Zhou, H-Jie.; Wustrow, D.; Rolfe, M., 2016:
Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis

Goda, J.S.; Pachpor, T.; Basu, T.; Chopra, S.; Gota, V., 2017:
Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers

Shimura, T., 2016:
Targeting the AKT/cyclin D1 pathway to overcome intrinsic and acquired radioresistance of tumors for effective radiotherapy

Ahmed, M.; Wang, F.; Levin, A.; Le, C.; Eltayebi, Y.; Houghton, M.; Tyrrell, L.; Barakat, K., 2016:
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA

Li, M.; Jiang, L.; Yan, L.; Yang, J., 2016:
Targeting the Achilles' heel of adult living donor liver transplant: Corner-sparing sutures with mucosal eversion technique of biliary anastomosis

Soin, A.; Pahari, H.; Goja, S.; Bhangui, P.; Rastogi, A., 2017:
Targeting the Achilles' heel of adult living donor liver transplant: Corner-sparing sutures with mucosal eversion technique of biliary anastomosis

Albrecht, M.H.; De Cecco, C.N.; Schoepf, U.Joseph.; Spandorfer, A.; Eid, M.; De Santis, D.; Varga-Szemes, A.; van Assen, M.; von Knebel-Doeberitz, P.L.; Tesche, C.; Puntmann, V.O.; Nagel, E.; Vogl, T.J.; Nance, J.W., 2018:
Dual-energy CT of the heart current and future status

van Soest, R.J.; de Morrée, E.S.; Kweldam, C.F.; de Ridder, C.M.A.; Wiemer, E.A.C.; Mathijssen, R.H.J.; de Wit, R.; van Weerden, W.M., 2016:
Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer

Ryan, C.J., 2018:
Targeting the Androgen Receptor: Remaining questions and future directions

Agathanggelou, A.; Weston, V.J.; Perry, T.; Davies, N.J.; Skowronska, A.; Payne, D.T.; Fossey, J.S.; Oldreive, C.E.; Wei, W.; Pratt, G.; Parry, H.; Oscier, D.; Coles, S.J.; Hole, P.S.; Darley, R.L.; McMahon, M.; Hayes, J.D.; Moss, P.; Stewart, G.S.; Taylor, A.Malcolm.R.; Stankovic, T., 2016:
Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants

Vestal, R.D.; LaJeunesse, D.R.; Taylor, E.W., 2016:
Targeting the Atypical Chemokine Receptor ACKR3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization

Rivero-Ríos, P.; Madero-Pérez, Jús.; Fernández, Bén.; Hilfiker, S., 2016:
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson's Disease

Wu, Y-Jin.; Guernon, J.; Yang, F.; Snyder, L.; Shi, J.; Mcclure, A.; Rajamani, R.; Park, H.; Ng, A.; Lewis, H.; Chang, C.; Camac, D.; Toyn, J.H.; Ahlijanian, M.K.; Albright, C.F.; Macor, J.E.; Thompson, L.A., 2016:
Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents

Hurley, K.A.; Santos, T.M.A.; Nepomuceno, G.M.; Huynh, V.; Shaw, J.T.; Weibel, D.B., 2016:
Targeting the Bacterial Division Protein FtsZ

Moschetta, M.; Kawano, Y.; Podar, K., 2017:
Targeting the Bone Marrow Microenvironment

Msaouel, P.; Galeas, J.Nahun.; Boiles, A.Recio.; Ruiz, R.Rancier.; Koutsilieris, M., 2016:
Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer

Marban, Céline.; Forouzanfar, F.; Ait-Ammar, A.; Fahmi, F.; El Mekdad, H.; Daouad, F.; Rohr, O.; Schwartz, C., 2016:
Targeting the Brain Reservoirs: Toward an HIV Cure

Miller, S.M.; Goulet, D.R.; Johnson, G.L., 2017:
Targeting the Breast Cancer Kinome

Müller, S., 2018:
Targeting the Bromome: are we there yet?

Lim, S.Yin.; Yuzhalin, A.E.; Gordon-Weeks, A.N.; Muschel, R.J., 2017:
Targeting the CCL2-CCR2 signaling axis in cancer metastasis

Louveau, A.; Nerrière-Daguin, Véronique.; Vanhove, B.; Naveilhan, P.; Neunlist, M.; Nicot, A.; Boudin, Hélène., 2016:
Targeting the CD80/CD86 costimulatory pathway with CTLA4-Ig directs microglia toward a repair phenotype and promotes axonal outgrowth

Bowers, L.W.; deGraffenried, L.A., 2015:
Targeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient Population

Gallo, A.; Jang, S-Ing.; Ong, H.Ling.; Perez, P.; Tandon, M.; Ambudkar, I.; Illei, G.; Alevizos, I., 2017:
Targeting the Ca(2+) Sensor STIM1 by Exosomal Transfer of Ebv-miR-BART13-3p is Associated with Sjögren's Syndrome

Cipolletta, E.; Rusciano, M.Rosaria.; Maione, A.Serena.; Santulli, G.; Sorriento, D.; Del Giudice, C.; Ciccarelli, M.; Franco, A.; Crola, C.; Campiglia, P.; Sala, M.; Gomez-Monterrey, I.; De Luca, N.; Trimarco, B.; Iaccarino, G.; Illario, M., 2016:
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy

Zhang, L.; Huang, H., 2017:
Targeting the Cancer Biomarker CD47: A Review on the Diverse Mechanisms of the CD47 Pathway in Cancer Treatment

Neugut, A.I.; Gross, C.P., 2016:
Targeting the Cancer Moonshot

Weber, K.T.; Díez, J., 2018:
Targeting the Cardiac Myofibroblast Secretome to Treat Myocardial Fibrosis in Heart Failure

Pobbati, A.V.; Han, X.; Hung, A.W.; Weiguang, S.; Huda, N.; Chen, G-Ying.; Kang, C.; Chia, C.San.Brian.; Luo, X.; Hong, W.; Poulsen, A., 2016:
Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy

To, J.; Surya, W.; Torres, J., 2016:
Targeting the Channel Activity of Viroporins

Benada, J.; Macurek, L., 2016:
Targeting the Checkpoint to Kill Cancer Cells

Huber, K.B.G.; Uteshev, V.V.; Pauly, J.R., 2017:
Targeting the Cholinergic System for Neuroprotection and/or Enhancement of Functional Recovery Following Neurotrauma

de Brito Ximenes, P.; Beltrão, E.Isidoro.Carneiro.; Macêdo, D.Patrícia.Cerqueira.; Buonafina, M.Daniela.Silva.; de Lima-Neto, R.Gonçalves.; Neves, R.Pereira., 2016:
Targeting the Cryptococcus neoformans var. grubii cell wall using lectins: study of the carbohydrate-binding domain

Abdel-Magid, A.F., 2016:
Targeting the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein for the Treatment of Cystic Fibrosis

Ortiz, D.; Forquer, I.; Boitz, J.; Soysa, R.; Elya, C.; Fulwiler, A.; Nilsen, A.; Polley, T.; Riscoe, M.K.; Ullman, B.; Landfear, S.M., 2017:
Targeting the Cytochrome bc1 Complex of Leishmania Parasites for Discovery of Novel Drugs

Huang, J.; Burston, J.J.; Li, L.; Ashraf, S.; Mapp, P.I.; Bennett, A.J.; Ravipati, S.; Pousinis, P.; Barrett, D.A.; Scammell, B.E.; Chapman, V., 2016:
Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis Pain

Song, L.; Zhang, Z.; Hu, R.; Cheng, J.; Li, L.; Fan, Q.; Wu, N.; Gan, J.; Zhou, M.; Liu, Z., 2016:
Targeting the D1-N-methyl-D-aspartate receptor complex reduces L-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's rats

O'Connor, M.J., 2016:
Targeting the DNA Damage Response in Cancer

Stewart, E.; Goshorn, R.; Bradley, C.; Griffiths, L.M.; Benavente, C.; Twarog, N.R.; Miller, G.M.; Caufield, W.; Freeman, B.B.; Bahrami, A.; Pappo, A.; Wu, J.; Loh, A.; Karlström, Åsa.; Calabrese, C.; Gordon, B.; Tsurkan, L.; Hatfield, M.Jason.; Potter, P.M.; Snyder, S.E.; Thiagarajan, S.; Shirinifard, A.; Sablauer, A.; Shelat, A.A.; Dyer, M.A., 2015:
Targeting the DNA repair pathway in Ewing sarcoma

Dobrowsky, R.T., 2017:
Targeting the Diabetic Chaperome to Improve Peripheral Neuropathy

Esparís-Ogando, A.; Montero, J.Carlos.; Arribas, Jín.; Ocaña, A.; Pandiella, A., 2016:
Targeting the EGF/HER Ligand-Receptor System in Cancer

Stothert, A.R.; Fontaine, S.N.; Sabbagh, J.J.; Dickey, C.A., 2016:
Targeting the ER-autophagy system in the trabecular meshwork to treat glaucoma

Zhang, D.; Bergsneider, M.; Wang, M.B.; Heaney, A.P., 2016:
Targeting the ERK pathway for the treatment of Cushing's disease

Ozaki, K-Ichi.; Awazu, M.; Tamiya, M.; Iwasaki, Y.; Harada, A.; Kugisaki, S.; Tanimura, S.; Kohno, M., 2016:
Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes

Hensel, T.; Giorgi, C.; Schmidt, O.; Calzada-Wack, J.; Neff, F.; Buch, T.; Niggli, F.K.; Schäfer, B.W.; Burdach, S.; Richter, Günther.H.S., 2016:
Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma

Tancredi, R.; Zambelli, A.; DaPrada, G.A.; Fregoni, V.; Pavesi, L.; Riccardi, A.; Burdach, S.; Grohar, P.J.; D'Incalci, M., 2015:
Targeting the EWS-FLI1 transcription factor in Ewing sarcoma

Lampel, A.; Bram, Y.; Ezer, A.; Shaltiel-Kario, R.; Saad, J.S.; Bacharach, E.; Gazit, E., 2016:
Targeting the Early Step of Building Block Organization in Viral Capsid Assembly

Cheung, C.M.Gemmy.; Wong, T.Y., 2015:
Targeting the Effect of VEGF in Diabetic Macular Edema

Katzman, M.A.; Furtado, M.; Anand, L., 2016:
Targeting the Endocannabinoid System in Psychiatric Illness

Riedl, S.J.; Pasquale, E.B., 2016:
Targeting the Eph System with Peptides and Peptide Conjugates

Tognolini, M.; Lodola, A., 2016:
Targeting the Eph-ephrin System with Protein-Protein Interaction (PPI) Inhibitors

Choe, M.C.; Valino, H.; Fischer, J.; Zeiger, M.; Breault, J.; McArthur, D.L.; Leung, M.; Madikians, A.; Yudovin, S.; Lerner, J.T.; Giza, C.C., 2016:
Targeting the Epidemic: Interventions and Follow-up Are Necessary in the Pediatric Traumatic Brain Injury Clinic

Neuschwander-Tetri, B.A., 2015:
Targeting the FXR nuclear receptor to treat liver disease

Levy, C., 2016:
Targeting the Farnesoid X Receptor in Patients With Cholestatic Liver Disease

Calmon-Hamaty, F.; Audo, R.; Combe, B.; Morel, J.; Hahne, M., 2016:
Targeting the Fas/FasL system in Rheumatoid Arthritis therapy: Promising or risky?

Elkhodiry, M.A.; Husseini, G.A.; Velluto, D., 2017:
Targeting the Folate Receptor: Effects of Conjugating Folic Acid to DOX Loaded Polymeric Micelles

Abdel-Magid, A.F., 2016:
Targeting the Follicle Stimulating Hormone Receptor (FSHR) To Treat Fertility Disorders